DERIVATIVES OF GLP-1 ANALOGS

Abstract: The present invention relates to derivatives of GLP-1 analogs having a lipophilic substituent. The derivatives of GLP-1 analogs of the present invention have a protracted profile of action.

Description: 1 DERIVATIVES OF GLP-1 ANALOGS FIELD OF THE INVENTION The present invention relates to novel derivatives of human glucagon-like peptide-1 (GLP-1) and fragments thereof and analogues of such fragments which have a protracted profile of action and to methods of making and using them. BACKGROUND OF THE INVENTION Peptides are widely used in medical practice, and since they can be produced by re- combinant DNA technology it can be expected that their importance will increase also in the years to come. When native peptides or analogues thereof are used in therapy it is generally found that they have a high clearance. A high clearance of a therapeutic agent is inconvenient in cases where it is desired to maintain a high blood level thereof over a prolonged period of time since repeated administrations will then be necessary. Examples of peptides which have a high clearance are: ACTH, corticotropin-releasing factor, angiotensin, calcitonin, insulin, glucagon, glucagon-like peptide-1 , glucagon-like peptide-2, insulin-like growth factor-1 , insulin-like growth factor-2, gastric inhibitory peptide, growth hormone-releasing factor, pituitary adenylate cyclase activating peptide, secretin, enterogastrin, somatostatin, somatotropin, somatomedin, parathyroid hormone, thrombopoietin, erythropoietin, hypothalamic releasing factors, prolactin, thyroid stimulating hormones, endorphins, enkephalins, vasopressin, oxytocin, opiods and analogues thereof, superoxide dismutase, interferon, asparaginase, arginase, arginine deaminase, adenosine deaminase and ribonuclease. In some cases it is possible to influence the release profile of peptides by applying suitable pharmaceutical compositions, but this approach has various shortcomings and is not generally applicable. The hormones regulating insulin secretion belong to the so-called enteroinsular a- xis, designating a group of hormones, released from the gastrointestinal mucosa in response to the presence and absorption of nutrients in the gut, which promote an early and potentiated release of insulin. The enhancing effect on insulin secretion, the so-called incretin effect, is probably essential for a normal glucose tolerance. Many of the gastrointestinal hormones, including gastrin and secretin (cholecystokinin is not insulinotropic in man), are insulinotropic, but the only physiologically important ones, those that are responsible for the incretin effect, are the glucose-dependent insulinotropic polypeptide, GIP, and glucagon-like peptide- 1 (GLP-1). Because of its insulinotropic effect, GIP, isolated in 1973 (1) immediately attracted considerable interest among diabetologists. However, numerous investigations carried 2 out during the following years clearly indicated that a defective secretion of GIP was not involved in the pathogenesis of insulin dependent diabetes mellitus (IDDM) or non insulin- dependent diabetes mellitus (NIDDM) (2). Furthermore, as an insulinotropic hormone, GIP was found to be almost ineffective in NIDDM (2). The other incretin hormone, GLP-1 is the most potent insulinotropic substance known (3). Unlike GIP, it is surprisingly effective in stimulating insulin secretion in NIDDM patients. In addition, and in contrast to the other insulinotropic hormones (perhaps with the exception of secretin) it also potently inhibits glucagon secretion. Because of these actions it has pronounced blood glucose lowering effects particularly in patients with NIDDM. GLP-1 , a product of the proglucagon (4), is one of the youngest members of the se- cretin-VIP family of peptides, but is already established as an important gut hormone with regulatory function in glucose metabolism and gastrointestinal secretion and metabolism (5). The glucagon gene is processed differently in the pancreas and in the intestine. In the pancreas (9), the processing leads to the formation and parallel secretion of 1) glucagon itself, occupying positions 33-61 of proglucagon (PG); 2) an N-terminal peptide of 30 amino acids (PG (1-30)) often called glicentin-related pancreatic peptide, GRPP (10, 11); 3) a hexapepti- de corresponding to PG (64-69); 4) and, finally, the so-called major proglucagon fragment (PG (72-158)), in which the two glucagon-like sequences are buried (9). Glucagon seems to be the only biologically active product. In contrast, in the intestinal mucosa, it is glucagon that is buried in a larger molecule, while the two glucagon-like peptides are formed separately (8). The following products are formed and secreted in parallel: 1) glicentin, corresponding to PG (1-69), with the glucagon sequence occupying residues Nos. 33-61 (12); 2) GLP- 1 (7-36)amide (PG (78-107))amide (13), not as originally believed PG (72-107)amide or 108, which is inactive). Small amounts of C-terminally glycine-extended but equally bioactive GLP-1 (7-37), (PG (78-108)) are also formed (14); 3) intervening peptide-2 (PG (111- 122)amide) (15); and 4) GLP-2 (PG (126-158)) (15, 16). A fraction of glicentin is cleaved further into GRPP (PG (1-30)) and oxyntomodulin (PG (33-69)) (17, 18). Of these peptides, GLP-1 , has the most conspicuous biological activities. Being secreted in parallel with glicentin/enteroglucagon, it follows that the many studies of enteroglucagon secretion (6, 7) to some extent also apply to GLP-1 secretion, but GLP-1 is metabolised more quickly with a plasma half-life in humans of 2 min (19). Carbohydrate or fat-rich meals stimulate secretion (20), presumably as a result of direct interaction of yet unabsorbed nutrients with the microvilli of the open-type L-cells of the gut mucosa. En- 3 docrine or neural mechanisms promoting GLP-1 secretion may exist but have not yet been demonstrated in humans. The incretin function of GLP-1 (29-31) has been clearly illustrated in experiments with the GLP-1 receptor antagonist, exendin 9-39, which dramatically reduces the incretin effect elicited by oral glucose in rats (21 , 22). The hormone interacts directly with the β-cells via the GLP-1 receptor (23) which belongs to the glucagon VIP/calcitonin family of G-protein- coupled 7-transmembrane spanning receptors. The importance of the GLP-1 receptor in regulating insulin secretion was illustrated in recent experiments in which a targeted disruption of the GLP-1 receptor gene was carried out in mice. Animals homozygous for the disruption had greatly deteriorated glucose tolerance and fasting hyperglycaemia, and even heterozygous animals were glucose intolerant (24). The signal transduction mechanism (25) primarily involves activation of adenylate cyclase, but elevations of intracellular Ca2 + are also essential (25, 26). The action of the hormone is best described as a potentiation of glucose stimulated insulin release (25), but the mechanism that couples glucose and GLP-1 stimula- tion is not known. It may involve a calcium-induced calcium release (26, 27). As already mentioned, the insulinotropic action of GLP-1 is preserved in diabetic β-cells. The relation of the latter to its ability to convey "glucose competence" to isolated insulin-secreting cells (26, 28), which respond poorly to glucose or GLP-1 alone, but fully to a combination of the two, is also not known. Equally importantly, however, the hormone also potently inhibits glucagon secretion (29). The mechanism is not known, but seems to be paracrine, via neighbouring insulin or somatostatin cells (25). Also the glucagonostatic action is glucose-dependent, so that the inhibitory effect decreases as blood glucose decreases. Because of this dual effect, if the plasma GLP-1 concentrations increase either by increased secretion or by exogenous infusion the molar ratio of insulin to glucagon in the blood that reaches the liver via the portal circulation is greatly increased, whereby hepatic glucose production decreases (30). As a result blood glucose concentrations decrease. Because of the glucose dependency of the insulinotropic and glucagonostatic actions, the glucose lowering effect is self-limiting, and the hormone, therefore, does not cause hypoglycaemia regardless of dose (31). The effects are preserved in patients with diabetes mellitus (32), in whom infusions of slightly supraphysiolo- gical doses of GLP-1 may completely normalise blood glucose values in spite of poor metabolic control and secondary failure to sulphonylurea (33). The importance of the glucagonostatic effect is illustrated by the finding that GLP-1 also lowers blood glucose in type-1 diabetic patients without residual β-cell secretory capacity (34). 4 In addition to its effects on the pancreatic islets, GLP-1 has powerful actions on the gastrointestinal tract. Infused in physiological amounts, GLP-1 potently inhibits pentagastrin- induced as well as meal-induced gastric acid secretion (35, 36). It also inhibits gastric emptying rate and pancreatic enzyme secretion (36). Similar inhibitory effects on gastric and pancreatic secretion and motility may be elicited in humans upon perfusion of the ileum with carbohydrate- or lipid-containing solutions (37, 38). Concomitantly, GLP-1 secretion is greatly stimulated, and it has been speculated that GLP-1 may be at least partly responsible for this so-called "ileal-brake" effect (38). In fact, recent studies suggest that, physiologically, the ileal-brake effects of GLP-1 may be more important than its effects on the pancreatic islets. Thus, in dose response studies GLP-1 influences gastric emptying rate at infusion rates at least as low as those required to influence islet secretion (39). GLP-1 seems to have an effect on food intake. Intraventricular administration of GLP-1 profoundly inhibits food intake in rats (40, 42). This effect seems to be highly specific. Thus, N-terminally extended GLP-1 (PG 72-107)amide is inactive and appropriate doses of the GLP-1 antagonist, exendin 9-39, abolish the effects of GLP-1 (41). Acute, peripheral administration of GLP-1 does not inhibit food intake acutely in rats (41 , 42). However, it remains possible that GLP-1 secreted from the intestinal L-cells may also act as a satiety signal. Not only the insulinotropic effects but also the effects of GLP-1 on the gastrointesti- nal tract are preserved in diabetic patients (43), and may help curtailing meal-induced glucose excursions, but, more importantly, may also influence food intake. Administered intravenously, continuously for one week, GLP-1 at 4 ng/kg/min has been demonstrated to dramatically improve glycaemic control in NIDDM patients without significant side effects (44). The peptide is fully active after subcutaneous administration (45), but is rapidly degraded mainly due to degradation by dipeptidyl peptidase IV-like enzymes (46, 47). The amino acid sequence of GLP-1 is given i.a. by Schmidt et al. (Diabetologia 28 704-707 (1985). Human GLP-1 is a 37 amino acid residue peptide originating from preprog- lucagon which is synthesised, i.a. in the L-cells in the distal ileum, in the pancreas and in the brain. Processing of preproglucagon to GLP-1 (7-36)amide, GLP-1(7-37) and GLP-2 occurs mainly in the L-cells. Although the interesting pharmacological properties of GLP-1 (7-37) and analogues thereof have attracted much attention in recent years only little is known about the structure of these molecules. The secondary structure of GLP-1 in micelles has been described by Thorton et al. (Biochemistry 33 3532-3539 (1994)), but in normal solution, GLP-1 is considered a very flexible molecule. Surprisingly, we found that derivatisation of this relati- 5 vely small and very flexible molecule resulted in compounds whose plasma profile were highly protracted and still had retained activity. GLP-1 and analogues of GLP-1 and fragments thereof are useful i.a. in the treatment of Type 1 and Type 2 diabetes and obesity. WO 87/06941 discloses GLP-1 fragments, including GLP-1(7-37), and functional derivatives thereof and to their use as an insulinotropic agent. WO. 90/11296 discloses GLP-1 fragments, including GLP-1(7-36), and functional derivatives thereof which have an insulinotropic activity which exceeds the insulinotropic activity of GLP-1 (1-36) or GLP-1(1-37) and to their use as insulinotropic agents. The amino acid sequence of GLP-1 (7-36) and GLP-1 (7-37) is: 7 8 9 10 11 12 13 14 15 16 17 His-Ala-Glu-Gly-Thr- Phe-Thr-Ser-Asp-Val -Ser- 18 19 20 21 22 23 24 25 26 27 28 Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-P e- 29 30 31 32 33 34 35 36 Ile-Ala-Trp-Leu-Val -Lys-Gly-Arg-X ( I ) wherein X is NH 2 for GLP-1 (7-36) and X is Gly for GLP-1 (7-37). WO 91/11457 discloses analogues of the active GLP-1 peptides 7-34, 7-35, 7-36, and 7-37 which can also be useful as GLP-1 moieties. Unfortunately, the high clearance limits the usefulness of these compounds. Thus there still is a need for improvements in this field. Accordingly, it is an object of the present inven- tion to provide derivatives of GLP-1 and analogues thereof which have a protracted profile of action relative to GLP-1(7-37). It is a further object of the invention to provide derivatives of GLP-1 and analogues thereof which have a lower clearance than GLP-1(7-37). It is a further object of the invention to provide a pharmaceutical composition comprising a compound of the invention and to use a compound of the invention to provide such a composition. Also, it is an object of the present invention to provide a method of treating insulin dependent and non- insulin dependent diabetes mellitus. References. 6 1. Pederson RA. Gastric Inhibitory Polypeptide. In Walsh JH, Dockray GJ (eds) Gut peptides: Biochemistry and Physiology. Raven Press, New York 1994, pp. 217259. 2. Krarup T. Immunoreactive gastric inhibitory polypeptide. Endocr Rev 1988;9:122-134. 3. ørskov C. Glucagon-like peptide-1 , a new hormone of the enteroinsular axis. Diabeto- logia 1992; 35:701-711. 4. Bell Gl, Sanchez-Pescador R, Laybourn PJ, Najarian RC. Exon duplication and divergence in the human preproglucagon gene. Nature 1983; 304: 368-371. 5. Hoist JJ. Glucagon-like peptide-1 (GLP-1) - a newly discovered Gl hormone. Gastro- enterology 1994; 107: 1848-1855. 6. Hoist JJ. Gut glucagon, enteroglucagon, gut GLI, glicentin - current status. Gastroen- terology 1983;84:1602-1613. 7. Hoist JJ, ørskov C. Glucagon and other proglucagon-derived peptides. In Walsh JH, Dockray GJ, eds. Gut peptides: Biochemistry and Physiology. Raven Press, New York, pp. 305-340, 1993. 8. ørskov C, Hoist JJ, Knuhtsen S, Baldissera FGA, Poulsen SS, Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from the pig small intestine, but not pancreas. Endocrinology 1986;119:1467-1475. 9. Hoist JJ, Bersani M, Johnsen AH, Kofod H, Hartmann B, ørskov C. Proglucagon pro- cessing in porcine and human pancreas. J Biol Chem, 1994; 269: 18827-1883. 10. Moody AJ, Hoist JJ, Thim L, Jensen SL. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas. Nature 1981 ; 289: 514-516. 11. Thim L, Moody AJ, Purification and chemical characterisation of a glicentin-related pancreatic peptide (proglucagon fragment) from porcine pancreas. Biochim Biophys Acta 1982;703:134-141. 12. Thim L, Moody AJ. The primary structure of glicentin (proglucagon). Regul Pept 1981 ;2:139-151. 13. ørskov C, Bersani M, Johnsen AH, Højrup P, Hoist JJ. Complete sequences of glucagon-like peptide- 1 (GLP-1) from human and pig small intestine. J. Biol. Chem. 1989;264:12826-12829. 14. ørskov C, Rabenhøj L, Kofod H, Wettergren A, Hoist JJ. Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 1991 ; 43: 535-539. 7 15. Buhl T, Thim L, Kofod H, ørskov C, Harling H, & Hoist JJ: Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. J. Biol. Chem. 1988;263:8621-8624. 16. ørskov C, Buhl T, Rabenhøj L, Kofod H, Hoist JJ: Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine. FEBS letters, 1989;247:193-106. 17. Hoist JJ. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin. Biochem J. 1980;187:337-343. 18. Bataille D, Tatemoto K, Gespach C, Jornvall H, Rosselin G, Mutt V. Isolation of gluca- gon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterisation of the peptide. FEBS Lett 1982;146:79-86. 19. ørskov C, Wettergren A, Hoist JJ. The metabolic rate and the biological effects of GLP-1 7-36amide and GLP-1 7-37 in healthy volunteers are identical. Diabetes 1993;42:658-661. 20. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V. Glucagon-like pepti- de-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993; 138: 159-166. 21. Kolligs F, Fehmann HC, Gόke R, Goke B. Reduction of the incretin effect in rats by the glucagon-like peptide-1 receptor antagonist exendin (9-39)amide. Diabetes 1995; 44: 16-19. 22. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei M, Bloom SR. Glucagon-like peptide-1 is a physiological incretin in rat. J. Clin. Invest. 1995; 95: 417-421. 23. Thorens B. Expression cloning of the pancreatic b cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci 1992;89:8641-4645. 24. Scrocchi L, Auerbach AB, Joyner AL, Drucker DJ. Diabetes in mice with targeted disruption of the GLP-1 receptor gene. Diabetes 1996; 45: 21 A. 25. Fehmann HC, Gόke R, Gϋke B. Cell and molecular biology of the incretin hormones glucagon-like peptide-l (GLP-1) and glucose-dependent insulin releasing polypeptide (GIP). Endocrine Reviews, 1995; 16: 390-410. 26. Gromada J, Dissing S, Bokvist K, Renstrom E, Frøkjaer-Jensen J, Wulff BS, Rorsman P. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting bTC3-cells by enhancement of intracellular calcium mobilisation. Diabetes 1995; 44: 767-774. 8 27. Holz GG, Leech CA, Habener JF. Activation of a cAMP-regulated Ca 2+ -signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem, 1996; 270: 17749-17759. 28. Holz GG, Kϋhltreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 1993;361 :362-365. 29. ørskov C, Hoist JJ, Nielsen OV: Effect of truncated glucagon-like peptide-1 (proglucagon 78-107 amide) on endocrine secretion from pig pancreas, antrum and stomach. Endocrinology 1988;123:2009-2013. 30. Hvidberg A, Toft Nielsen M, Hilsted J, ørskov C, Hoist JJ. Effect of glucagon-like pep- tide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism 1994;43:104-108. 31. Qualmann C, Nauck M, Hoist JJ, ørskov C, Creutzfeldt W. Insulinotropic actions of intravenous glucagon-like peptide-1 [7-36 amide] in the fasting state in healthy subjects. Acta Diabetologica, 1995; 32: 13-16. 32. Nauck MA, Heimesaat MM, ørskov C, Hoist JJ, Ebert R, Creutzfeldt W. Preserved incretin activity of GLP-1 (7-36amide) but not of synthetic human GIP in patients with type 2-diabetes mellitus. J Clin Invest 1993;91 :301-307. 33. Nauck MA, Kleine N, ørskov C, Hoist JJ, Willms B, Creutzfeldt W. Normalisation of fasting hyperglycaemia by exogenous GLP-1 (7-36amide) in type 2-diabetic patients. Diabetologia 1993;36:741-744. 34. Creutzfeldt W, Kleine N, Willms B, ørskov C, Hoist JJ, Nauck MA. Glucagonostatic actions and reduction of fasting hyperglycaemia by exogenous glucagon-liem, pepti- de-1 (7-36amide) in type I diabetic patients. Diabetes Care 1996; 19: 580-586. 35. Schjoldager BTG, Mortensen PE, Christiansen J, ørskov C, Hoist JJ. GLP-1 (glucagon-like peptide-1) and truncated GLP-1 , fragments of human proglucagon, inhibit gastric acid secretion in man. Dig. Dis. Sci. 1989; 35:703-708. 36. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Hoist JJ. Truncated GLP-1 (proglucagon 72-107amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993;38:665-673. 37. Layer P, Hoist JJ, Grandt D, Goebell H: Heal release of glucagon-like peptide-1 (GLP-1): association with inhibition of gastric acid in humans. Dig Dis Sci 1995; 40: 1074-1082. 9 38. Layer P, Hoist JJ. GLP-1 : A humoral mediator of the ileal brake in humans? Digestion 1993; 54: 385-386. 39. Nauck M, Ettler R, Niedereichholz U, ørskov C, Hoist JJ, Schmiegel W. Inhibition of gastric emptying by GLP-1(7-36 amide) or (7-37): effects on postprandial glycaemia and insulin secretion. Abstract. Gut 1995; 37 (suppl. 2): A124. 40. Schick RR, vorm Walde T, Zimmermann JP, Schusdziarra V, Classen M. Glucagon-like peptide 1 - a novel brain peptide involved in feeding regulation, in Ditschuneit H, Gries FA, Hauner H, Schusdziarra V, Wechsler JG (eds.) Obesity in Europe. John Libbey & Company ltd, 1994; pp. 363-367. 41. Tang-Christensen M, Larsen PJ, Gόke R, Fink-Jensen A, Jessop DS, Møller M, Sheikh S. Brain GLP-1 (7-36) amide receptors play a major role in regulation of food and water intake. Am. J. Physiol., 1996, in press. 42. Turton MD, O'Shea D, Gunn I, Beak SA, Edwards CMB, Meeran K, et al. A role for glucagon-like peptide-1 in the regulation of feeding. Nature 1996; 379: 69-72. 43. Willms B, Werner J, Creutzfeldt W, ørskov C, Hoist JJ, Nauck M. Inhibition of gastric emptying by glucagon-like peptide-1 (7-36 amide) in patients with type-2-diabetes mellitus. Diabetologia 1994; 37, suppl.1 : A118. 44. Larsen J, Jallad N, Damsbo P. One-week continuous infusion of GLP-1(7-37) improves glycaemic control in NIDDM. Diabetes 1996; 45, suppl. 2: 233A. 45. Ritzel R, ørskov C, Hoist JJ, Nauck MA. Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response relationships. Diabetologia 1995; 38: 720-725. 46. Deacon CF, Johnsen AH, Hoist JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 1995; 80: 952-957. 47. Deacon CF, Nauck MA, Toft-Nielsen M, Pridal L, Willms B, Hoist JJ. 1995. Both subcutaneous and intravenously administered glucagon-like peptide-1 are rapidly degraded from the amino terminus in type II diabetic patients and in healthy subjects. Diabetes 44: 1126-1131. SUMMARY OF THE INVENTION The present invention relates to derivatives of GLP-1 analogues of formula I: 7 8 9 10 11 12 13 14 15 16 17 His-Xaa-Xaa-Gly-Xaa-Phe-Thr-Xaa-Asp-Xaa-Xaa- 10 18 19 20 21 22 23 24 25 26 27 28 Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Phe- 29 30 31 32 33 34 35 36 37 38 Ile-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa 39 40 41 42 43 44 45 Xaa -Xaa- Xaa - Xaa - Xaa - Xaa - Xaa ( I ) wherein Xaa at posit ion 8 is Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at posit ion 9 is Glu, Asp, or Lys, Xaa at posit ion 11 i. s Thr, Ala, Gly, Ser, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 14 i s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 16 i s Val, Ala, Gly, Ser, Thr, Leu, lie, Tyr, Glu, Asp, or Lys, Xaa at positi ion 17 i s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 18 i s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 19 i s Tyr, Phe, Trp, Glu, Asp, or Lys, Xaa at positi ion 20 i s Leu, Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 21 i s Glu, Asp, or Lys, Xaa at positi ion 22 i s Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 23 i s Gin, Asn, Arg, Glu, Asp, or Lys, Xaa at positi ion 24 i s Ala, Gly, Ser, Thr, Leu, lie, Val, Arg, Glu, Asp, or Lys, Xaa at positi ion 25 i s Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at positi ion 26 i s Lys, Arg, Gin, Glu, Asp, or His, Xaa at posit ion 27 i s Glu, Asp, or Lys, Xaa at posit tiion 30 i s Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at posit tiion 31 i s Trp, Phe, Tyr, Glu, Asp, or Lys, Xaa at posit tiion 32 i s Leu, Gly, Ala, Ser, Thr, lie, Val, Glu, Asp, or Lys, Xaa at posit tiion 33 i s Val, Gly, Ala, Ser, Thr, Leu, lie, Glu, Asp, or Lys, Xaa at posit tiion 34 i s Lys, Arg, Glu, Asp, or His, Xaa at posit tiion 35 i s Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at posit t iion 36 i s Arg, Lys, Glu, Asp, or His, 11 Xaa at position 37 is Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, or is deleted, Xaa at position 38 is Arg, Lys, Glu, Asp, or His, or is deleted, Xaa at position 39 is Arg, Lys, Glu, Asp, or His, or is deleted, Xaa at position 40 is Asp, Glu, or Lys, or is deleted, Xaa at position 41 is Phe, Trp, Tyr, Glu, Asp, or Lys, or is deleted, Xaa at position 42 is Pro, Lys, Glu, or Asp, or is deleted, Xaa at position 43 is Glu, Asp, or Lys, or is deleted, Xaa at position 44 is Glu, Asp, or Lys, or is deleted, and Xaa at position 45 is Val, Glu, Asp, or Lys, or is deleted, or (a) a C-1-6-ester thereof, (b) amide, C-1-6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that (i) when the amino acid at position 37, 38, 39, 40, 41 , 42, 43 or 44 is deleted, then e- ach amino acid downstream of the amino acid is also deleted, (ii) the derivative of the GLP-1 analog contains only one or two Lys, (iii) the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, (iv) the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. DETAILED DESCRIPTION OF THE INVENTION A simple system is used to describe fragments and analogues of GLP-1. For example, Gly 8 -GLP-1 (7-37) designates a fragment of GLP-1 formally derived from GLP-1 by deleting the amino acid residues Nos. 1 to 6 and substituting the naturally occurring amino acid residue in position 8 (Ala) by Gly. Similarly, Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37) designates GLP-1(7- 37) wherein the ε-amino group of the Lys residue in position 34 has been tetradecanoylated. Where reference in this text is made to C-terminally extended GLP-1 analogues, the amino acid residue in position 38 is Arg unless otherwise indicated, the optional amino acid residue in position 39 is also Arg unless otherwise indicated and the optional amino acid residue in positi- on 40 is Asp unless otherwise indicated. Also, if a C-terminally extended analogue extends to position 41 , 42, 43, 44 or 45, the amino acid sequence of this extension is as in the corresponding sequence in human preproglucagon unless otherwise indicated. GLP-1 Analogs 12 The present invention relates to derivatives of GLP-1 analogues. The derivatives of the invention have interesting pharmacological properties, in particular they have a more protracted profile of action than the parent peptides. In the present text, the designation "an analogue" is used to designate a peptide whe- rein one or more amino acid residues of the parent peptide have been substituted by another amino acid residue. The total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. Preferably, the number of different amino acids is five. More preferably, the number of different amino acids is four. Even more preferably, the number of different amino acids is three. Even more preferably, the number of different amino acids is two. Most preferably, the number of different amino acids is one. In order to determine the number of different amino acids, one should compare the amino acid sequence of the derivative of the GLP-1 analog of the present invention with the corresponding native GLP-1. For example, there are two different amino acids between the deriva- tive Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-40) and the correspondiing native GLP-1 (i.e., GLP-1(7-40)). The differences are located at positions 8 and 26. Similarly, there is only different amino acid between the derivative Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-40) and the corresponding native GLP-1. The difference is located at position 34. The derivatives of the GLP-1 analogs of the present invention have only one or two Lys. The ε-amino group of one or both Lys is substituted with a lipophilic substituent, Preferably, the derivatives of the GLP-1 analogs of the present invention have only one Lys. In a more preferred embodiment, there is only one Lys which is located at the carboxy terminus of the derivative of the GLP-1 analogs. In an even more preferred embodiment, the derivatives of the GLP-1 analogs of the present invention have only one Lys and Glu or Asp is adjacent to Lys. In a preferred embodiment, the amino acids at positions 37-45 are absent. In another preferred embodiment, the amino acids at positions 38-45 are absent. In another preferred embodiment, the amino acids at positions 39-45 are absent. In another preferred embodiment, Xaa at position 8 is Ala, Gly, Ser, Thr, or Val. In another preferred embodiment, Xaa at position 9 is Glu. In another preferred embodiment, Xaa at position 11 is Thr. In another preferred embodiment, Xaa at position 14 is Ser. In another preferred embodiment, Xaa at position 16 is Val. In another preferred embodiment, Xaa at position 17 is Ser. 13 n another preferred embodiment Xaa at positi ion 18 i s Ser, Lys, Glu, or Asp. n another preferred embodiment Xaa at positi ion 19 i s Tyr, Lys, Glu, or Asp. n another preferred embodiment Xaa at positi ion 20 i s Leu,, Lys, Glu, or Asp. n another preferred embodiment Xaa at positi ion 21 i s Glu, Lys, or Asp. n another preferred embodiment Xaa at positi ion 22 i s Gly, Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 23 i s Gin, Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 24 i s Ala, Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 25 i s Ala, Glu, Asp, or Lys. n another preferred embodiment Xaa at positi ion 26 i s Lys, Glu, Asp, or Arg. n another preferred embodiment Xaa at posit ion 27 i s Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 30 i s Ala, Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 31 i s Trp, Glu, Asp, or Lys. n another preferred embodiment Xaa at posit ion 32 i s Leu, Glu, Asp, or Lys. n another preferred embodiment Xaa at positi ion 33 i s Val, Glu, Asp, or Lys. n another preferred embodiment Xaa at positi ion 34 i is Lys, Arg, Glu, or Asp. n another preferred embodiment Xaa at positi ion 35 i s Gly, Glu, Asp, or Lys. In another preferred embodiment, Xaa at posit t iio* n 36 i s Arg, Lys, Glu, or Asp. In another preferred embodiment, Xaa at position 37 is Gly, Glu, Asp, or Lys. In another preferred embodiment, Xaa at position 38 is Arg, or Lys, or is deleted. In another preferred embodiment, Xaa at position 39 is deleted. In another preferred embodiment, Xaa at position 40 is deleted. In another preferred embodiment, Xaa at position 41 is deleted. In another preferred embodiment, Xaa at position 42 is deleted. In another preferred embodiment, Xaa at position 43 is deleted. In another preferred embodiment, Xaa at position 44 is deleted. In another preferred embodiment, Xaa at position 45 is deleted. In another preferred embodiment, Xaa at position 26 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). In another preferred embodiment, Xaa at position 26 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-37). In another preferred embodiment, Xaa at position 26 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). In another preferred embodiment, Xaa at position 34 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). 14 In another preferred embodiment, Xaa at position 34 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-37). In another preferred embodiment, Xaa at position 34 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). In another preferred embodiment, Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). In another preferred embodiment, Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-37). In another preferred embodiment, Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). In another preferred embodiment, Xaa at positions 26 and 34 is Arg, Xaa at position 38 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 36 is Lys, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-37). In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 36 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 38 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). In another preferred embodiment, Xaa at position 18, 23 or 27 is Lys, and Xaa at positions 26 and 34 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). In another preferred embodiment, Xaa at position 18, 23 or 27 is Lys, and Xaa at po- sitions 26 and 34 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-37). In another preferred embodiment, Xaa at position 18, 23 or 27 is Lys, and Xaa at positions 26 and 34 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). 15 In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 37- 45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 38- 45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-37). In another preferred embodiment, Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 39- 45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). Derivatives The term "derivative" is defined as a modification of one or more amino acid residues of a peptide by chemical means, either with or without an enzyme, e.g., by alkylation, acylation, ester formation, or amide formation. Lipophilic Substituents To obtain a satisfactory protracted profile of action of the GLP-1 derivative, the lipophilic substituent attached to the GLP-1 moiety preferably comprises 4-40 carbon atoms, in particular 8-25 carbon atoms. The lipophilic substituent may be attached to an amino group of the GLP-1 moiety by means of a carboxyl group of the lipophilic substituent which forms an amide bond with an amino group of the amino acid residue to which it is attached. In one preferred embodiment of the invention, the lipophilic substituent is attached to the GLP-1 moiety by means of a spacer in such a way that a carboxyl group of the spacer forms an amide bond with an amino group of the GLP-1 moiety. In a preferred embodiment, the spacer is an α,ω-amino acid Examples of suitable spacers are succinic acid, Lys, Glu or Asp, or a dipeptide such as Gly-Lys. When the spacer is succinic acid, one carboxyl group thereof may form an amide bond with an amino group of the amino acid residue, and the other carboxyl group thereof may form an amide bond with an amino group of the lipophilic substituent. When the spacer is Lys, Glu or Asp, the carboxyl group thereof may form an amide bond with an amino group of the amino acid residue, and the amino group thereof may form an amide bond with a carboxyl group of the lipophilic substituent. When Lys is used as the spacer, a further spacer may in some instances be inserted between the ε-amino group of Lys and the lipophilic substituent. In one preferred embodiment, such a further spacer is succinic acid which forms an amide bond with the ε-amino group of Lys and with an amino group 16 present in the lipophilic substituent. In another preferred embodiment such a further spacer is Glu or Asp which forms an amide bond with the ε-amino group of Lys and another amide bond with a carboxyl group present in the lipophilic substituent, that is, the lipophilic substituent is a N ε -acylated lysine residue. Other preferred spacers are N ε -(γ-L-glutamyl), N ε -(β-L-asparagyl), N ε -glycyl, and N ε -(α-(γ-aminobutanoyl). In another preferred embodiment of the present invention, the lipophilic substituent has a group which can be negatively charged. One preferred group which can be negatively charged is a carboxylic acid group. In a further preferred embodiment, the lipophilic substituent comprises from 4 to 40 carbon atoms, more preferred from 8 to 25 carbon atoms. In a further preferred embodiment, the lipophilic substituent is attached to the parent peptide by means of a spacer which is an unbranched alkane α,ω-dicarboxyiic acid group having from 1 to 7 methylene groups, preferably two methylene groups which spacer forms a bridge between an amino group of the parent peptide and an amino group of the lipophilic sub- stituent. In a further preferred embodiment, the lipophilic substituent is attached to the parent peptide by means of a spacer which is an amino acid residue except Cys, or a dipeptide such as Gly-Lys. In the present text, the expression "a dipeptide such as Gly-Lys" is used to designate a dipeptide wherein the C-terminal amino acid residue is Lys, His or Trp, preferably Lys, and wherein the N-terminal amino acid residue is selected from the group comprising Ala, Arg, Asp, Asn, Gly, Glu, Gin, lie, Leu, Val, Phe and Pro. In a further preferred embodiment, the lipophilic substituent is attached to the parent peptide by means of a spacer which is an amino acid residue except Cys, or is a dipeptide such as Gly-Lys and wherein an amino group of the parent peptide forms an amide bond with a carboxylic group of the amino acid residue or dipeptide spacer, and an amino group of the amino acid residue or dipeptide spacer forms an amide bond with a carboxyl group of the lipophilic substituent. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which comprises a partially or completely hydrogenated cyclo- pentanophenathrene skeleton. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a straight-chain or branched alkyl group. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is the acyl group of a straight-chain or branched fatty acid. 17 In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is an acyl group selected from the group comprising CH 3 (CH 2 ) n CO-, wherein n is an integer from 4 to 38, preferably an integer from 4 to 24, more preferred selected from the group comprising CH 3 (CH 2 ) 6 CO-, CH 3 (CH 2 ) 8 CO-, CH 3 (CH 2 ) 10 CO-, CH 3 (CH 2 ) 12 CO-, CH 3 (CH 2 ) 14 CO-, CH 3 (CH 2 ) 16 CO-, CH 3 (CH 2 ) 18 CO-, CH 3 (CH 2 ) 20 CO- and CH 3 (CH 2 ) 22 CO-. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is an acyl group of a straight-chain or branched alkane α,ω-dicarboxylic acid. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is an acyl group selected from the group comprising HOOC(CH 2 ) m CO-, wherein m is an integer from 4 to 38, preferably an integer from 4 to 24, more preferred selected from the group comprising HOOC(CH 2 ) 14 CO-, HOOC(CH 2 ) 16 CO-, HOOC(CH 2 ) 18 CO-, HOOC(CH 2 ) 20 CO- and HOOC(CH 2 ) 22 CO-. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula CH 3 (CH 2 ) p ((CH 2 ) q COOH)CHNH- CO(CH 2 ) 2 CO-, wherein p and q are integers and p+q is an integer of from 8 to 33, preferably from 12 to 28. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula CH 3 (CH 2 ) r CO- NHCH(COOH)(CH 2 ) 2 CO-, wherein r is an integer of from 10 to 24. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula CH 3 (CH 2 ) s CO- NHCH((CH 2 ) 2 COOH)CO-, wherein s is an integer of from 8 to 24. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula COOH(CH 2 ) t CO- wherein t is an integer of from 8 to 24. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH- CO(CH 2 ) u CH 3 , wherein u is an integer of from 8 to 18. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula CH 3 (CH 2 ) v CO-NH-(CH 2 ) z -CO, wherein n is an integer of from 8 to 24 and z is an integer of from 1 to 6. 18 In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH- COCH((CH 2 ) 2 COOH)NH-CO(CH 2 ) w CH 3 , wherein w is an integer of from 10 to 16. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH- CO(CH 2 ) 2 CH(COOH)NH-CO(CH 2 ) x CH 3 , wherein x is an integer of from 10 to 16. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH- CO(CH 2 ) 2 CH(COOH)NHCO(CH 2 ) y CH 3 , wherein y is zero or an integer of from 1 to 22. In a further preferred embodiment, the present invention relates to a GLP-1 derivative having a lipophilic substituent which can be negatively charged. Such a lipophilic substituent can for example be a substituent which has a carboxyl group. In a further preferred embodiment the present invention relates to a GLP-1 derivative of formula I provided that a) when no spacer is present the lipophilic substituent is not selected from: tetradecanoyl, ω-carboxynonadecanoyl, lithocholyl, ω-carboxytridecanoyl , ω-carboxyheptadecanoyl, ω-carboxyundecanoyl, ω-carboxy heptanoy I , ω-carboxypentadecanoyl, 7-deoxycholoyl, choloyl, hexadecanoyl, and b) the GLP-1 derivative of formula I is not selected from: Glu 22 ' 23 ' 30 Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 2326 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Lys 26 ' 3 -bis(N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1(7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, 19 Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1(7-38)-OH. In a further preferred embodiment the present invention relates to a GLP-1 derivative of formula I provided that it is not selected from: Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-37), Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-37), Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37), Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37)-OH, Lys 26 ' 34 bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38)-OH, Arg 34 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptadecanoyl))-GLP-1(7-37)-OH, Arg 26,3 Lys 36 (N ε .( ω _ car boχyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 263 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-38)-OH, Lys 2634 bis(N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-36)-OH, Arg^Lys 26 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 263 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Lys 2634 bis(N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH , Arg^Lys 26 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 34 Lys 26 (N ε -lithocholyl)-GLP-1 (7-37)-OH, Glu 22 ' 23 ' 30 Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 23 ' 26 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, 20 Lys 26 ' 34 -bis(N ε -(ω-carboxytridecanoyl))-GLP-1 (7-37)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1(7-38)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N°-hexadecanoyl)))-GLP-1(7-37)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N E -(ω-carboxypentadecanoyl))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, Arg 1823 ' 26 ' 3 34 Lys 38 (N ε -hexadecanoyl)-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1 (7-38)-OH, Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Lys 3 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-37); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-38); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1 (7-38); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); 21 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 3 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-40); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-40); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-40); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-40); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36); Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1 (7-36); Gly 8 Lys 6 (N ε -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-36); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36); Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-35); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-35); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-35); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-35); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-35); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1 (7-35); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-35); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Lys 26 ' 34 -bis(N f -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-36)amide; Gly 8 Lys 34 (N c -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Lys^N etradecanoy Arg^-GLP-l (7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37); 22 Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -tetradecanoyl)-GLP-1 (7-38); Gly 8 Arg 634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-40); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-40); Arg MιM Lys M (N etradecanoyl)-GLP-1 (7-40); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-40); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Lys 3 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Lys 26,3 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); 23 Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26ι34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-40); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 3 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Lys 26,34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 :34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); 24 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP- 1(7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 3 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-40); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxy nonadecanoyl))-G LP- 1 (7-40) ; Gly 8 Arg 6 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-37); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-38); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); 25 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-39); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N e -(7-deoxycholoyl))-GLP-1(7-40); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-40); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-40); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-36); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-36); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36); Arg 6 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-35); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-35); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-35); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-35); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-35); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-35); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; 26 Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Lys 26 (N ε -(choloyl))-GLP-1 (7-37); Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 26 ' 34-bis(N ε -(choloyl))-GLP-1(7-37); Arg 6 Lys 34 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-38); Arg 634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Arg 6 ' 34 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N ε -(choloyl))-GLP-1 (7-38); Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Lys 6 ' 34 -bis(N ε -(choioyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(choloyl))-GLP-1(7-39); Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-39); 27 Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-39); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-40); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-40); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-40); Arg 26 ' 3 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Gly 8 Arg 263 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 26 (N ε -(choloyl))-GLP-1 (7-40); Lys 34 (N ε -(choloyl))-GLP-1 (7-40); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-40); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-40); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-40); Lys 26 (N ε -(choloyl))-GLP-1(7-36); Lys 34 (N ε -(choloyl))-GLP-1 (7-36); Lys 2634 -bis(N ε -(choloyl))-GLP-1 (7-36); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-36); Arg 6 Lys 34 (N ε -(choloyl))-GLP-1(7-36); Lys 26 (N ε -(choloyl))-GLP-1(7-35); Lys 34 (N ε -(choloyl))-GLP-1 (7-35); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-35); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-35); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-35); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-35); Lys 26 (N ε -(choloyl))-GLP-1(7-36)amide; Lys 34 (N ε -(choloyl))-GLP-1(7-36)amide; Lys 2634 -bis(N ε -(choloyl))-GLP-1 (7-36)amide; 28 Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 3 -bis(N ε -(choloyl))-GLP-1(7-36)amide; Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-36)amide; Gly β Arg 26 Lys 34 (N B -(choloyl))-GLP-1 (7-37); Arg 26 ,Lys 34 (N ε -(octanoyl)) GLP-1 (7-37)-OH; Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-37); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-38); Lys 6 (N ε -(choloyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(choloyl))-GLP-1 (7-38); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-39); 29 Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-39); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-40); Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-40); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1 (7-40); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-40); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-40); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-40); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-40); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-35); Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-35); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-35); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-35); 30 Gly 8 Lys 634 -bis(N ε -(lithocholoyl))-GLP-1(7-35); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-35); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-36)amide; Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-37); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-37); Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-37); Arg 2634 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Arg 2634 Lys 38 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-39); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-39); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-40); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-40); Gly 8 Lys 6 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-40); Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-40) and Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-40). Other Derivatives 31 The derivatives of GLP-1 analogues of the present invention may be in the form one or more of (a) a C-1-6-ester, (b) an amide, C-1-6-alkylamide, or C-1-6-dialkylamide, and (c) a pharmaceutical salt. In a preferred embodiment, the derivatives of GLP-1 analogues are in the form of an acid addition salt or a carboxylate salt, most preferably in the form of an acid addition salt. Preferred Derivatives of GLP-1 Analogues of the Present Invention In a further preferred embodiment, a parent peptide for a derivative of the invention is Arg 26 -GLP-1(7-37); Arg 34 -GLP-1(7-37); Lys 36 -GLP-1(7-37); Arg 2634 Lys 36 -GLP-1(7-37); Arg 26 - 34 Lys 38 GLP-1(7-38); Arg 2634 Lys 39 -GLP- 1(7-39); Arg^Lys^-GLP- 1(7-40); Arg 26 Lys 36 -GLP- 1(7-37); Arg 34 Lys 36 -GLP-1(7-37); Arg 26 Lys 39 -GLP- 1(7-39); Arg 34 Lys 40 -GLP-1(7-40); Arg 26 ' 34 Lys 36 ' 39 -GLP-1(7-39); Arg 26 ' 3 Lys 36 ' 40 -GLP-1(7-40); Gly 8 Arg 26 -GLP-1(7-37); Gly'Αrg 34 - GLP-1(7-37); Gly 8 Lys 36 -GLP-1(7-37); Gly 8 Arg 2634 Lys 36 -GLP- 1(7-37); Gly'Αrg^Lys∞-GLP-l (7- 39); Gly 8 Arg 2634 Lys 40 -GLP-1(7-40); Gly 8 Arg 26 Lys 36 -GLP-1 (7-37); Gly 8 Arg 34 Lys 36 -GLP-1(7-37); Gly 8 Arg 26 Lys 39 -GLP-1(7-39); Gly 8 Arg 34 Lys 40 -GLP-1 (7-40); Gly^rg∞^Lys∞^-GLP- 1(7-39); or G | y 8 Arg 26,3 4[ _ ys 36, 4 0. GL p. 1 (y^Q) In a further preferred embodiment, a parent peptide for a derivative of the invention is: Arg 6 - 34 Lys 38 GLP-1(7-38); Arg 263 Lys 39 GLP-1(7-39); Arg 26 ' 34 Lys 40 GLP-1(7-40); Arg 2634 Lys 41 GLP-1(7-41); Arg 2634 Lys 2 GLP-1(7-42); Arg 2634 Lys 3 GLP-1(7-43); Arg 2634 Lys 44 GLP-1 (7-44); Arg 26 ' 34 Lys 5 GLP-1(7-45); Arg 26 Lys 38 GLP-1(7-38); Arg 34 Lys 38 GLP-1(7-38); Arg 2634 Lys 36 ' 38 GLP-1 (7-38); Arg 26 ' 34 Lys 38 GLP-1(7-38); Arg 26 Lys 39 GLP-1 (1-39); Arg^Lys GLP-I -SΘ); Arg 2634 Lys 36 ' 39 GLP-1 (1-39); Arg 26 Lys 39 GLP-1(7-39); Arg 3 Lys 39 GLP-1(7-39); 32 Arg 634 Lys 36 ' 39 GLP-1(7-39); In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is selected from the group comprising Arg 6 -GLP-1 (7-37), Arg 34 - GLP-1(7-37), Lys 36 -GLP-1(7-37), Arg 2634 Lys 36 -GLP-1(7-37), Arg 26 Lys 36 -GLP-1(7-37), Arg 34 Lys 36 -GLP-1 (7-37), Gly 8 Arg 26 -GLP-1(7-37), Gly 8 Arg 34 -GLP-1 (7-37), Gly 8 Lys 36 -GLP-1 (7- 37), Gly 8 Arg 2634 Lys 36 -GLP-1 (7-37), Gly 8 Arg 26 Lys 36 -GLP-1 (7-37) and Gly β Arg 34 Lys 36 -GLP-1 (7- 37). In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is selected from the group comprising Arg 26 Lys 38 -GLP-1(7-38), Arg 263 Lys 38 -GLP-1 (7-38), Arg 2634 Lys 36 ' 38 -GLP-1(7-38), Gly 8 Arg 26 Lys 38 -GLP-1 (7-38) and Gly 8 Arg 26 ' 34 Lys 36 ' 38 -GLP-1(7-38). In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is selected from the group comprising Arg 6 Lys 39 -GLP-1(7-39), Arg 634 Lys 3639 -GLP-1(7-39), Gly 8 Arg 26 Lys 39 -GLP-1 (7-39) and Gly 8 Arg 26 ' 34 Lys 36 ' 39 -GLP-1 (7-39). In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is selected from the group comprising Arg^Lys^-GLP-l (7-40), Arg 26 ' 34 Lys 36 ' 0 -GLP-1 (7-40), GI/Arg^Lys^-GLP-l (7-40) and Gly 8 Arg 26 ' 34 Lys 36 ' 40 -GLP-1(7-40). In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is: Arg 26 -GLP-1(7-36); Arg^-GLP- 1(7-36); Arg 2634 Lys 36 -GLP-1(7-36); Arg 26 -GLP-1(7-36)amide; Arg 34 -GLP-1(7-36)amide; Arg 2634 Lys 36 -GLP-1 (7-36)amide; Arg 26 -GLP-1(7-37); Arg^-GLP-I (7- 37); Arg 2634 Lys 36 -GLP-1(7-37); Arg 26 -GLP- 1(7-38); Arg^-GLP-I (7-38) ; Arg 2634 Lys 38 GLP-1 (7- 38); Arg 26 -GLP-1 (7-39); Arg^-GLP-I (7-39); Arg 2634 Lys 39 -GLP-1(7-39); Gly 8 Arg 6 -GLP-1 (7-36); Gly 8 Arg 34 -GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -GLP-1(7-36); Gly 8 Arg 26 -GLP- 1(7-36)amide; GI/Arg^-GLP-l (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -GLP-1(7-36)amide; Gly 8 Arg 26 - GLP-1(7-37); Gly 8 Arg 34 -GLP-1(7-37); Gly β Arg 26 " 34 Lys 3β -GLP-1 (7-37); Gly 8 Arg 26 -GLP- 1 (7-38); Gly 8 Arg 34 -GLP-1(7-38) ; Gly 8 Arg 2634 Lys 38 GLP-1 (7-38); Gly 8 Arg 26 -GLP-1(7-39); Gly^rg^-GLP- 1 (7-39); Gly 8 Arg 2634 Lys 39 -GLP-1 (7-39); Val 8 Arg 26 -GLP-1 (7-36); Val 8 Arg 34 -GLP-1(7-36); Val 8 Arg 2634 Lys 36 -GLP-1 (7-36); Val 8 Arg 26 -GLP- 1 (7-36)amide; Val β Arg 34 -GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -GLP-1 (7-36)amide; Val 8 Arg 26 - GLP-1(7-37); Val 8 Arg 34 -GLP-1(7-37); Val 8 Arg 26 ' 34 Lys 36 -GLP-1(7-37); Val 8 Arg 26 -GLP-1 (7-38); Val 8 Arg 34 -GLP-1(7-38); Val 8 Arg 26 ' 3 Lys 38 GLP-1 (7-38); Val 8 Arg 26 -GLP-1 (7-39); Val β Arg M -GLP- 1 (7-39); Val 8 Arg 2634 Lys 39 -GLP-1 (7-39); 33 Ser 8 Arg 26 -GLP-1 (7-36); Ser 8 Arg 34 -GLP-1(7-36); Ser β Arg aw4 Lys 3β -GLP-1 (7-36); Sei^Arg^-GLP- 1(7-36)amide; Sei^Arg^-GLP-l (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -GLP-1(7-36)amide; SeHΑrg 26 - GLP-1(7-37); Ser 8 Arg 34 -GLP-1(7-37); Ser 8 Arg 2M Lys 3β -GLP-1(7-37); Ser 8 Arg 26 -GLP-1(7-38); Ser 8 Arg 34 -GLP-1(7-38) ; SeH'Arg^Lys GLP-l (7-38); SeHΑrg∞-GLP-l (7-39); Sei^Arg^-GLP- 1(7-39); Ser 8 Arg 2634 Lys 39 -GLP-1(7-39); Thr 8 Arg 26 -GLP-1 (7-36); Thr £ Arg 34 -GLP-1(7-36); Thi^Arg^Lys -GLP- 1 (7-36); Th^Arg^-GLP- 1(7-36)amide; Thr^Arg^-GLP-l (7-36)amide; Thr 8 Arg 2634 Lys 36 -GLP-1(7-36)amide; Thi^Arg 26 - GLP-1(7-37); Thr 8 Arg 34 -GLP-1 (7-37); Thr 8 Arg 2634 Lys 36 -GLP-1 (7-37); Thr 8 Arg 26 -GLP-1(7-38); Thr 8 Arg 34 -GLP-1(7-38) ; Thr 8 Arg 26 ' 34 Lys 38 GLP-1(7-38); Thr^Arg^-GLP- 1(7-39); Thr'Arg^-GLP- 1 (7-39); Thi^Arg ^Lys^-GLP-l (7-39); Va Glu Arg ^Lys^-GLP-l (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -GLP-1 (7-36)amide; VaPGIu^Arg∞^Lys^GLP-l (7-37); VafGlu^Arg^Lys∞GLP-l (7-38); Val 8 Glu 38 Arg 2634 Lys 39 - GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -GLP-1 (7-36)amide; Va Glu∞Arg^Lys^GLP-l (7-37); VaPGIu^Arg^Lys GLP-l (7-38); Va Glu∞Arg∞^Lys 39 - GLP-1(7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -GLP-1 (7-36); VafAsp Arg ^Lys -GLP-l (7-36)amide; Val 8 Asp 36 Arg 6 ' 34 Lys 37 GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 GLP-1 (7-38); VaPAsp∞Arg ^Lys 39 - GLP-1 (7-39); Va Asp Arg^Lys∞-GLP-l (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 GLP-1 (7-38); Va Asp∞Arg^Lys 39 - GLP-1(7-39); Se^Glu Arg^Lys∞-GLP-l (7-36); Sei^Glu∞Arg∞^Lys^-GLP-l (7-36)amide; Se^Glu Arg^Lys^GLP-l (7-37); Ser^Glu^Arg∞^Lys^GLP-l (7-38); Sei^Glu∞Arg^Lys 39 - GLP-1 (7-39); Sei^Glu Arg^Lys^-GLP-l (7-36); Sei^Glu Arg ^Lys∞-GLP-l (7-36)amide; Sei^Glu∞Arg^Lys^GLP-l (7-37); Se^Glu^Arg^Lys∞GLP-l (7-38); Sei^Glu∞Arg^Lys 39 - GLP-1(7-39); Sei^Asp∞Arg^Lys∞-GLP-l (7-36); Ser'Αsp∞Arg^Lys^-GLP-l (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 GLP-1 (7-38); Ser'Αsp Arg^Lys 39 - GLP-1 (7-39); Sei^Asp∞Arg ^Lys -GLP-l (7-36); Ser'Αsp^Arg^Lys -GLP-l (7-36)amide; SeHWsp Arg^Lys^GLP-l (7-37); Ser'Asp^Arg^Lys∞GLP-l (7-38); Sei sp∞Arg^Lys 39 - GLP-1(7-39); Thi^Glu∞Arg∞^Lys∞-GLP-l (7-36); Thr^Glu Arg ^Lys∞-GLP-l (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 GLP-1 (7-37); Thi^Glu^Arg^Lys^GLP-l (7-38); Thi^Glu∞Arg^Lys 39 - GLP-1 (7-39); Th^Glu Arg^Lys^-GLP-l (7-36); Thi^Glu Arg^Lys -GLP-l (7-36)amide; 34 ,39 Thr β Glu 36 Arg 2β,34 Lys 37 GLP-1 (7-37); Th^Glu^Arg ^Lys∞GLP-l (7-38); Thi^Glu∞Arg^Lys 3 GLP-1(7-39); Thr'Αsp Arg^Lys∞-GLP-l (7-36); Th Asp∞Arg^Lys∞-GLP-l (7-36)amide; Thr β Asp 36 Arg 2β,34 Lys 37 GLP-1 (7-37); Thi^Asp^Arg∞^Lys∞GLP-l (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 - GLP-1(7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -GLP-1(7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -GLP-1(7-36)amide; Th^Asp Arg ^Lys^GLP-l (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 GLP-1 (7-38); Thr'Αsp Arg^Lys 39 - GLP-1(7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 3 Lys 38 GLP-1 (7-38); GI Glu∞Arg^Lys 39 - GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -GLP-1(7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -GLP-1(7-36)amide; Gly β Glu 3β Arg 2β - 34 Lys 37 GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 GLP-1 (7-38); Gly β Glu 3β Arg 2W4 Lys 3β - GLP-1(7-39); GI Asp∞Arg^Lys∞-GLP-l (7-36); Gly B Asp 35 Arg 2β - 34 Lys 3β -GLP-1 (7-36)amide; Gly β Asp 3β Arg 2M4 Lys 37 GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 GLP-1 (7-38); Gly^sp Arg^Lys 39 - GLP-1(7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -GLP-1(7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 GLP-1 (7-37); GI Asp^Arg^Lys^GLP-l (7-38); Gly B Asp 3β Arg W4 Lys 39 - GLP-1(7-39); Arg 2634 Lys 18 -GLP-1 (7-36); Arg 2634 Lys 8 -GLP-1 (7-36)amide; Arg^Lys^GLP-l (7-37); Arg 2634 Lys 8 GLP-1 (7-38); Gly β Asp 19 Aιg 2W4 Lys 1β -GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 18 -GLP-1(7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 8 -GLP-1 (7-36)amide; Gly β Asp 1β Arg 2W Lys 1β GLP-1 (7-37); Gly 8 Asp 9 Arg 2634 Lys 18 GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 GLP-1(7-38); Arg 2634 Lys 23 -GLP-1 (7-36); Arg 2634 Lys 23 -GLP-1 (7-36)amide; Arg 2634 Lys 23 GLP-1 (7-37); Arg 2634 Lys 23 GLP-1 (7-38); GI Asp^Arg^Lys∞-GLP-l (7-36); Gly 8 Asp 22 Arg 2634 Lys 23 -GLP-1 (7- 36); Gly 8 Asp 24 Arg 26 ' 34 Lys 23 -GLP-1(7-36)amide; Gly 8 Asp 22 Arg 26 ' 34 Lys 23 -GLP-1 (7-36)amide; GI/Asp^Arg^Lys^GLP-l (7-37); Gly'Αsp^Arg ^Lys∞GLP-l (7-38); Gly 8 Asp 22 Arg 26 ' 34 Lys 23 GLP-1(7-38); Arg 26,3 4| _ ys 27 _ GLp . 1 (7 _ 36) . Arg 2634 Lys 27 -GLP-1 (7-36)amide; Arg 2634 Lys 27 GLP-1 (7-37); Arg 2634 Lys 27 GLP-1 (7-38); Gly 8 Asp 28 Arg 2634 Lys 27 -GLP-1 (7-36); Gly'Αsp Arg^Lys^-GLP-l (7- 36); Gly 8 Asp 28 Arg 2634 Lys 27 -GLP-1(7-36)amide; Gly 8 Asp 26 Arg 26 ' 34 Lys 27 -GLP-1(7-36)amide; Gly 8 Asp 28 Arg 2634 Lys 27 GLP-1 (7-37); Gly 8 Asp 28 Arg 2634 Lys 27 GLP-1 (7-38); Gly 8 Asp 26 Arg 2634 Lys 27 GLP-1 (7-38); Arg 2634 Lys 18 -GLP-1 (7-36); Arg 2634 Lys 18 -GLP-1 (7-36)amide; Arg^Lys^GLP-l (7-37); Arg 2634 Lys 18 GLP-1 (7-38); VafAsp^Arg^Lys^-GLP-l (7-36); Val β Asp 17 Arg 2β,34 Lys 1β -GLP-1 (7- 35 36); Va Asp^Arg^Lys^-GLP-l (7-36)amide; Va Asp^Arg∞^Lys^-GLP-l (7-36)amide; Va Asp^Arg^Lys^GLP-l (7-37); Va Asp^Arg^Lys^GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 18 GLP-1(7-38); Arg∞^Lys -GLP-l (7-36); Arg 2634 Lys 23 -GLP-1 (7-36)amide; Arg 2634 Lys 23 GLP-1 (7-37); Arg 2634 Lys 23 GLP-1(7-38); Val 8 Asp 24 Arg 26 ' 34 Lys 23 -GLP-1(7-36); Va Asp Arg∞^Lys -GLP-l (7- 36); Val 8 Asp 24 Arg 2634 Lys 23 -GLP-1 (7-36)amide; Val 8 Asp 22 Arg 2634 Lys 23 -GLP-1 (7-36)amide; Val 8 Asp 24 Arg 2634 Lys 23 GLP-1 (7-37); VaPAsp^Arg^Lys∞GLP-l (7-38); Val 8 Asp 22 Arg 26 ' 34 Lys 23 GLP-1(7-38); Arg 2634 Lys 27 -GLP-1 (7-36); Arg 2634 Lys 7 -GLP-1 (7-36)amide; Arg 2634 Lys 27 GLP-1 (7-37); Arg 2W4 Lys 27 GLP-1 (7-38); Val 8 Asp 28 Arg 26 ' 34 Lys 27 -GLP-1(7-36); Val 8 Asp 26 Arg 2W4 Lys 27 -GLP-1 (7- 36); Va Asp^Arg ^Lys^-GLP-l (7-36)amide; Val 8 Asp 26 Arg 263 Lys 27 -GLP-1 (7-36)amide; Val 8 Asp 28 Arg 2634 Lys 27 GLP-1 (7-37); Val 8 Asp 28 Arg 26 ' 34 Lys 27 GLP-1 (7-38); Val 8 Asp 26 Arg 26 ' 34 Lys 27 GLP-1(7-38); Arg 2634 Lys 18 -GLP-1 (7-36); Arg 2634 Lys 18 -GLP-1 (7-36)amide; Arg 2634 Lys 18 GLP-1 (7-37); Arg 2634 Lys 18 GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 18 -GLP-1 (7-36); Sei^Asp^Arg∞^Lys^-GLP-l (7- 36); Sei^Asp^Arg^^Lys^-GLP-l (7-36)amide; Sei^Asp^Arg∞^Lys^-GLP-l (7-36)amide; SeHΑsp^Arg∞^Lys^GLP-l (7-37); Ser^Asp^Arg ^Lys^GLP-l (7-38); Ser 8 Asp 17 Arg 2634 Lys 18 GLP-1(7-38); Arg 2634 Lys 23 -GLP-1 (7-36); Arg 2634 Lys 23 -GLP-1 (7-36)amide; Arg 2634 Lys 23 GLP-1 (7-37); Arg 2634 Lys 23 GLP-1(7-38); Ser 8 Asp 24 Arg 26 ' 34 Lys 23 -GLP-1(7-36); Sei^Asp^Arg^Lys∞-GLP-l (7- 36); Sei sp^Arg^Lys -GLP-l (7-36)amide; Ser'Αsp^Arg^Lys -GLP-l (7-36)amide; Sei^Asp^Arg^Lys GLP-l (7-37); Sei^Asp^Arg ^Lys∞GLP-l (7-38); Ser 8 Asp 22 Arg 2634 Lys 23 GLP-1(7-38); Arg 2634 Lys 27 -GLP-1 (7-36); Arg 2634 Lys 27 -GLP-1 (7-36)amide; Arg 2634 Lys 27 GLP-1 (7-37); Arg 26 ' 34 Lys 27 GLP-1(7-38); Ser s Asp 28 Arg 2634 Lys 27 -GLP-1(7-36); Ser^Asp^Arg∞^Lys^-GLP-l (7- 36); Sei^Asp Arg^Lys^-GLP-l (7-36)amide; SerV p Arg^Lys^-GLP-l (7-36)amide; Ser'Wsp Arg^Lys^GLP-l (7-37); Ser 8 Asp 28 Arg 26 ' 34 Lys 27 GLP-1 (7-38); Ser 8 Asp 26 Arg 26 ' 34 Lys 27 GLP-1(7-38); Arg 2634 Lys 18 -GLP-1 (7-36); Arg 2634 Lys 18 -GLP-1 (7-36)amide; Arg 2634 Lys 8 GLP-1 (7-37); Arg 26 ' 34 Lys 18 GLP-1 (7-38); Thr 8 Asp 9 Arg 26 ' 34 Lys 18 -GLP-1(7-36); Thi^Asp^Arg^^Lys^-GLP-l (7- 36); Thi^Asp^Arg^Lys^-GLP-l (7-36)amide; Thi sp^Arg^Lys^-GLP-l (7-36)amide; Thή sp^Arg^Lys^GLP-l (7-37); Th^Asp^Arg ^Lys^GLP-l (7-38); Thr B Asp 17 Arg 263 Lys 18 GLP-1(7-38); 36 Arg 63 Lys 23 -GLP-1 (7-36); Arg 2634 Lys 23 -GLP-1 (7-36)amide; Arg 2634 Lys 23 GLP-1 (7-37); Arg 634 Lys 23 GLP-1 (7-38); Thr'Αsp^Arg^Lys -GLP-l (7-36); Thi^Asp Arg 26 ' 4 Lys 23 -GLP-1 (7- 36); Thr 8 Asp 24 Arg aM4 Lys 23 -GLP-1 (7-36)amide; Thr β Asp 22 A g 2W4 Lys 23 -GLP-1 (7-36)amide; Thr B Asp 24 Arg 2634 Lys 23 GLP-1 (7-37); Thr 8 Asp 24 Arg 26 ' 34 Lys 23 GLP-1 (7-38); Thr 8 Asp 22 Arg 26 ' 34 Lys 23 GLP-1 (7-38); Arg 2634 Lys 7 -GLP-1 (7-36); Arg 2634 Lys 27 -GLP-1 (7-36)amide; Arg 2634 Lys 27 GLP-1 (7-37); Arg 2634 Lys 27 GLP-1 (7-38); Thr 3 Asp 28 Arg 26 ' 34 Lys 27 -GLP-1 (7-36); Thi^Asp'^rg 2634 Lys 27 -GLP-1 (7- 36); Thi^Asp Arg^Lys^-GLP-l (7-36)amide; Th^Asp Arg^Lys^-GLP-l (7-36)amide; Thr 8 Asp 28 Arg 26 ' 34 Lys 27 GLP-1 (7-37); Thr β Asp 2β Arg 2β - 34 Lys 27 GLP-1 (7-38); Thi^Asp Arg^Lys^GLP-l (7-38). In a further preferred embodiment, the present invention relates to a GLP-1 derivative wherein the parent peptide is: Arg 26 Lys 36 -GLP-1(7-36); Arg^Lys∞-GLP- 1(7-36); Arg 26 Lys 36 -GLP-1(7-37); Arg^Lys -GLP-l (7- 37); Arg 26 Lys 37 -GLP-1(7-37); Arg^Lys^-GLP- 1(7-37); Arg 26 Lys 39 -GLP- 1(7-39); Arg^Lys∞-GLP- 1 (7-39); Arg β - 34 Lys 3β - 39 -GLP-1 (7-39); Arg 26 Lys 18 -GLP-1(7-36); Arg 34 Lys 18 -GLP-1 (7-36); Arg 26 Lys 18 GLP-1(7-37); Arg^Lys^GLP-l (7- 37); Arg 26 Lys 18 GLP-1(7-38); Arg 34 Lys 18 GLP-1 (7-38); Arg 26 Lys 18 GLP-1(7-39); Arg^Lys^GLP- 1(7-39); Arg 26 Lys 23 -GLP-1(7-36); Arg 34 Lys 23 -GLP-1(7-36); Arg 26 Lys 23 GLP-1(7-37); Arg M Lys 3 GLP-1 (7- 37); Arg 26 Lys 23 GLP-1(7-38); Arg 34 Lys 23 GLP-1(7-38); Arg 26 Lys 23 GLP-1(7-39); Arg^Lys GLP- 1(7-39); Arg 26 Lys 27 -GLP-1(7-36); Arg^Lys^-GLP- 1(7-36); Arg 26 Lys 27 GLP-1(7-37); Arg^Lys^GLP-l (7- 37); Arg 26 Lys 27 GLP-1(7-38); Arg^Lys^GLP- 1(7-38); Arg 26 Lys 27 GLP-1 (7-39); Arg^Lys^GLP- 1(7-39); Arg 26 ' 34 Lys 18 ' 36 -GLP-1(7-36); Arg 2634 Lys 18 GLP-1(7-37); Arg 2634 Lys 1837 GLP-1(7-37) Arg∞^Lys^∞GLP-l (7-38); Arg 263 Lys 18 ' 39 GLP-1 (7-39); Arg 2634 Lys 2336 -GLP-1 (7-36) Arg ^Lys GLP-l (7-37); Arg 2634 Lys 2337 GLP-1 (7-37); Arg 26 ' 34 Lys 2338 GLP-1 (7-38) Arg 2634 Lys 23 ' 39 GLP-1 (7-39); Arg ^Lys^-GLP-l (7-36); Arg 263 Lys 27 GLP-1 (7-37) Arg 2634 Lys 2737 GLP-1 (7-37); Arg^Lys^GLP-l (7-38); Arg^Lys^∞GLP-l (7-39); Gly 8 GLP-1 (7-36); Gly 8 GLP-1 (7-37); Gly 8 GLP-1 (7-38); Gly 8 GLP-1 (7-39) Gly 8 Arg 26 Lys 36 -GLP-1 (7-36); Gly^rg^Lys^-GLP-l (7-36); Gly 8 Arg 26 Lys 36 -GLP-1 (7-37); Gly'Αrg^Lys -GLP-l (7-37) Gly 8 Arg 26 Lys 37 -GLP-1 (7-37); Gly'Arg^Lys^-GLP-l (7-37); Gly 8 Arg 26 Lys 39 -GLP-1 (7-39) Gly'Αrg^Lys∞-GLP-l (7-39); Gly'Αrg^Lys∞∞-GLP-l (7-39); 37 Gly 8 Arg 26 Lys 18 -GLP-1 (7-36); GI Arg^Lys^-GLP-l (7-36); Gly 8 Arg 26 Lys 18 GLP-1 (7-37); GlyΑrglys^GLP-l (7-37); Gly 8 Arg 26 Lys 18 GLP-1 (7-38); Gly 8 Arg 34 Lys 18 GLP-1 (7-38); Gly 8 Arg 26 Lys 18 GLP-1 (7-39); GI Arg^Lys^GLP-l (7-39); Gly 8 Arg 26 Lys 23 -GLP-1 (7-36); Gly β Arg 34 Lys 23 -GLP-1 (7-36); Gly 8 Arg 26 Lys 23 GLP-1 (7-37); GI Arg^Lys^GLP-l (7-37); Gly 8 Arg 26 Lys 23 GLP-1 (7-38); GI Arg^Lys^GLP-l (7-38); Gly 8 Arg 26 Lys 23 GLP-1 (7-39); GI Arg^Lys∞GLP-l (7-39); Gly 8 Arg 26 Lys 27 -GLP-1 (7-36); GI Aig^Lys^-GLP-l (7-36); Gly 8 Arg 26 Lys 27 GLP-1 (7-37); GI Arg^Lys^GLP-l (7-37); Gly 8 Arg 6 Lys 27 GLP-1 (7-38); Gly 8 Arg 34 Lys 27 GLP-1 (7-38); Gly 8 Arg 26 Lys 27 GLP-1 (7-39); Gly^rg^Lys^GLP-l (7-39); G l y 8 Arg 26,3 4Lys i8,36 _ GLp _ 1 (7.35). QI Arg^Lys^GLP-l (7-37); Gly 8 Arg 2634 Lys 8 ' 37 GLP-1 (7-37) G|y 8 Arg 26,3 4Lys i8,38 GLP . 1 (7.33). QI Arg^Lys^∞GLP-l (7-39); Gly β Arg 2βl34 Lys 2Wβ -GLP-1 (7-36) G|y 8 Arg 26,3 |_ ys 23 GLp _ 1 (7.37). QI Arg^Lys^GLP-l (7-37); GI Arg^Lys∞^GLP-l (7-38) G l y 8 Arg 26,3 4Lys 23 . 39 GLp _ 1 (7.39). QI Arg^Lys^-GLP-l (7-36); Gly 8 Arg 2634 Lys 27 GLP-1 (7-37) G l y 8 Arg 26,3 4Lys 27,37 GLp . 1 (7.37). QI Arg∞^Lys^GLP-l (7-38); GI Arg^Lys^GLP-l (7-39); Val 8 GLP-1 (7-36); Val 8 GLP-1 (7-37); Val 8 GLP-1 (7-38); Val 8 GLP-1 (7-39) Val 8 Arg 26 Lys 36 -GLP-1 (7-36); Val β Arg 34 Lys 3β -GLP-1 (7-36); Val 8 Arg 26 Lys 36 -GLP-1 (7-37); Val β Arg 34 Lys 3β -GLP-1 (7-37) Val 8 Arg 26 Lys 37 -GLP-1 (7-37); Va Arg^Lys^-GLP-l (7-37); Val 8 Arg 26 Lys 39 -GLP-1 (7-39) VaPAr^Lys∞-GLP-l (7-39); Val 8 Arg 2634 Lys 36 ' 39 -GLP-1 (7-39); Val 8 Arg 26 Lys 18 -GLP-1 (7-36) VaPArg^Lys^-GLP-l (7-36); Val 8 Arg 26 Lys 18 GLP-1 (7-37); VaPArg^Lys^GLP-l (7-37); Val 8 Arg 26 Lys 18 GLP-1 (7-38); Val 8 Arg 34 Lys 18 GLP-1 (7-38); Val 8 Arg 26 Lys 18 GLP-1 (7-39); VaPArg^Lys^GLP-l (7-39); Val 8 Arg 26 Lys 23 -GLP-1 (7-36); Va Arg^Lys -GLP-l (7-36); Val 8 Arg 26 Lys 23 GLP-1 (7-37); Val'Arg^Lys∞GLP-l (7-37); Val 8 Arg 26 Lys 23 GLP-1 (7-38); VaPArg^Lys∞GLP-l (7-38); Val 8 Arg 26 Lys 23 GLP-1 (7-39); VaPArg^Lys^GLP-l (7-39); Val 8 Arg 26 Lys 27 -GLP-1 (7-36); Va Arg^Lys^-GLP-l (7-36); Val 8 Arg 26 Lys 27 GLP-1 (7-37); VaPArg^Lys^GLP-l (7-37); Val 8 Arg 6 Lys 27 GLP-1 (7-38); VaPArg^Lys^GLP-l (7-38); Val 8 Arg 26 Lys 27 GLP-1 (7-39); VaPArg^Lys^GLP-l (7-39); Val 8 Arg 2634 Lys 18 ' 36 -GLP-1 (7-36); VaPArg∞^Lys^GLP-l (7-37); Val β Aιg 2W4 Lys 1W7 GLP-1 (7-37) Val 8 Arg 2634 Lys 18 ' 38 GLP-1 (7-38); VaPArg^Lys^GLP-l (7-39); VaPArg^Lys^∞-GLP-l (7-36) Val 8 Arg 2634 Lys 23 GLP-1 (7-37); Val 8 Arg 2634 Lys 23 ' 37 GLP-1 (7-37); Val 8 Arg 2634 Lys 2338 GLP-1 (7-38) Val 8 Arg 2634 Lys 23 ' 39 GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 27 ' 36 -GLP-1 (7-36); Val 8 Arg 2634 Lys 27 GLP-1 (7-37) Va | 8 Arg 26,3 4Lys 27,37 GLp . 1 (7.37). vaPArg^Lys^GLP-l (7-38); Val 8 Arg 26 ' 34 Lys 2739 GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl GLP-1 (7-37). 38 In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -tetradecanoyl)- GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 2634 -bis(N ε - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl)- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys^N'-tetradecanoyl)- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,3 -bis(N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl)- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -tetradecanoyl)- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 2634 -bis(N ε - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1 (7-39). 39 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N 8 - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl)- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -tetradecanoyl)- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ' 34 -bis(N ε - tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N 6 - tetradecanoyl)-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl)- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys^N etradecanoyl)- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Glylys 34 ^- tetradecanoyl)-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-36). 40 In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -tetradecanoyl)- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -tetradecanoyl)- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 2634 -bis(N ε - tetradecanoyl)-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoyl)-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - tetradecanoyl)-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N 6 - tetradecanoyl)-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly'Αrg^Lys 34 ^ 6 - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - tetradecanoyl)Arg M -GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg^^Lys^N 6 - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε - tetradecanoyl)-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε - tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 38 (N ε - tetradecanoyl)-GLP-1 (7-38). 41 In a further preferred embodiment, the GLP-1 derivative is GI Arg^Lys^N'- tetradecanoyl)-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly^rg^Lys^N 6 - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-39); In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 28,34 Lys 36 (N ε - tetradecanoyl)-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26;34 Lys 36 (N ε - tetradecanoyl)-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε - tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - tetradecanoy Arg^-GLP-l (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 26 ' 34 Lys 36 (N ε - tetradecanoyl)-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly'Αrg^Lys 36 ^- tetradecanoyl)-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 6 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26,3 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP- 1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 2634 -bis(N ε -(ω- carboxynonadecanoy l))-GLP- 1 (7-37) . 42 In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(co- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 ;34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 2634 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). 43 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ' 3 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 2634 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 6 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε -(ω- carboxynonadecanoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1(7-37). 44 In a further preferred embodiment, the GLP-1 derivative is Arg 26 ' 34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl^Arg^-GLP-l (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26 ' 34 Lys 38 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 2634 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 2634 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). 45 In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(ω- carboxynonadecanoyl))Arg 34 -GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε -(ω- carboxynonadecanoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 3 (N ε -(7-deoxycholoyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(7-deoxycholoyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 2634 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 3 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-38). 46 In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(7-deoxycholoyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26;34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(7-deoxycholoyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,3 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(7-deoxycholoyl))- GLP-1(7-36). 47 In a further preferred embodiment, the GLP-1 derivative is Lys 26|34 -bis(N E -(7- deoxycholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ' 34 -bis(N ε -(7- deoxycholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7-deoxycholoyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 3 (N ε -(7-deoxycholoyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 26|34 -bis(N ε -(7- deoxycholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ' 34 -bis(N ε -(7- deoxycholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7- deoxycholoy JArg^-GLP-l (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoy JArg^-GLP-l (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-37). 48 In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(choloyl))- GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(choloyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (choloyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(choloyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7- deoxycholoyl))Arg 34 -GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyl^Arg^-GLP-l (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 38 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 ; 4 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(choloyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(choloyl))- GLP-1(7-38). 49 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 2634 -bis(N ε - (choloyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(choloyl))- GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7- deoxycholoyl^Arg^-GLP-l (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoy JArg^-GLP-l (7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(choloyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(choloyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (choloyl))-GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(choloyl))- GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(7- deoxycholoyl^Arg^-GLP-l (7-40). 50 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(7- deoxycholoyO Arg^-GLP-l (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 2634 Lys 36 (N ε -(7- deoxycholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(choloyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(choloyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (choloyl))-GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N^choloyl))- GLP-1(7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε -(choloyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(choloyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (choloyl))-GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(choloyl))- GLP-1(7-36). 51 In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))-GLP- 1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(choloyl))-GLP- 1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 26 ' 34 -bis(N ε -(choloyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 6 (N ε -(choloyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(choloyl))- GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (choloyl))-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε -(choloyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly^rg^Lys^N 6 - (choloyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))Arg 34 - GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (choloyl))Arg 34 -GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 2634 Lys 36 (N ε -(choloyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 :34 Lys 36 (N ε - (choloyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(lithocholoyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(lithocholoyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(lithocholoyl))- GLP-1(7-37). 52 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 6 Lys 34 (N ε - (choloyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))Arg 34 - GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (choloyl))Arg 34 -GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(choloyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 26,3 Lys 38 (N ε -(choloyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Gly'Αrg^^Lys 36 ^- (choloyl))-GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(lithocholoyl))- GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(lithocholoyl))- GLP-1(7-38) In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-38), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-38), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 3 (N ε -(lithocholoyl))- GLP-1(7-38), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 2634 -bis(N ε - (lithocholoyl))-GLP-1 (7-38), In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1(7-38), In a further preferred embodiment, the GLP-1 derivative is Gly'Αrg^Lys 34 ^- (choloyl))-GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))Arg 34 - GLP-1(7-39), 53 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (choloylJJArg^-GLP-l (7-39), In a further preferred embodiment, the GLP-1 derivative is Arg 26 ' 34 Lys 36 (N ε -(choloyl))- GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 2634 Lys 36 (N ε - (choloyl))-GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(Iithocholoyl))- GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Lys 3 (N ε -(lithocholoyl))- GLP-1 (7-39), In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-39), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(lithocholoyl))- GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-39), In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N 6 - (lithocholoyl))-GLP-1(7-39), In a further preferred embodiment, the GLP-1 derivative is Gly^rg^Lys^N 6 - (choloyl))-GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(choloyl))Arg 34 - GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (choloy JArg^-GLP-l (7-40), In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε -(choloyl))- GLP-1 (7-40), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε - (choloyl))-GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(lithocholoyl))- GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(lithocholoyl))- GLP-1(7-40), 54 In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-40), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(lithocholoyl))- GLP-1(7-40), In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg^Lys^N 6 - (lithocholoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(lithocholoyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(lithocholoyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(lithocholoyl))- GLP-1(7-36). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ' 34 -bis(N ε - (lithocholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1 (7-36). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε -(lithocholoyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(lithocholoyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Lys 26,34 -bis(N ε - (lithocholoyl))-GLP-1 (7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε -(lithocholoyl))- GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 34 (N ε -(lithocholoyl))- GLP-1(7-36)amide. 55 In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 ; 4 -bis(N ε - (lithocholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1(7-36)amide. In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 3 (N ε - (lithocholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - (lithocholoyl))Arg 34 -GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (lithocholoyl^Arg^-GLP-l (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 26 ' 34 Lys 36 (N ε - (lithocholoyl))-GLP-1(7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 28,34 Lys 38 (N ε - (lithocholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - (lithocholoy JArg^-GLP-l (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (lithocholoyl))Arg 34 -GLP-1(7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 6 ;J4 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Arg 2634 Lys 38 (N E - (lithocholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26,34 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-38). In a further preferred embodiment, the GLP-1 derivative is Gly^rg^Lys^N 8 - (lithocholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - (lithocholoyl))Arg 34 -GLP-1(7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (lithocholoyl))Arg 34 -GLP-1(7-39). 56 In a further preferred embodiment, the GLP-1 derivative is Arg^Lys 36 ^- (lithocholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 ' 34 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-39). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Arg 26 Lys 34 (N ε - (lithocholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Lys 26 (N ε - (lithocholoyl))Arg 34 -GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly 8 Lys 26 (N ε - (lithocholoyl^Arg^-GLP-l (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 26,34 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Gly s Arg 26,34 Lys 36 (N ε - (lithocholoyl))-GLP-1 (7-40). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 (N ε -decanoyl) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Lys 34 (N ε -(γ-glutamyl(N α - tetradecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 6,34 ,Lys 8 (N ε -(γ- glutamyl(N α -hexadecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 ( L -(γ- glutamyl(N α -dodecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 (N ε -(β- alanyl(N°-hexadecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 (N ε -(α- glutamyl(N α -hexadecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 (N ε -(piperidinyl- 4-carbonyl(N-hexadecanoyl))) GLP-1 (7-37). In a further preferred embodiment, the GLP-1 derivative is Arg 34 ,Lys 26 (N ε -(γ- glutamyl(N α -decanoyl))) GLP-1 (7-37). Other preferred embodiments will be described using the following abbreviations: Glut = N ε -(γ-L-glutamyl) 57 Aspa = N ε -(β-L-asparagyl) Glyc = N ε -glycyl GAB = N ε -(α-(γ-aminobutanoyl) ADod = N α -dodecanoyl ATet = N α -tetradecanoyl AHex = N α -hexadecanoyl AOct = N α -octadecanoyl ALit = N α -lithocholyl GDod = N Y -dodecanoyl GTet = N etradecanoyl GHex = N γ -hexadecanoyl GOct = N γ -octadecanoyl GLit = N ithocholyl Other preferred derivatives of GLP-1 analogues of the present invention are: Arg 26 Lys 34 -(Glut-ADod)-GLP-1(7-36); Arg 34 Lys 26 -(Glut-ADod)-GLP-1(7-36); Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1(7-36); Arg 26 Lys 34 -(Glut-ADod)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glut-ADod)-GLP- 1(7-36)amide; Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Glut-ADod)-GLP-1(7- 37); Arg 34 Lys 26 -(Glut-ADod)-GLP-1(7-37); Arg 2634 Lys 36 -(Glut-ADod)-GLP-1(7-37); Arg Lys 34 - (Glut-ADod)-GLP-1(7-38); Arg 34 Lys 26 -(Glut-ADod)-GLP-1(7-38) ; Arg 2634 Lys 38 -(Glut-ADod)- GLP-1(7-38); Arg 26 Lys 34 -(Glut-ADod)-GLP-1(7-39); Arg 34 Lys 26 -(Glut-ADod)-GLP-1(7-39); Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 3 Lys 26 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1(7-37); Gly 8 Arg 34 Lys 6 -(Glut-ADod)-GLP-1(7-37) Gly 8 Arg 2W4 Lys 36 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-37); Val 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-38); 58 Val 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Ser 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36); Ser 3 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 3 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 3 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-37) Ser 8 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-38) ; Ser 8 Arg 2634 Lys 38 -(Glut-ADod)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-39) Ser 8 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 3 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Arg 6 Lys 34 -(Glut-ADod)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-38) ; Thr 8 Arg 28 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(Glut-ADod)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Glut-ADod)-GLP-1 (7-39) Thr 8 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Glu 35 Arg 634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 6 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)- GLP-1(7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- 59 ADod)-GLP-1 (7-36); Val 8 Glu 35 Arg 28 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 6 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Val 8 Asp 38 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 3 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Ser 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glut-ADod)- GLP-1 (7-38); Thr 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 6 ' 34 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)- GLP-1(7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Glut-ADod)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ADod)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ADod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ADod)-GLP-1 (7- 38); Thr 3 Asp 38 Arg 263 Lys 39 -(Glut-ADod)-GLP-1 (7-39); 60 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 3 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Gly 8 Asp 9 Arg 26:i4 Lys 18 - (Glut-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 263 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 3 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 7 Arg 26 ' 34 Lys 23 -(Glut-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Gly'Αsp^Arg∞^Lys 23 - (Glut-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Gly 8 Asp 7 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 27 - (Glut-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 3 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Arg W4 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 263 Lys 18 - (Glut-ADod)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Vai 8 Asp 19 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Va Asp^Arg ^Lys 23 - (Glut-ADod)-GLP-l (7-38); Val 8 Asp 17 Arg 2834 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 7 -(Glut-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 27 -(Glut-ADod)- 61 GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (Glut-ADod)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7- 36); Ser s Asp 19 Arg 6 ' 34 Lys 8 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Sei sp^Arg^Lys 18 - (Glut-ADod)-GLP-l (7-38); Ser 8 Asp 17 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Ser β Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Se^Asp^Arg ^Lys 23 - (Glut-ADod)-GLP-l (7-38); Ser β Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Arg 263 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 263 Lys 27 -(Glut-ADod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 27 -(Glut-ADod)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Ser^Asp^Arg^^Lys 27 - (Glut-ADod)-GLP-l (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 3 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Thr s Asp 19 Arg 2634 Lys 8 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 18 -(Glut-ADod)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(Glut-ADod)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 18 - (Glut-ADod)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 3 -(Glut-ADod)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36); Thr 3 Asp 17 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ADod)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ADod)-GLP-1 (7-37); Thr*Asp 19 Arg 2634 Lys 23 - (Glut-ADod)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glut-ADod)-GLP-1 (7-38); Arg 2634 Lys 7 -(Glut-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); 62 Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ADod)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 263 Lys 27 -(Glut-ADod)-GLP-1 (7-37); Thr sp^Arg^Lys 27 - (Glut-ADod)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ADod)-GLP-1 (7-38); Arg 26 Lys 34 -(Glut-ATet)-GLP-1(7-36); Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-36); Arg 26 ' 34 Lys 36 -(Glut- ATet)-GLP-1(7-36); Arg 26 Lys 34 -(Glut-ATet)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glut-ATet)-GLP- 1(7-36)amide; Arg 263 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Glut-ATet)-GLP-1(7- 37); Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-37); Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1(7-37); Arg∞Lys 34 - (Glut-ATet)-GLP-1 (7-38); Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-38) ; Arg 2634 Lys 38 -(Glut-ATet)-GLP- 1(7-38); Arg 26 Lys 34 -(Glut-ATet)-GLP-1(7-39); Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-39); Arg 634 Lys 39 - (Glut-ATet)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Arg 34 Lys 6 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1(7-37); Gly 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-37) Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7-38) Gly 8 Arg 6 Lys 34 -(Glut-ATet)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-39) Gly 8 Arg 634 Lys 39 -(Glut-ATet)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-37) Val 8 Arg 634 Lys 36 -(Glut-ATet)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-39) Val 8 Arg 634 Lys 39 -(Glut-ATet)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 3δ -(Glut-ATet)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-37) Ser 3 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-37); Ser 8 Arg 6 Lys 34 -(Glut-ATet)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7-38) 63 Ser B Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1(7-39); Ser 8 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36); Thr 3 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36); Thr s Arg 634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Glut-ATet)-GLP-1 (7-38) ; Thr B Arg 2634 Lys 38. (G | ut . ATet) . GL p. 1 (7.33) Thr 8 Arg 26 Lys 34 -(Glut-ATet)-GLP-1 (7-39); Thr 8 Arg 3 Lys 6 -(Glut-ATet)-GLP-1 (7-39) Thr s Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37) Gly 8 Glu 37 Arg Z634 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 263 Lys 36 -(Glut-ATet)- GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut- ATet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 6 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Glut- ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 6 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glut-ATet)- GLP-1 (7-36); Val 8 Glu 35 Arg 263 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut- ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Val 8 Glu 38 Arg 2634 Lys 39 -(Glut- ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 3 Lys 36 -(Glut- ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 6 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); 64 Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Glu 35 Arg 6 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- ATet)-GLP-1 (7-36); Ser β Glu 35 Arg 26 - 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 3 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Ser s Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 3 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ATet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Thr 3 Glu 35 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Thr s Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut-ATet)- GLP-1 (7-36); Thr 3 Glu 35 Arg 2634 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(Glut- ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Thr 8 Glu 38 Arg 2634 Lys 39 -(Glut- ATet)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Thr B Asp 37 Arg 2634 Lys 38 -(Glut-ATet)- GLP-1 (7-38); Thr s Asp 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- ATet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 634 Lys 37 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 3 Lys 38 -(Glut-ATet)-GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Glut-ATet)-GLP-1 (7-39); Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 8 -(Glut-ATet)-GLP-1 (7-38) Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP- 1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 -(Glut- ATet)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 3 -(Glut-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-38) Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 3 Lys 23 -(Glut-ATet)-GLP 65 1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut- ATet)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Arg 263 Lys 27 -(Glut-ATet)-GLP-1 (7-38) Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 7 -(Glut-ATet)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 27 -(Glut-ATet)-GLP- 1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- ATβt)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-38) Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36) Val 8 Asp 19 Arg 6 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-ATet)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut- ATet)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38) Val 8 Asp 19 Arg 2634 Lys 3 -(Glut-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ;34 Lys 23 -(Glut-ATet)-GLP-1 (7-36) Val 8 Asp 19 Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 - 34 Lys 23 -(Glut-ATet)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 3 Lys 23 -(Glut ATet)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38); Arg 263 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-38) Val 8 Asp 19 Arg 26:34 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 7 -(Glut-ATet)-GLP-1 (7-36) Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP- 1 (7-36)amide; Val 8 Asp 9 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 7 -(Glut- ATet)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Ser 3 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7- 36); Ser s Asp 19 Arg 26 ' 34 Lys 8 -(Glut-ATet)-GLP-1 (7-36)amide; Ser B Asp 17 Arg 2634 Lys 18 -(Glut-ATet)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Ser*Asp 19 Arg 2634 Lys 18 - (Glut-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-38); 66 Ser a Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 7 Arg 26 ' 34 Lys 23 -(Glut-ATet)- GLP-1 (7-36)amide; Ser 8 Asp 9 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); SeHΑsp^Arg∞^Lys 23 - (Glut-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-38); Ser 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)- GLP-1 (7-36)amide; Ser 3 Asp 9 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1(7-37); Sei sp^Arg^Lys 27 - (Glut-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 - 3 Lys 27 -(Glut-ATet)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-38) Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36); Thr a Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36) Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 3 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP- 1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 18 -(Glut- ATet)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ATet)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38) Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-36) Thr 8 Asp 19 Arg 2634 Lys 23 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 23 -(Glut-ATet)-GLP- 1 (7-36)amide; Thr s Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ATet)-GLP-1 (7-37); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glut- ATet)-GLP-1 (7-38); Thr 8 Asp 17 Arg 2δ 34 Lys 23 -(Glut-ATet)-GLP-1 (7-38); Arg 263 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Arg 634 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-38) Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-36) Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP- 1 (7-36)amide; Thr 8 Asp 9 Arg 2634 Lys 27 -(Glut-ATet)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut- ATet)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ATet)-GLP-1 (7-38); Arg∞Lys^Glut-AHexJ-GLP-l (7-36); Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Glut-AHex)-GLP- 1 (7-36)amide; Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7- 37); Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-37); Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-37); Arg 26 Lys M - (Glut-AHex)-GLP-1(7-38); Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-38) ; Arg 6 ' 34 Lys 38 -(Glut-AHex)-GLP- 67 1 (7-38); Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-39); Arg 34 Lys 26 -(Glut-AHex)-GLP-1(7-39); Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36); Giy 8 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Arg 6 Lys 34 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-37) Gly 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-38) ; Gly 8 Arg 2634 Lys 38 -(Glut-AHex)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1(7-39) Gly 8 Arg 2634 Lys 39 -(Glut-AHex)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1(7-37); Val 8 Arg 26 Lys 3 -(Glut-AHex)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Glut-AHex)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1(7-39); Val 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1(7-39) Val 8 Arg 26 ' 3 Lys 39 -(Glut-AHex)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36); Ser 8 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36)amide; Ser 3 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36)amide; Ser a Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1(7-37); Ser 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1(7-38) Ser 3 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1(7-38) Ser 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1(7-39) Ser a Arg 2634 Lys 39 -(Glut-AHex)-GLP-1(7-39); Thr 3 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36); Thr s Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-36); Thr 8 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 6 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Thr B Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Glut-AHex)-GLP-1 (7-38) Thr 8 Arg 34 Lys 6 -(Glut-AHex)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7-38) Thi^Arg^Lys^Glut-AHexJ-GLP-l (7-39); Thr 8 Arg 34 Lys 26 -(Glut-AHex)-GLP-1 (7-39) Thr 3 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1(7-39); 68 Gly β Glu 3S Arg 2W4 Lys b -(Glut-AHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Gly 8 Glu 38 Arg 6 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Gly'Olu∞Arg^Lys 37 - (Glut-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 634 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Val 8 Asp 38 Arg 6 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Ser 3 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Ser 3 Glu 35 Arg 2634 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Ser 8 Glu 35 Arg 6 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Ser a Asp 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Ser 3 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Ser 3 Asp 37 Arg 2634 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Ser 8 Asp 35 Arg 63 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; 69 Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Thr B Glu 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Thr*Glu 36 Arg 263 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Thr a Glu 38 Arg 2634 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Thr s Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Thr 3 Asp 35 Arg 2634 Lys 36 -(Glut-AHex)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 3 Lys 36 -(Glut-AHex)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Thr 3 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AHex)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- AHex)-GLP-1 (7-36); Thr a Asp 35 Arg 26 ' 34 Lys 38 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glut-AHex)-GLP-1 (7- 38); Thr 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AHex)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (Glut-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 3 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 3 -(Glut-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 - (Glut-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 27 - (Glut-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); 70 Val 8 Asp 19 Arg 26 ' 34 Lys 8 -(Glut-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 18 - (Glut-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 3 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 6 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Glut-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Glut-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 7 -(Glut-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7- 36); Val 8 Asp 9 Arg 26 ' 3 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 27 -(Glut-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); VaPAsp^Arg∞^Lys 27 - (Glut-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7- 36); Ser 8 Asp 9 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 18 - (Glut-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Arg 634 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Ser β Asp 17 Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Ser^Asp^Arg^^Lys 23 - (Glut-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 3 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Ser 3 Asp 17 Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 263 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 27 - (Glut-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-38); 71 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AHex)- GLP-1(7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AHex)-GLP-1(7-37); Thi^Asp^Arg^Lys 18 - (Glut-AHex)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 18 -(Glut-AHex)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7-36); Thr s Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1 (7- 36); Thr s Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1(7-36)amide; Thr 8 Asp 17 Arg 634 Lys 23 -(Glut-AHex)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AHex)-GLP-1(7-37); Thi sp^Arg^Lys 23 - (Glut-AHex)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glut-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36); Thr B Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7- 36); Thr B Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AHex)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-37); Thr'Αsp^Arg^Lys 27 - (Glut-AHex)-GLP-l (7-38); Thr 8 Asp 7 Arg 26 ' 34 Lys 27 -(Glut-AHex)-GLP-1 (7-38); Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36); Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 36 -(Glut- AOct)-GLP-1(7-36); Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glut-AOct)-GLP- 1(7-36)amide; Arg 634 Lys 36 -(Glut-AOct)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7- 37); Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-37); Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7-37); Arg Lys 34 - (Glut-AOct)-GLP-1(7-38); Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-38) ; Arg 2634 Lys 38 -(Glut-AOct)-GLP- 1(7-38); Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-39); Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-39); Arg 2634 Lys 39 - (Glut-AOct)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-37) Gly 8 Arg 26 ' 3 Lys 36 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Arg 6 Lys 34 -(Glut-AOct)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-39) Gly 8 Arg 28 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); 72 Val 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-37) Val 8 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1(7-37); Val 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Glut-AOct)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-39); Val 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-39) Val 8 Arg 2634 Lys 39 -(Giut-AOct)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-36); Ser 8 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7-36); Ser 3 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-36)amide; Ser 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-36)amide; Ser B Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-37) Ser 8 Arg 6 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7-37); Ser 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1(7-38) Ser 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-39) Ser 8 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-36); Thr 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-36); Thr £ Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-36)amide; Thr 3 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-36)amide; Thr 8 Arg 263 Lys 36 -(Glut-AOct)-GLP-1(7- 36)amide; Thr 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glut-AOct)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7-37); Thr 8 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-38) Thr 3 Arg 3 Lys 26 -(Glut-AOct)-GLP-1 (7-38) ; Thr 3 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7-38) Thr 3 Arg 26 Lys 34 -(Glut-AOct)-GLP-1(7-39); Thr 3 Arg 34 Lys 26 -(Glut-AOct)-GLP-1(7-39) Thr 8 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1(7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1(7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1(7- 36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1(7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1(7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1(7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 28 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; 73 Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 3 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 2W4 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glut-AOct)-GLP-1 (7-38); Val 8 Glu 38 Arg 6 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Ser a Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Ser 8 Glu 36 Arg 26 ' 34 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7-38); Ser s Glu 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Ser s Asp 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Ser s Asp 36 Arg 2634 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Thr 3 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 263 Lys 38 -(Glut-AOct)- GLP-1 (7-38); Thr 3 Glu 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 3 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Thr B Glu 36 Arg 26 ' 34 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)-GLP-1 (7-38); Thr 8 Glu 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Giut-AOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-AOct)- 74 GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut- AOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 263 Lys 37 -(Glut-AOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glut-AOct)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-AOct)-GLP-1 (7-39); Arg 2W4 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Gly'Αsp^Arg ^Lys 18 - (Glut-AOct)-GLP-l (7-38); Gly 8 Asp 7 Arg 634 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 :34 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 263 Lys 3 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 23 -(Glut-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 :34 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 - (Glut-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Gly'Αsp^Arg ^Lys 27 - (Glut-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 18 - (Glut-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 8 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 3 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)- GLP-1 (7-36)amide; Val 8 Asp 9 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Glut-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-38); 75 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 7 -(Glut-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ;i4 Lys 27 - (Glut-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Arg 2834 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Sei sp^Arg^Lys 18 - (Glut-AOct)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 3 -(Glut-AOct)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Sei^Asp^Arg ^Lys 23 - (Glut-AOct)-GLP-l (7-38); Ser s Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 6 ' 34 Lys 27 -(Glut-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Sei^Asp^Arg ^Lys 27 - (Glut-AOct)-GLP-l (7-38); Ser s Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36); Thr^Asp^Arg^Lys^Glut-AOctj-GLP-l (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 18 -(Glut-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-AOct)-GLP-1 (7-37); Thi^Asp^Arg∞^Lys 18 - (Glut-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 - 34 Lys 18 -(Glut-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7- 36); Thr 3 Asp 19 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)- 76 GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 23 -(Glut-AOct)-GLP-1 (7-37); Thi^Asp^Arg^Lys 23 - (Glut-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-AOct)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Arg 834 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 27 -(Glut-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-37); Thi sp^Arg^Lys 27 - (Glut-AOct)-GLP-l (7-38); Thr 3 Asp 17 Arg 6 ' 34 Lys 27 -(Glut-AOct)-GLP-1 (7-38); Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-36); Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7- 36)amide; Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-37); Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 34 -(Glut-ALit)- GLP-1 (7-38); Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1(7-38); Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-39); Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-39); Arg 2634 Lys 39 -(Glut-ALit)- GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36); Gly 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-36) Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-36); Gly 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36)amide Gly 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-36)amide Gly 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-37); Gly 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-37) Gly 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-38) Gly 8 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36); Val 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-36) Val 8 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1(7-36); Val 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36)amide Val 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-36)amide Val 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-37); Val 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1(7-37); Val 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-39); Val 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1(7-39) Val 8 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Ser fl Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36); Ser 3 Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-36) Ser 8 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1(7-36); Ser 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1(7-36)amide Ser 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide 77 Ser 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-37) Ser 8 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-38) Ser 8 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-39); Ser β Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-39) Ser 8 Arg 634 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Arg 3 Lys 26 -(Glut-ALit)-GLP-1 (7-36) Thr 8 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-36)amide Thr B Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide Thr 3 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-37) Thr 8 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-37); Thr 3 Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-38) Thr B Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-38) Thr 8 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-38) Thr s Arg 26 Lys 34 -(Glut-ALit)-GLP-1 (7-39); Thr β Arg 34 Lys 26 -(Glut-ALit)-GLP-1 (7-39) Thr 8 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Gly 8 Glu 38 Arg 263 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 3 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Glu 38 Arg 26 - 34 Lys 39 -(Glut- ALit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 - 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glut- ALit)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP- 1 (7-38); Val 8 Glu 38 Arg 2634 Lys 39 -(Glut-Aϋt)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP- 1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glut-ALit)- GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ALit)- GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glut-ALit)- 78 GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(Glut- Aϋt)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-36); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Ser 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Ser B Glu 36 Arg 2634 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glut- ALit)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Ser B Asp 36 Arg 26 ' 34 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 3 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Ser s Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Ser s Asp 36 Arg 2634 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Ser s Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1(7-38); Ser B Asp 38 Arg 26 ' 34 Lys 39 -(Glut- Aϋt)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Thr 3 Glu 36 Arg 2634 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Thr 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Thr 8 Glu 35 Arg 263 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Glu 3t Arg 26 ' 34 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Glu 8 Arg 26 ' 34 Lys 39 -(Glut- ALit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36); Thr B Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7- 36)amide; Thr 3 Asp 36 Arg 263 Lys 37 -(Glut-ALit)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glut-ALit)- GLP-1 (7-38); Thr 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glut-ALit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glut-ALit)- GLP-1 (7-36); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(Glut- ALit)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Asp 38 Arg 263 Lys 39 -(Glut- ALit)-GLP-1 (7-39); Arg 26 ' 34 Lys 8 -(Glut-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amιde; Arg 2634 Lys 18 - (Glut-ALit)-GLP-l (7-37); Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 1a Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 3 Lys 18 -(Glut-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut- ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 8 -(Glut-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 8 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-38); 79 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glut-ALit)-GLP-l (7-37); Arg 634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glut- ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glut- ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Arg 2W4 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut- ALit)-GLP-1 (7-36); Gly 8 Asp 7 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- Aϋt)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 8 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Glut-Aϋt)-GLP-1 (7-36); Val 8 Asp 19 Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 3 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1(7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glut-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 3 -(Glut- ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut- ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Val 8 Asp 9 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(Glut- ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- Aϋt)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 6 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glut-ALit)-GLP-l (7-37); Arg 6 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 8 -(Glut- ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; 80 Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 8 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut- ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glut- ALit)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 263 Lys 27 - (Glut-ALit)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Ser 3 Asp 19 Arg 2634 Lys 27 -(Glut- ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-37); Ser β Asp 19 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Thr 3 Asp 9 Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 8 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Glut- ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-37); Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glut-ALit)-GLP-l (7-37); Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 23 -(Glut- ALit)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glut- ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 3 Lys 23 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Thr B Asp 17 Arg 26 ' 34 Lys 23 -(Glut-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glut-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 7 -(Glut-ALit)-GLP-1 (7-36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glut- ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 27 -(Glut-ALit)-GLP-1 (7-37); Thr 3 Asp 19 Arg 26 ' 3 Lys 7 -(Glut-ALit)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glut-ALit)-GLP-1 (7-38); Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36); Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36); Arg 2634 Lys 36 - (Aspa-ADod)-GLP-1 (7-36); Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Aspa- 81 ADod)-GLP-1(7-36)amide; Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Aspa- ADod)-GLP-1 (7-37); Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP- 1(7-37); Arg 26 Lys 34 -(Aspa-ADod)-GLP-1(7-38); Arg 34 Lys 26 -(Aspa-ADod)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-38); Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-39); Arg^Lys 26 - (Aspa-ADod)-GLP-l (7-39); Arg 2634 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7- 37); Gly 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 3 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Aspa-ADod)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-39) Val 8 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Ser 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36); Ser 3 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1(7-37); Ser 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1(7- 37); Ser 3 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-38) Ser B Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-39) Ser 8 Arg 263 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Thr B Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7- 37); Thr 8 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-38); 82 Thr 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-38) ; Thr B Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-38) Thr a Arg 26 Lys 34 -(Aspa-ADod)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Aspa-ADod)-GLP-1 (7-39) Thr*Arg 2834 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36) Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Aspa-ADod)- GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Glu 38 Arg 6 ' 34 Lys 39 -(Aspa- ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Gly^lu^Arg^Lys 36 - (Aspa-ADod)-GLP-l (7-36)amide; Gly 8 Glu 36 Arg 26 ' 3 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 263 Lys 38 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7- 39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 - (Aspa-ADod)-GLP-l (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 3 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Va Glu Arg^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Va Asp^Arg ^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 6 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 634 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Val 8 Asp 38 Arg 263 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Sei^Glu Arg^^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Ser a Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); 83 Ser 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Ser a Asp 35 Arg aW4 Lys 3β -(Aspa-ADod)-GLP- 1 (7-36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Sei^Asp∞Arg∞^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 2634 Lys 38 -(Aspa-ADod)-GLP- 1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Thr 3 Glu 37 Arg 2634 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Thr a Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Thr'Glu^Arg^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Thr B Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Thr a Glu 38 Arg 2634 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ADod)-GLP-1 (7- 36)amide; Thr a Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- ADod)-GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Thr sp Arg^Lys 36 - (Aspa-ADod)-GLP-l (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 3 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ADod)-GLP-1 (7-37); Thr s Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ADod)-GLP-1 (7- 38); Thr a Asp 38 Arg 2634 Lys 39 -(Aspa-ADod)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Arg 263 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 8 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa- ADod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 3 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 3 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa- ADod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Asp 17 Arg 63 Lys 23 -(Aspa-ADod)-GLP-1 (7- 38); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); 84 Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 263 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa- ADod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Gly 8 Asp 9 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 634 Lys 18 -(Aspa-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa- ADod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa- ADod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7- 38); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Val 8 Asp 7 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa- ADod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ADod)-GLP- 1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Ser 8 Asp 9 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ADod)-GLP- 1(7-38); 85 Arg 634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ADod)-GLP- 1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Ser s Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP- 1(7-38); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Ser B Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP- 1 (7-36); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Ser 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ADod)-GLP- 1 (7-38); Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-36); Thι 3 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7- 36); Thr 8 Asp 9 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 18 -(Aspa- ADod)-GLP-1 (7-36)amide; Thr s Asp 19 Arg 2634 Lys 18 -(Aspa-ADod)-GLP-1 (7-37); Thr s Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ADod)-GLP-1 (7- 38); Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 23 -(Aspa- ADod)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 3 -(Aspa-ADod)-GLP-1 (7-37); Thr 8 Asp 9 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa- ADod)-GLP-1 (7-36)amide; Thr B Asp 19 Arg 2634 Lys 27 -(Aspa-ADod)-GLP-1 (7-37); 86 Thr £ Asp 19 Arg 26 ' 34 Lys 7 -(Aspa-ADod)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ADod)-GLP-1 (7- 38); Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36); Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 36 -(Aspa- ATet)-GLP-1(7-36); Arg 26 Lys 34 -(Aspa-ATet)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Aspa-ATet)-GLP- 1(7-36)amide; Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7- 37); Arg 34 Lys 26 -(Aspa-ATet)-GLP-1(7-37); Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1(7-37); Arg Lys 34 - (Aspa-ATet)-GLP-1(7-38); Arg 34 Lys 26 -(Aspa-ATet)-GLP-1(7-38) ; Arg 2634 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-39); Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-39); Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Arg 263 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-37) Gly 8 Arg 26;34 Lys 36 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1(7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-37) Val 8 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-39) Val 8 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Ser 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-39); Ser 8 Arg 3 Lys 26 -(Aspa-ATet)-GLP-1 (7-39) Ser 8 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); 87 Thr 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr 3 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-37) Thr 8 Arg 263 Lys 36 -(Aspa-ATet)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(Aspa-ATet)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Aspa-ATet)-GLP-1 (7-39) Thr 8 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 28 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)- 88 GLP-1 (7-38); Ser 8 Giu 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Ser Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Ser 8 Glu 35 Arg 263 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Se^Glu∞Arg^Lys 3 -(Aspa-ATet)-GLP-l (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Asp 37 Arg 2634 Lys 38 -(Aspa-ATet)- GLP-1(7-38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Ser s Asp 35 Arg 26 - 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Thr a Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr a Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ATet)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Thr 3 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)- GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- ATet)-GLP-1 (7-36); Thr fi Asp 35 Arg 2634 Lys 36 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ATet)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ATet)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ATet)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (Aspa-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Arg 2634 Lys 3 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 634 Lys 23 -(Aspa-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 23 - (Aspa-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); 89 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 7 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 3 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 - (Aspa-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ATet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Asp 9 Arg 2634 Lys 18 - (Aspa-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ATet)- GLP-1 (7-36)amide; Val 8 Asp 9 Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Aspa-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); VaPAsp^Arg ^Lys 27 - (Aspa-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 26 ' 34 Lys 8 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 8 -(Aspa-ATet)- GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Se Asp^Arg∞^Lys 18 - (Aspa-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ATet)- 90 GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 - (Aspa-ATet)-GLP-l (7-38); Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 7 -(Aspa-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 7 -(Aspa-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 27 - (Aspa-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 6 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7- 36); Thr 8 Asp 9 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr a Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ATet)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ATet)-GLP-1 (7-37); Thi^Asp^Arg^Lys 18 - (Aspa-ATet)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 3 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7- 36); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)- GLP-1 (7-36)amide; Thr a Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-37); Thr'Αsp^Arg^Lys 23 - (Aspa-ATet)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Arg 26 :3 Lys 27 -(Aspa-ATet)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Thr a Asp 19 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ATet)- GLP-1(7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 27 -(Aspa-ATet)-GLP-1(7-37); Thi^Asp^Arg^^Lys 27 - (Aspa-ATet)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 - 34 Lys 27 -(Aspa-ATet)-GLP-1 (7-38); Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36); Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36); Arg 2834 Lys 36 - (Aspa-AHex)-GLP-1(7-36); Arg 26 Lys 34 -(Aspa-AHex)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Aspa- AHex)-GLP-1(7-36)amide; Arg 6 ' 34 Lys 36 -(Aspa-AHex)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Aspa- AHex)-GLP-1 (7-37); Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7- 37); Arg 26 Lys 34 -(Aspa-AHex)-GLP-1(7-38); Arg 34 Lys 26 -(Aspa-AHex)-GLP-1(7-38) ; Arg 263 Lys 38 - (Aspa-AHex)-GLP-l (7-38); Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-39); Arg 34 Lys 26 -(Aspa-AHex)- GLP-1 (7-39); Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); 91 Gly 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-37) Gly 8 Arg 6 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-38) ; Gly 8 Arg 2634 Lys 38 -(Aspa-AHex)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-39) Gly 8 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-37) Val 8 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-38) ; Val 8 Arg 26 ' 3 Lys 38 -(Aspa-AHex)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-39) Val 8 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 3 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 3 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1(7- 37); Ser 3 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-38) ; Ser 3 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7-38) Ser a Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-39) Ser 3 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1(7-39); Thr a Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36); Thr £ Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Thr B Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr s Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-37) Thr 3 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-38) Thr 3 Arg 34 Lys 26 -(Aspa-AHex)-GLP-1(7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(Aspa-AHex)-GLP-1 (7-39); Thr s Arg 34 Lys 26 -(Aspa-AHex)-GLP-1 (7-39) Thr 8 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1(7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa- 92 AHex)-GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 - (Aspa-AHex)-GLP-l (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Gly' sp Arg^Lys 36 - (Aspa-AHex)-GLP-l (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26:34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Va Asp∞Arg^Lys 38 - (Aspa-AHex)-GLP-l (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Ser 3 Glu 35 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Ser 3 Glu 35 Arg 28 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Sei^Glu Arg^Lys 36 - (Aspa-AHex)-GLP-l (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Ser 3 Asp 38 Arg 2634 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 - (Aspa-AHex)-GLP-l (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Ser 3 Asp 38 Arg 6 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); 93 Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Th^Glu^Arg^Lys 36 - (Aspa-AHex)-GLP-l (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Thr B Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Thr 8 Asp M Arg 2W4 Lys 3β -(Aspa-AHex)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AHex)-GLP-1 (7- 36)amide; Thr B Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa- AHex)-GLP-1 (7-38); Thr a Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Thi^Asp^Arg^^Lys 38 - (Aspa-AHex)-GLP-l (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AHex)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AHex)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa- AHex)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7- 38); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 3 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 263 Lys 23 -(Aspa- AHex)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 634 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 7 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 7 -(Aspa- AHex)-GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 38); 94 Arg 2W4 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 8 -(Aspa-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 8 -(Aspa- AHex)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 6 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 263 Lys 18 -(Aspa-AHex)-GLP-1 (7- 38); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ;34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7- 36); Val 8 Asp 9 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa- AHex)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 3 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 9 Arg 6 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 6 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 27 -(Aspa- AHex)-GLP-1 (7-36)amide; Val 8 Asp 9 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 38); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa- AHex)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7- 38); Arg 2W4 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Ser 3 Asp 19 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa- AHex)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); 95 Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 3 Lys 23 -(Aspa-AHex)-GLP-1 (7- 38); Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7- 36); Ser B Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 27 -(Aspa- AHex)-GLP-1 (7-36)amide; Ser 8 Asp 9 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Thr 3 Asp 19 Arg 6 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 3 Lys 18 -(Aspa-AHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa- AHex)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AHex)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 ' 3 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Arg 634 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7- 36); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr s Asp 17 Arg 26 ' 34 Lys 23 -(Aspa- AHex)-GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Arg 2634 Lys 7 -(Aspa-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 36); Thr a Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa- AHex)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AHex)-GLP-1 (7-38); Thr B Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AHex)-GLP-1 (7- 38); Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36); Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Aspa-AOct)-GLP- 1(7-36)amide; Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7- 37); Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-37); Arg Lys 34 - 96 (Aspa-AOct)-GLP-1(7-38); Arg 34 Lys 26 -(Aspa-AOct)-GLP-1(7-38) ; Arg 2634 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-39); Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-39); Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-37) Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-38) ; Gly 8 Arg 2634 Lys 38 -(Aspa-AOct)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-39) Gly 8 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1(7-37); Val 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1(7-37) Val 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Aspa-AOct)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-39) Val 8 Arg 263 Lys 39 -(Aspa-AOct)-GLP-1(7-39); Ser 8 Arg 6 Lys 34 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Ser 3 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 6 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Arg 3 Lys 26 -(Aspa-AOct)-GLP-1 (7-37) Ser 8 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-37); Ser 3 Arg 6 Lys 34 -(Aspa-AOct)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-38) ; Ser B Arg 2634 Lys 38 -(Aspa-AOct)-GLP-1(7-38) Ser 3 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-39); Ser a Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-39) Ser 8 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Arg 28 Lys 34 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 28 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-37) Thr 8 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-37); Thr 8 Arg 6 Lys 34 -(Aspa-AOct)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7-38) 97 Thr 8 Arg 26 Lys 34 -(Aspa-AOct)-GLP-1 (7-39); Thr s Arg 34 Lys 26 -(Aspa-AOct)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 6 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ;34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Val 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 6 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 3 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Asp 38 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Ser β Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Ser 3 Asp 37 Arg 6 ' 34 Lys 38 -(Aspa- 98 AOct)-GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Ser'Αsp^Arg^Lys 36 - (Aspa-AOct)-GLP-l (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Ser*Asp 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 38 -(Aspa-AOct)-GLP-1 (7- 36)amide; Thr s Glu 36 Arg 2634 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Thr 3 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr B Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Thr 3 Glu 37 Arg 26 ' 3 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Thr s Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Thr B Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(Aspa-AOct)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)- GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- AOct)-GLP-1 (7-36); Thr B Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 3 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-AOct)-GLP-1 (7-37); Thr B Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-AOct)-GLP-1 (7- 38); Thr 3 Asp 38 Arg 2634 Lys 39 -(Aspa-AOct)-GLP-1 (7-39); Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-AOct)~GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 263 Lys 18 - (Aspa-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 23 - (Aspa-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 634 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 - (Aspa-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); 99 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); VafAsp^Arg^Lys 18 - (Aspa-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ;34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 28 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 :34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ;34 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Va Asp^Arg∞^Lys 23 - (Aspa-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Arg 263 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Val 8 Asp 7 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (Aspa-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Arg 2W4 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa^AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa- AOct)-GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 3 Lys 18 -(Aspa-AOct)-GLP-1 (7- 38); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 263 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa- AOct)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7- 38); Arg 2634 Lys 7 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); 100 Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 7 -(Aspa-AOct)-GLP-1 (7- 36); Ser B Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Ser*Asp 7 Arg 2634 Lys 27 -(Aspa- AOct)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 3 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Thr B Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-AOct)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-AOct)-GLP-1(7-37); Thr'Αsp^Arg^Lys 18 - (Aspa-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 6 ' 34 Lys 18 -(Aspa-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 23 -(Aspa-AOct)-GLP-1 (7-37); Thi sp^Arg ^Lys 23 - (Aspa-AOct)-GLP-l (7-38); Thr 3 Asp 7 Arg 26 ' 34 Lys 23 -(Aspa-AOct)-GLP-1 (7-38); Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 7 -(Aspa-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 3 Lys 27 -(Aspa-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7- 36); Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-AOct)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 27 - (Aspa-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 27 -(Aspa-AOct)-GLP-1 (7-38); Arg 26 Lys 3 -(Aspa-ALit)-GLP-1 (7-36); Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-36); Arg 2634 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7- 36)amide; Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Aspa-ALit)-GLP- 1(7-37); Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 Lys 34 -(Aspa- ALit)-GLP-1(7-38); Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1(7-38); Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-39); Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-39); Arg 2634 Lys 39 -(Aspa- ALit)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-37); 101 Gly 8 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Arg 3 Lys 26 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Val 8 Arg 6 Lys 34 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Aspa-ALit)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-39) Val 8 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-36); Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1(7-36); Ser 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-36)amide; Ser 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1(7- 36)amide; Ser 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-37); Ser 3 Arg 3 Lys 26 -(Aspa-ALit)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-38) ; Ser 8 Arg 6 ' 34 Lys 38 -(Aspa-ALit)-GLP-1(7-38) Ser 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-39); Ser 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-39) Ser 8 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-36); Thr B Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-36); Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-36)amide; Thr 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1(7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1(7- 36)amide; Thr 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-37) Thr 3 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1(7-37); Thr 8 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1(7-38) Thr 3 Arg 26 Lys 34 -(Aspa-ALit)-GLP-1 (7-39); Thr 3 Arg 34 Lys 26 -(Aspa-ALit)-GLP-1 (7-39) Thr 3 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1(7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1(7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)- GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 3 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly^lu^Arg^^Lys 37 - (Aspa-ALit)-GLP-l (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7-38); G^GIu^Arg^^Lys 39 - (Aspa-ALit)-GLP-1(7-39); 102 Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 6 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)- GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; VafGlu∞Arg^Lys 37 - (Aspa-ALit)-GLP-l (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7-38); VaPGIu∞Arg∞^Lys 39 - (Aspa-ALit)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 35 Arg 634 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Val 8 Asp 38 Arg 6 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 3 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 - (Aspa-ALit)-GLP-l (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Ser 3 Glu 35 Arg 6 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Ser B Glu 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Ser fi Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Sei^Glu∞Arg∞^Lys 37 - (Aspa-ALit)-GLP-l (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7-38); Ser 3 Glu 38 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 3 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Ser B Asp 35 Arg 2634 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7- 38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 3 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)- GLP-1 (7-36); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Thi^Glu Arg^Lys 37 - 103 (Aspa-ALit)-GLP-l (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Aspa-ALit)-GLP-1 (7-38); Th^Glu∞Arg∞^Lys 39 - (Aspa-ALit)-GLP-1 (7-39); Thr 3 Asp 35 Arg 6 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7- 36)amide; Thr s Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Thr £ Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Aspa- ALit)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Aspa-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Aspa-ALit)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Aspa-ALit)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 2634 Lys 39 -(Aspa-ALit)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Asp ,7 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ALit)-GLP- 1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (Aspa-ALit)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Gly 8 Asp 9 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7- 36); Gly 8 Asp 9 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ALit)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 23 - (Aspa-ALit)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ;34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Arg 28 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ALit)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 - (Aspa-ALit)-GLP-l (7-38); Gly 8 Asp 7 Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ALit)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 634 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa- ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Aspa-Aϋt)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); 104 Val 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 3 Lys 23 -(Aspa-ALit)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 3 -(Aspa- ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-Aϋt)-GLP-1 (7-38); Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 -(Aspa- ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 8 -(Aspa-ALit)-GLP-1 (7-36); Ser s Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ALit)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Sei^Asp^Arg^Lys 18 - (Aspa-ALit)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 3 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 3 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ALit)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-37); Set^Asp^Arg^^Lys 23 - (Aspa-ALit)-GLP-l (7-38); Ser 8 Asp 7 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Ser 3 Asp 19 Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 7 -(Aspa-ALit)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 27 - (Aspa-ALit)-GLP-l (7-38); Ser 3 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Aspa-ALit)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 7 Arg 2634 Lys 8 -(Aspa-ALit)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-37); Thi sp^Arg^Lys 18 - (Aspa-ALit)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 18 -(Aspa-ALit)-GLP-1 (7-38); 105 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-37); Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Aspa-ALit)-GLP-1 (7- 36); Thr B Asp 19 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Aspa-ALit)- GLP-1(7-36)amide; Thr 8 Asp 9 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1(7-37); Thi^Asp^Arg^^Lys 23 - (Aspa-ALit)-GLP-l (7-38); Thr 8 Asp 7 Arg 26 ' 34 Lys 23 -(Aspa-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1(7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Aspa-ALit)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Aspa-ALit)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 27 - (Aspa-ALit)-GLP-l (7-38); Thr 3 Asp 17 Arg 2634 Lys 27 -(Aspa-ALit)-GLP-1 (7-38); Arg 6 Lys 34 -(Glyc-ADod)-GLP-1 (7-36); Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36); Arg 2634 Lys 36 -(Glyc- ADod)-GLP-1(7-36); Arg 26 Lys 34 -(Glyc-ADod)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glyc-ADod)-GLP- 1 (7-36)amide; Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7- 37); Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-37); Arg 2634 Lys 36 -(Glyc-ADod)-GLP- 1(7-37); Arg Lys 34 - (Glyc-ADod)-GLP-1 (7-38); Arg 34 Lys 26 -(Glyc-ADod)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-39); Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-39); Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Arg 6 Lys 34 -(Glyc-ADod)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1(7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 6 -(Glyc-ADod)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-38) Val 8 Arg 34 Lys 6 -(Glyc-ADod)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7-38) 106 Val 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Arg 2634 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Ser 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Ser 3 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36)amide; Seι Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser 8 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Ser β Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-37) Ser 3 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-37); Ser 3 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-39) Ser B Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Thr B Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-37); Thr B Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-37); Thr 3 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(Glyc-ADod)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Glyc-ADod)-GLP-1 (7-39) Thr 8 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Giyc-ADod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 3 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Val 8 Glu 38 Arg 2634 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; 107 Val 8 Glu 36 Arg 2634 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Glu 37 Arg 263 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc- ADod)-GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Sei^Asp^Arg∞^Lys 36 - (Glyc-ADod)-GLP-l (7-36); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser s Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Thr 3 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Thr 3 Glu 38 Arg 2634 Lys 39 -(Giyc-ADod)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 2634 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7- 36)amide; Thr 3 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Thr 8 Asp 35 Arg 263 Lys 36 -(Glyc- ADod)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr fi Asp 36 Arg 2634 Lys 37 -(Glyc-ADod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ADod)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ADod)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); 108 Gly 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 8 -(Glyc-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (Glyc-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 263 Lys 23 -(Glyc-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Gly^sp^Arg∞^Lys 23 - (Glyc-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 6 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 - (Glyc-ADod)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Asp 7 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7- 36); Val 8 Asp 9 Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Giyc-ADod)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Va Asp^Arg ^Lys 18 - (Glyc-ADod)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Asp 7 Arg 26 ' 34 Lys 23 -(Glyc-ADod)- GLP-1 (7-36)amide; Val 8 Asp 9 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Glyc-ADod)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 3 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Val 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (Glyc-ADod)-GLP-l (7-38); Val 8 Asp 7 Arg 26 ' 3 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); 109 Arg 263 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Ser 3 Asp 9 Arg 26 ' 3 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 18 -(Glyc- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Ser 8 Asp 19 Arg 634 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Ser s Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Arg 28 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7- 36); Ser s Asp 19 Arg 26 ' 3 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 3 -(Giyc-ADod)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Arg 2634 Lys 27 -(Giyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc- ADod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Ser 3 Asp 19 Arg 26 ' 34 Lys 7 -(Glyc-ADod)-GLP-1 (7-38); Ser 3 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(Giyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 3 Asp 7 Arg 26 ' 34 Lys 18 -(Glyc-ADod)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ADod)-GLP-1 (7-37); Thi^Asp^Arg^Lys 18 - (Glyc-ADod)-GLP-l (7-38); Thr 8 Asp 17 Arg 6 ' 34 Lys 18 -(Glyc-ADod)-GLP-1 (7-38); Arg 2W4 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-37); Thi^Asp^Arg∞^Lys 23 - (Glyc-ADod)-GLP-l (7-38); Thr a Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ADod)-GLP-1 (7-38); 110 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Arg 28 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-ADod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-36); Thr 8 Asp 7 Arg 6 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7- 36); Thr £ Asp 19 Arg 26 ' 34 Lys 7 -(Glyc-ADod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 27 -(Glyc-ADod)- GLP-1(7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1(7-37); Thi^Asp^Arg^Lys 27 - (Glyc-ADod)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ADod)-GLP-1 (7-38); Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36); Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36); Arg 2634 Lys 36 -(Glyc- ATet)-GLP-1(7-36); Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Glyc-ATet)-GLP- 1(7-36)amide; Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Glyc-ATet)-GLP-1(7- 37); Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1(7-37); Arg^Lys 34 - (Glyc-ATet)-GLP-1 (7-38); Arg 34 Lys 26 -(Glyc-ATet)-GLP-1(7-38) ; Arg 2634 Lys 38 -(Glyc-ATet)-GLP- 1(7-38); Arg 26 Lys 34 -(Glyc-ATet)-GLP-1(7-39); Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-39); Arg 2634 Lys 39 - (Glyc-ATet)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Giyc-ATet)-GLP-1 (7-36); Gly 8 Arg 6 Lys 34 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 6 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-37) Gly 8 Arg 6 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glyc-ATet)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-39) Gly 8 Arg 2δ ' 34 Lys 39 -(Glyc-ATet)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1(7-37); Val 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glyc-ATet)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-39) Val 8 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Ser 8 Arg 26 Lys 3 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser 3 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-38); 111 Ser 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-38) ; Ser 8 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1(7-38); Ser 8 Arg 26 Lys 3 -(Glyc-ATet)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1(7-39); Ser 8 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36); Thr 3 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36); Thr 3 Arg 6 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 8 Arg 2634 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Thr B Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-37) Thr 8 Arg 26 ' 3 Lys 36 -(Glyc-ATet)-GLP-1 (7-37); Thr 8 Arg 6 Lys 34 -(Glyc-ATet)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Glyc-ATet)-GLP-1 (7-38) Thr 3 Arg 26 Lys 34 -(Glyc-ATet)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Glyc-ATet)-GLP-1 (7-39) Thr 8 Arg 2634 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 3 Lys 38 -(Glyc-ATet)-GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)-GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; 112 Val 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Ser 3 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Ser B Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Ser B Glu 35 Arg 26 ' 34 Lys 36 -(Giyc-ATet)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Ser 3 Asp 36 Arg 2634 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser B Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Ser 8 Asp 37 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Giyc-ATet)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Thr 3 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ATet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7- 36)amide; Thr £ Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Thr 3 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ATet)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Thr 8 Asp 35 Arg 263 Lys 36 -(Glyc- ATet)-GLP-1 (7-36); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr^Asp 36 Arg 2634 Lys 37 -(Glyc-ATet)-GLP-1 (7-37); Thr 3 Asp 37 Arg 2634 Lys 38 -(Glyc-ATet)-GLP-1 (7- 38); Thr 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ATet)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Gly'Αsp^Arg∞^Lys 18 - (Glyc-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Arg 263 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); 113 Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 3 -(Glyc-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 - (Glyc-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Giyc-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 - (Glyc-ATet)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2834 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 18 - (Glyc-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Arg 8 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ATet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Glyc-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Giyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Val 8 Asp 7 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (Glyc-ATet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 263 Lys 18 -(Glyc-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Ser^Asp^Arg^Lys 18 - (Glyc-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); 114 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 263 Lys 23 -(Glyc-ATet)- GLP-1(7-36)amide; Ser B Asp 19 Arg 26 ' 34 Lys 23 -(Giyc-ATet)-GLP-1(7-37); Se Asp^Arg'^Lys 23 - (Glyc-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 2634 Lys 3 -(Glyc-ATet)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 7 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Ser 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 7 -(Glyc-ATet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)- GLP-1 (7-36)amide; Ser 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Sei^Asp^Arg∞^Lys 27 - (Glyc-ATet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Giyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Giyc-ATet)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Thr a Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36); Thr s Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7- 36); Thr s Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 3 Asp 17 Arg 2634 Lys 8 -(Glyc-ATet)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ATet)-GLP-1 (7-37); Thi^Asp^Arg^Lys 18 - (Glyc-ATet)-GLP-l (7-38); Thr 3 Asp 17 Arg 2634 Lys 18 -(Glyc-ATet)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 634 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ATet)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ATet)-GLP-1 (7-37); Thi^Asp^Arg^Lys 23 - (Glyc-ATet)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ATet)-GLP-1 (7-36) ; Thr 8 Asp 17 Arg 2834 Lys 27 -(Glyc-ATet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ATet)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ATet)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 27 - (Glyc-ATet)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 7 -(Glyc-ATet)-GLP-1 (7-38); Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36); Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1(7-36); Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glyc-AHex)-GLP- 1(7-36)amide; Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1(7-36)amide; Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7- 37); Arg 3 Lys 26 -(Glyc-AHex)-GLP-1(7-37); Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1(7-37); Arg Lys 34 - 115 (Glyc-AHex)-GLP-1(7-38); Arg 34 Lys 26 -(Glyc-AHex)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-39); Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-39); Arg 2634 Lys 39 -(Glyc-AHex)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-37) Gly 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1(7-38) Gly 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-39); Gly 8 Arg 3 Lys 26 -(Glyc-AHex)-GLP-1(7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Val 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Arg 3 Lys 26 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1(7-37); Val 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(Glyc-AHex)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-39); Val 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1(7-39) Val 8 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1(7-39); Ser 3 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36); Ser 3 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36); Ser 3 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser 3 Arg 34 Lys 26 -(Giyc-AHex)-GLP-1 (7-36)amide; Ser*Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-37) Ser 8 Arg 263 Lys 36 -(Glyc-AHex)-GLP-1(7-37); Ser 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 3 Lys 38 -(Glyc-AHex)-GLP-1(7-38) Ser 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1(7-39); Ser 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1(7-39) Ser 8 Arg 2634 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Thr 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36); Thr 3 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr £ Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 8 Arg 263 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7-38) 116 Thr 8 Arg 26 Lys 34 -(Glyc-AHex)-GLP-1 (7-39); Thr 3 Arg 34 Lys 26 -(Glyc-AHex)-GLP-1 (7-39); Thr 8 Arg 2634 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Gly 8 GIu 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 263 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Val 8 GIu 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); VaI 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 3 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 3 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Ser 3 Asp 37 Arg 2634 Lys 38 -(Glyc-AHex)- 117 GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Ser 8 Asp 35 Arg 28 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser B Asp 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 3 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Thr 8 Glu 38 Arg 2634 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Thr 8 Glu 35 Arg 28 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Thr 8 Asp 35 Arg 6 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc-AHex)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glyc-AHex)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Thr 3 Asp 35 Arg 2634 Lys 36 -(Glyc- AHex)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 3 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glyc-AHex)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AHex)-GLP-1 (7-39); Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 8 -(Glyc-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(Glyc-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 3 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (Glyc-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 634 Lys 23 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 263 Lys 23 -(Glyc-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Gly^sp^Arg^Lys 23 - (Glyc-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Arg 2834 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AHex)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 27 - (Glyc-AHex)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); 118 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Arg 263 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Glyc-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 634 Lys 18 - (Glyc-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glyc-AHex)-GLP~1 (7-36)amide; Arg 26 ' 34 Lys 3 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 2834 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); VaPAsp^Arg∞^Lys 23 - (Glyc-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Arg 2634 Lys 7 -(Glyc-AHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26;34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AHex)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (Glyc-AHex)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Ser 3 Asp 19 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 6 ' 34 Lys 18 -(Glyc-AHex)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Se^Asp^Arg ^Lys 18 - (Glyc-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Giyc-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 634 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Ser 8 Asp 9 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 2634 Lys 23 -(Glyc-AHex)- GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 6 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Ser^Asp^Arg^Lys 23 - (Glyc-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Arg 28 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); Ser 8 Asp 9 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)- 119 27 GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Ser 8 Asp 1β Arg aw4 Lys ; (Glyc-AHex)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 3 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AHex)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 3 Lys 18 -(Glyc-AHex)-GLP-1 (7-37); Th Asp^Arg∞^Lys 18 - (Glyc-AHex)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Arg 2634 Lys 3 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-AHex)-GLP-1 (7-38); Thr s Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 3 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AHex)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AHex)-GLP-1 (7-37); Thi^Asp^Arg ^Lys 23 - (Glyc-AHex)-GLP-l (7-38); Thr 3 Asp 17 Arg 2634 Lys 3 -(Giyc-AHex)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ;34 Lys 27 -(Glyc-AHex)-GLP-1 (7- 36); Thr B Asp 19 Arg 2634 Lys 27 -(Glyc-AHex)-GLP-1 (7-36)amide; Thr 3 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AHex)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AHex)-GLP-1 (7-37); Thr'Αsp^Arg^Lys 27 - (Glyc-AHex)-GLP-l (7-38); Thr s Asp 17 Arg 2634 Lys 7 -(Glyc-AHex)-GLP-1 (7-38); Arg 26 Lys 3 -(Glyc-AOct)-GLP-1 (7-36); Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1(7-36); Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-36)amide; Arg 34 Lys 26 -(Glyc-AOct)-GLP- 1 (7-36)amide; Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7- 37); Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-37); Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1(7-37); Arg∞Lys 34 - (Glyc-AOct)-GLP-l (7-38); Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-38) ; Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP- 1 (7-38); Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-39); Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-39); Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(Giyc-AOct)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7-38) 120 Gly 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-36); Val 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-36); Val 8 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1(7-36); Val 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-36)amide; Val 8 Arg 34 Lys 6 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 3 Lys 36 -(Glyc-AOct)-GLP-1(7- 36)amide; Val 8 Arg 6 Lys 34 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Arg 34 Lys 2δ -(Glyc-AOct)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1(7-38) Val 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-39); Val 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-39) Val 8 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1(7-39); Ser B Arg 2δ Lys 34 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36); Ser B Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 3 Lys 36 -(Giyc-AOct)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(Giyc-AOct)-GLP-1 (7-37); Ser 3 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-37) Ser 8 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1(7-37); Ser s Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-38) ; Ser 8 Arg 2634 Lys 38 -(Glyc-AOct)-GLP-1(7-38) Ser 8 Arg 6 Lys 34 -(Glyc-AOct)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-39) Ser 8 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Thr 3 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 3 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Thr s Arg 26 Lys 34 -(Glyc-AOct)-GLP-1 (7-37); Thr 8 Arg 3 Lys 26 -(Glyc-AOct)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1(7-37); Thr 8 Arg 26 Lys 34 -(Glyc-AOct)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1 (7-38) ; Thr 3 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1(7-38) Thr 8 Arg 26 Lys 34 -(Giyc-AOct)-GLP-1(7-39); Thr 8 Arg 34 Lys 26 -(Glyc-AOct)-GLP-1(7-39) Thr B Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1(7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1(7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1(7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Gly 8 Glu 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 6 ' 34 Lys 38 -(Glyc-AOct)- 121 GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 3 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 6 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Ser a Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Ser 8 Glu 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Giyc-AOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Ser 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Ser a Asp 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Thr 3 Glu 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Thr 3 Glu 38 Arg 2634 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Thr a Glu 35 Arg 26 ' 34 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); 122 Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 38 -(Glyc-AOct)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-AOct)- GLP-1 (7-38); Thr 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc- AOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(Glyc-AOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(Glyc-AOct)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-AOct)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 8 -(Glyc-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2834 Lys 18 -(Glyc-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 6 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 263 Lys 18 - (Glyc-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1(7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 6 ' 34 Lys 23 -(Glyc-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 634 Lys 23 - (Glyc-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 7 -(Glyc-AOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 27 - (Glyc-AOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 18 -(Giyc-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); VaPAsp^Arg∞^Lys 18 - (Glyc-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AOct)- 123 GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (Glyc-AOct)-GLP-l (7-38); Val 8 Asp 7 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Giyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 3 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Val 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP -1 (7-37); Va Asp^Arg∞^Lys 27 - (Glyc-AOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser fi Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 18 - (Glyc-AOct)-GLP-l (7-38); Ser 3 Asp 17 Arg 26 ' 3 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Arg 2S34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Aιg aw4 Lys 23 -(GlyoAOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Ser 3 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Ser'Αsp^Arg^Lys 23 - (Glyc-AOct)-GLP-l (7-38); Ser B Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Arg 634 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Sei^Asp^Arg^^Lys 27 - (Glyc-AOct)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-AOct)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 18 - (Glyc-AOct)-GLP-l (7-38); Thr B Asp 17 Arg 2634 Lys 18 -(Glyc-AOct)-GLP-1 (7-38); Arg 2634 Lys 23 -(Glyc-AOct)-GLP- 1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); 124 Thr s Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 23 -(Glyc-AOct)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 23 - (Glyc-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Arg 263 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 7 -(Glyc-AOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7- 36); Thr s Asp 19 Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7-36)amide; Thι Λ Asp 17 Arg 6 ' 34 Lys 27 -(Glyc-AOct)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-AOct)-GLP-1 (7-37); Thi sp^Arg^Lys 27 - (Glyc-AOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 27 -(Glyc-AOct)-GLP-1 (7-38); Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36); Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 36 -(Glyc- ALit)-GLP-1(7-36); Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(Glyc-ALit)-GLP-1(7- 36)amide; Arg 634 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-37); Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-37); Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-37); Arg 26 Lys 34 -(Glyc- ALit)-GLP-1(7-38); Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-38) ; Arg 2634 Lys 38 -(Glyc-ALit)-GLP-1(7-38); Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-39); Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-39); Arg 26 ' 34 Lys 39 -(Glyc- Aϋt)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36) Gly 8 Arg 26 ' 3 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36)amide Gly 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide Gly 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Val 8 Arg 26 Lys 3 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Arg 25 Lys 34 -(Glyc-ALit)-GLP-1 (7-36)amide Val 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide Val 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Arg 3 Lys 26 -(Glyc-ALit)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-39) Val 8 Arg 2634 Lys 39 -(Glyc-ALit)-GLP-1(7-39); 125 Ser a Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36) Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Ser B Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36)amide Ser 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide Ser 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-38) Ser 8 Arg 2634 Lys 38 -(Glyc-ALit)-GLP-1 (7-38) Ser 3 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-39) Ser 8 Arg 634 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Thr β Arg 6 Lys 34 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36) Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-36)amide Thr 3 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide Thr 3 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-37) Thr 3 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(Glyc-ALit)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(Glyc-ALit)-GLP-1 (7-39) Thr 3 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc- ALit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 634 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc- ALit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(Giyc-ALit)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 3 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Gly' sp∞Arg^Lys 37 - (Giyc-ALit)-GLP-l (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 - (Glyc-ALit)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Glu 35 Arg 8 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 - 34 Lys 37 -(Giyc-ALit)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(Giyc-ALit)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(Glyc- ALit)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc- ALit)-GLP-1 (7-39); 126 Val 8 Asp 35 Arg 26 ' 3 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(Glyc- ALit)-GLP-1 (7-37); Val 8 Asp 37 Arg 263 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc- ALit)-GLP-1 (7-39); Ser a Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Ser 8 Glu 35 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Ser 3 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Ser 3 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc- ALit)-GLP-1 (7-37); Ser 3 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Sei^Glu∞Arg∞^Lys^Glyc- ALit)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Ser s Asp 35 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Ser 8 Asp 35 Arg 6 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Sei^Asp∞Arg ^Lys 37 - (Glyc-ALit)-GLP-l (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Ser'Asp∞Arg^Lys 39 - (Glyc-ALit)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Thr 3 Glu 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(Glyc- ALit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Giu 38 Arg 26 - 34 Lys 39 -(Glyc- ALit)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ALit)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(Glyc-ALit)-GLP-1 (7-37); Thr B Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)- GLP-1 (7-38); Thr 3 Asp 38 Arg 26 ' 34 Lys 39 -(Glyc-ALit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(Glyc-ALit)- GLP-1 (7-36); Thr 8 Asp 35 Arg 28 ' 34 Lys 36 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 2834 Lys 37 - (Glyc-ALit)-GLP-l (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(Glyc-ALit)-GLP-1 (7-38); Th^Asp∞Arg ^Lys 39 - (Glyc-Aϋt)-GLP-1 (7-39); Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 3 Lys 18 -(Glyc- Aϋt)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 634 Lys 18 -(Glyc- ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; 127 Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glyc-ALit)-GLP-l (7-37); Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glyc- Aϋt)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glyc-ALit)-GLP-1 (7-37); Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glyc- ALit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc- ALit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Gly 8 Asp 9 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 7 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 8 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 634 Lys 18 -(Glyc- ALit)-GLP-1 (7-36); Val 8 Asp 7 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc- Aϋt)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 634 Lys 23 - (Glyc-Aϋt)-GLP-I (7-37); Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 263 Lys 23 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 6 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc- ALit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc- ALit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 - 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 3 Lys 18 -(Glyc- 128 ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Giyc-ALit)-GLP-1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 18 -(Glyc- ALit)-GLP-1 (7-36)amide; Ser 8 Asp 7 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 3 Lys 18 -(Glyc-ALit)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 263 Lys 23 - (Glyc-ALit)-GLP-l (7-37); Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Ser 8 Asp 19 Arg 2634 Lys 23 -(Glyc- ALit)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-37); Ser 3 Asp 19 Arg 263 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Ser s Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc- ALit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc- ALit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 18 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 8 -(Glyc- ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Asp 9 Arg 6 ' 34 Lys 8 -(Glyc- ALit)-GLP-1 (7-36)amide; Thr s Asp 17 Arg 2634 Lys 18 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-37); Thr s Asp 19 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(Glyc-ALit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 23 - (Glyc-ALit)-GLP-l (7-37); Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-36); Thr B Asp 19 Arg 26 ' 34 Lys 23 -(Glyc- ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 23 -(Glyc-ALit)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2534 Lys 3 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Asp 7 Arg 26 ' 34 Lys 23 -(Glyc-ALit)-GLP-1 (7-38); Arg 2634 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Arg 2634 Lys 27 - (Glyc-ALit)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Asp 9 Arg 2634 Lys 27 -(Glyc- ALit)-GLP-1 (7-36); Thr a Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36); Thr 8 Asp 19 Arg 2634 Lys 27 -(Glyc- ALit)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-36)amide; Thr B Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-37); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(Glyc-ALit)-GLP-1 (7-38); 129 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36); Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36); Arg∞^Lys 36 - (GAB-GDod)-GLP-l (7-36); Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(GAB- GDod)-GLP-1(7-36)amide; Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1(7-36)amide; Arg 26 Lys 34 -(GAB- GDod)-GLP-1 (7-37); Arg 34 Lys 6 -(GAB-GDod)-GLP-1 (7-37); Arg 2634 Lys 36 -(GAB-GDod)-GLP- 1(7-37); Arg 26 Lys 34 -(GAB-GDod)-GLP-1(7-38); Arg 34 Lys 26 -(GAB-GDod)-GLP-1(7-38) ; Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7-38); Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-39); Arg^Lys 26 - (GAB-GDod)-GLP-l (7-39); Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Arg 26 Lys 3 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Gly 8 Arg 6 Lys 34 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-37) Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Val 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Arg 2634 Lys 38 -(GAB-GDod)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 3 -(GAB-GDod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-37) Val 8 Arg 2W4 Lys 36 -(GAB-GDod)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-38) ; Val 8 Arg 2634 Lys 38 -(GAB-GDod)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-39) Val 8 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 28 -(GAB-GDod)-GLP-1 (7-36)amide; Ser 8 Arg 263 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 28 -(GAB-GDod)-GLP-1 (7- 37); Ser 8 Arg 26 ' 3 Lys 36 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-38) ; Ser 3 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7-38) Ser 3 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-39) Ser 8 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-36)amide; Thr £ Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 3 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7- 130 36)amide; Thr 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-37); Thr 3 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-38) ; Thr 8 Arg 2634 Lys 38 -(GAB-GDod)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(GAB-GDod)-GLP-1 (7-39); Thr 3 Arg 34 Lys 26 -(GAB-GDod)-GLP-1 (7-39) Thr s Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Gly^lu^Arg^^Lys 36 - (GAB-GDod)-GLP-l (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 3 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Gly'Αsp^Arg ^Lys 36 - (GAB-GDod)-GLP-l (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Val 8 Glu 37 Arg 2834 Lys 38 -(GAB-GDod)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GDod)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Val 8 Glu 37 Arg 6 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Vai 8 Asp 38 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Va Asp Arg∞^Lys 36 - (GAB-GDod)-GLP-l (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Se Glu Arg∞^Lys 36 - (GAB-GDod)-GLP-l (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; 131 Ser 3 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Ser B Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Ser B Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 3 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Ser £ Asp 38 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Sei sp Arg^^Lys 36 - (GAB-GDod)-GLP-l (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Ser 3 Asp 37 Arg 2834 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Thi^Glu Arg∞^Lys 36 - (GAB-GDod)-GLP-l (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GDod)-GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Thr^Asp Arg ^Lys 36 - (GAB-GDod)-GLP-l (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 3 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GDod)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GDod)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 263 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 6 ' 34 Lys 18 -(GAB- GDod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Arg 26 ' 3 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 9 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB- GDod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7- 38); 132 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Arg 2834 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- GDod)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Gly 8 Asp 7 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 3 Lys 8 -(GAB-GDod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 263 Lys 18 -(GAB- GDod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Val 8 Asp 7 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(GAB- GDod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ;34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 9 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- GDod)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Val 8 Asp 17 Arg 28 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 38); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Ser 3 Asp 19 Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 8 -(GAB-GDod)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GDod)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-37); 133 Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 38); Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Arg 6 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 3 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Ser 8 Asp 9 Arg 26 ' 34 Lys' 3 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7- 36); Ser a Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Ser a Asp 17 Arg 26 ' 34 Lys 23 -(GAB- GDod)-GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Se^Asp^Arg ^Lys 2" (GAB-GDod)-GLP-l (7-38); Ser 3 Asp 7 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7- 38); Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- GDod)-GLP-1 (7-36)amide; Ser a Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Ser 3 Asp 7 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 38); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Thr 8 Asp 9 Arg 26 ' 34 Lys 8 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 36); Thr β Asp 19 Arg 2634 Lys 8 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GDod)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GDod)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Arg 28 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Thr 3 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 3 Lys 23 -(GAB-GDod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB- GDod)-GLP-1 (7-36)amide; Thr 3 Asp 9 Arg 634 Lys 23 -(GAB-GDod)-GLP-1 (7-37); Thr 3 Asp 19 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7-38); Thr 8 Asp 7 Arg 2634 Lys 23 -(GAB-GDod)-GLP-1 (7- 38); Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- 134 GDod)-GLP-1 (7-36)amide; Thr 8 Asp 9 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 27 -(GAB-GDod)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GDod)-GLP-1 (7- 38); Arg 6 Lys 34 -(GAB-GTet)-GLP-1 (7-36); Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36); Arg 263 Lys 36 -(GAB- GTet)-GLP-1(7-36); Arg 26 Lys 34 -(GAB-GTet)-GLP-1(7-36)amide; Arg 34 Lys 26 -(GAB-GTet)-GLP- 1(7-36)amide; Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1(7-36)amide; Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7- 37); Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1(7-37); Arg∞Lys 34 - (GAB-GTet)-GLP-1 (7-38); Arg 34 Lys 26 -(GAB-GTet)-GLP-1(7-38) ; Arg 2634 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Arg 26 Lys 3 -(GAB-GTet)-GLP-1 (7-39); Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-39); Arg 28 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Val 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-39) Val 8 Arg 2634 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Ser 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Ser 3 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(GAB-GTet)-GLP- 1(7-37); Ser 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1(7-37) Ser B Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-39) Ser 3 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1(7-39); 135 Thr β Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7-38) Thr 8 Arg 26 Lys 34 -(GAB-GTet)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(GAB-GTet)-GLP-1 (7-39) Thr 3 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 634 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 2634 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 263 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Gly 8 Asp 35 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Val 8 Asp 35 Arg 263 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Val 8 Asp 38 Arg 2834 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Val 8 Asp 35 Arg 2S ' 3 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 263 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- 136 GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Ser B Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Ser B Glu 38 Arg 2634 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 3 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Ser B Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Ser 3 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Ser s Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 3 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 634 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Thr B Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Thr β Glu 37 Arg 2634 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Thr 3 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Thr β Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(GAB-GTet)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GTet)- GLP-1 (7-38); Thr 3 Asp 38 Arg 2634 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB- GTet)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GTet)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(GAB-GTet)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GTet)-GLP-1 (7-39); Arg 263 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 3 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7- 36); Gly 8 Asp 9 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 3 Lys 18 -(GAB-GTet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Gly^sp^Arg'^Lys 18 - (GAB-GTet)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 23 -(GAB-GTet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 3 -(GAB-GTet)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 - (GAB-GTet)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-38); 137 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GTet)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Gly'Αsp^Arg^Lys 27 - (GAB-GTet)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 3 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-37); VafAsp^Arg∞^Lys 18 - (GAB-GTet)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-37); VafAsp^Arg^Lys 23 - (GAB-GTet)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2W4 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GTet)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 3 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (GAB-GTet)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 8 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 8 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 263 Lys 18 -(GAB-GTet)-GLP-1 (7-37); SeH'Asp^Arg^Lys 18 - (GAB-GTet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(GAB-GTet)- 138 ,23 GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Ser'Αsp^Arg^Lys 2 (GAB-GTet)-GLP-l (7-38); Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Arg 2634 Lys 7 -(GAB-GTet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Ser 3 Asp 17 Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 27 -(GAB-GTet)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Ser'Αsp^Arg^Lys 27 - (GAB-GTet)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 7 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Thr 3 Asp 19 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 18 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 18 -(GAB-GTet)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GTet)-GLP-1 (7-37); Th^Asp^Arg∞^Lys 18 - (GAB-GTet)-GLP-l (7-38); Thr B Asp 17 Arg 634 Lys 18 -(GAB-GTet)-GLP-1 (7-38); Arg 26 ' 3 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Arg 2634 Lys 3 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 23 -(GAB-GTet)- GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GTet)-GLP-1 (7-37); Thi^Asp^Arg ^Lys 23 - (GAB-GTet)-GLP-l (7-38); Thr 8 Asp 17 Arg 2634 Lys 23 -(GAB-GTet)-GLP-1 (7-38); Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-37); Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Thr 8 Asp 19 Arg 2634 Lys 27 -(GAB-GTet)-GLP-1 (7-36); Thr 3 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 7 -(GAB-GTet)- GLP-1(7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GTet)-GLP-1(7-37); Thi^Asp^Arg'^Lys 27 - (GAB-GTet)-GLP-l (7-38); Thr 8 Asp 17 Arg 28 ' 34 Lys 27 -(GAB-GTet)-GLP-1 (7-38); Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36); Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36); Arg 2634 Lys 36 - (GAB-GHex)-GLP-l (7-36); Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(GAB- GHex)-GLP-1(7-36)amide; Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(GAB- GHex)-GLP-1 (7-37); Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-37); Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7- 37); Arg 26 Lys 34 -(GAB-GHex)-GLP-1(7-38); Arg 34 Lys 26 -(GAB-GHex)-GLP-1(7-38) ; Arg 2634 Lys 38 - (GAB-GHex)-GLP-l (7-38); Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-39); Arg 34 Lys 26 -(GAB-GHex)- GLP-1 (7-39); Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); 139 Gly 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-38) ; Gly 8 Arg 2634 Lys 38 -(GAB-GHex)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Val 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-37) Val 8 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-39) Val 8 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1(7-39); Ser 3 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7-36); Ser 3 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 6 -(GAB-GHex)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-37); Ser 3 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-38) ; Ser 8 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7-38) Ser s Arg 26 Lys 3 -(GAB-GHex)-GLP-1 (7-39); Ser 8 Arg 34 Lys 6 -(GAB-GHex)-GLP-1 (7-39) Ser 8 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Thr 3 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-36)amide; Thr 8 Arg 26 ' 34 Lys 3δ -(GAB-GHex)-GLP-1 (7- 36)amide; Thr s Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-37); Thr 3 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-37); Thr 3 Arg 28 Lys 34 -(GAB-GHex)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1(7-38) ; Thr a Arg 2634 Lys 38 -(GAB-GHex)-GLP-1 (7-38) Thr 3 Arg 26 Lys 34 -(GAB-GHex)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(GAB-GHex)-GLP-1 (7-39) Thr 3 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1(7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GHex)- 140 GLP-1 (7-38); Gly 8 Glu 38 Arg 263 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GHex)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Glu 37 Arg 634 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GHex)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ;i4 Lys 36 - (GAB-GHex)-GLP-l (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Asp 37 Arg 2634 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 263 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GHex)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GHex)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Val 8 Glu 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- GHex)-GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 - (GAB-GHex)-GLP-l (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Val 8 Asp 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB- GHex)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Sei^Glu Arg^Lys 36 - (GAB-GHex)-GLP-l (7-36); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Ser 3 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Ser 3 Asp 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 263 Lys 38 -(GAB- GHex)-GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Sei sp Arg^Lys 36 - (GAB-GHex)-GLP-l (7-36); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Asp 37 Arg 28 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Ser 3 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); 141 Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Thr β Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(GAB-GHex)- GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB- GHex)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Thr a Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Thr 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(GAB- GHex)-GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 38 - (GAB-GHex)-GLP-l (7-36); Thr B Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GHex)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(GAB-GHex)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GHex)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GHex)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Arg 6 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 9 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 634 Lys 18 -(GAB-GHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GHex)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Arg 2634 Lys 3 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Asp 7 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB- GHex)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 38); Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 9 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 27 -(GAB- GHex)-GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Gly 8 Asp 17 Arg 28 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7- 38); 142 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GHex)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(GAB- GHex)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 38); Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Arg 634 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 27 -(GAB- GHex)-GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Val 8 Asp 19 Arg 6 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Arg 2W4 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 8 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GHex)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 3 Lys 18 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 36); Ser 3 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(GAB- GHex)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-37); 143 Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 3 -(GAB-GHex)-GLP-1 (7- 38); Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Arg 2W4 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Ser*Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Ser 8 Asp 17 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7- 36); Ser s Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- GHex)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7- 38); Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Arg 2634 Lys 8 -(GAB-GHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 263 Lys 18 -(GAB-GHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-36)amide; Thr s Asp 17 Arg 2634 Lys 18 -(GAB- GHex)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GHex)-GLP-1 (7-37); Thr 8 Asp 19 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7-38); Thr 3 Asp 7 Arg 2634 Lys 18 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 3 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP~1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 23 -(GAB-GHex)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 23 -(GAB- GHex)-GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-37); Thr 3 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7-38); Thr 3 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-36)amide; Thr 3 Asp 17 Arg 26 ' 34 Lys 27 -(GAB- GHex)-GLP-1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7-37); Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GHex)-GLP-1 (7-38); Thr 8 Asp 17 Arg 2634 Lys 27 -(GAB-GHex)-GLP-1 (7- 38); Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36); Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36)amide; Arg^Lys -fGAB-GOctj-GLP- 1 (7-36)amide; Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7- 37); Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-37); Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-37); Arg^Lys 34 - 144 (GAB-GOct)-GLP-1 (7-38); Arg 34 Lys 26 -(GAB-GOct)-GLP-1(7-38) ; Arg 2634 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-39); Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-39); Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-37) Gly 8 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-38) ; Gly 8 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7-38) Gly 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-39) Gly 8 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Val 8 Arg 6 Lys 34 -(GAB-GOct)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36); Val 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Val 8 Arg 6 Lys 34 -(GAB-GOct)-GLP-1(7-37); Val 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1(7-37) Val 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-38) Val 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-38) ; Val 8 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-39) Val 8 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1(7-39); Ser B Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36); Ser B Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36); Ser 3 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Ser 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36)amide; Ser 3 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36)amide; Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Ser 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-37); Ser 3 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-37) Ser 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-38) Ser 3 Arg 34 Lys 26 -(GAB-GOct)-GLP-1(7-38) ; Ser 8 Arg 2634 Lys 38 -(GAB-GOct)-GLP-1(7-38) Ser 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-39) Ser 8 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36); Thr a Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Thr 3 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 3 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Thr 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-37); Thr 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-38) ; Thr 8 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7-38) 145 Thr 8 Arg 26 Lys 34 -(GAB-GOct)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 -(GAB-GOct)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Gly 8 Glu 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 26 ' 3 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Asp 37 Arg 28 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Gly 8 Asp 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 2634 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Val 8 Glu 35 Arg 2634 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Glu 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Val 8 Glu 37 Arg 634 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Val 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Val 8 Asp 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Asp 36 Arg 6 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Val 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Val 8 Asp 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Ser 8 Glu 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Ser 3 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Ser 8 Glu 38 Arg 634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Ser 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Ser 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Ser 8 Glu 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Ser 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Ser 8 Asp 35 Arg 263 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB- 146 GOct)-GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Se^Asp Arg∞^Lys 36 - (GAB-GOct)-GLP-l (7-36); Ser 8 Asp 35 Arg 263 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Ser 8 Asp 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Thr 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Thr 8 Glu 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Thr 8 Glu 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Thr B Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Thr B Glu 38 Arg 2634 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 38 -(GAB-GOct)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 2634 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GOct)- GLP-1 (7-38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Thr 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB- GOct)-GLP-1 (7-36); Thr*Asp 35 Arg 2634 Lys 36 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Asp 36 Arg 6 ' 34 Lys 37 -(GAB-GOct)-GLP-1 (7-37); Thr 8 Asp 37 Arg 2634 Lys 38 -(GAB-GOct)-GLP-1 (7- 38); Thr 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GOct)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Arg 2634 Lys 8 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2834 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 18 -(GAB-GOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 - (GAB-GOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 2W4 Lys 8 -(GAB-GOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Arg 28 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 634 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 23 - (GAB-GOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 7 -(GAB-GOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Gly 8 Asp 17 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7- 36); Gly 8 Asp 19 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 2634 Lys 7 -(GAB-GOct)- GLP-1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Gly^sp^Arg^^Lys 27 - (GAB-GOct)-GLP-l (7-38); Gly 8 Asp 17 Arg 2634 Lys 7 -(GAB-GOct)-GLP-1 (7-38); 147 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 263 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7- 36); Val 8 Asp 9 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 18 -(GAB-GOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-37); VafAsp^Arg∞^Lys 18 - (GAB-GOct)-GLP-l (7-38); Val 8 Asp 17 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 2634 Lys 23 -(GAB-GOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 23 - (GAB-GOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 7 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7- 36); Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GOct)- GLP-1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 27 - (GAB-GOct)-GLP-l (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Ser 8 Asp 19 Arg 2634 Lys 8 -(GAB-GOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7- 36); Ser B Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Ser a Asp 17 Arg 26 ' 34 Lys 18 -(GAB- GOct)-GLP-1 (7-36)amide; Ser 3 Asp 19 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 8 -(GAB-GOct)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7- 38); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Arg 6 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Ser 3 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 2634 Lys 23 -(GAB- GOct)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 3 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Ser 8 Asp 17 Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7- 38); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-38); 148 Ser 8 Asp 19 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Ser B Asp 17 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Ser a Asp 7 Arg 26 ' 34 Lys 27 -(GAB- GOct)-GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Ser 8 Asp 19 Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 7 -(GAB-GOct)-GLP-1 (7- 38); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Thr 3 Asp 9 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Asp 7 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 2634 Lys 18 -(GAB-GOct)- GLP-1(7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1(7-37); Thi^Asp^Arg^^Lys 18 - (GAB-GOct)-GLP-l (7-38); Thr 3 Asp 17 Arg 2634 Lys 18 -(GAB-GOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7- 36); Thr 8 Asp 9 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)- GLP-1 (7-36)amide; Thr B Asp 19 Arg 2634 Lys 23 -(GAB-GOct)-GLP-1 (7-37); ThHΑsp^Arg^Lys 23 - (GAB-GOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GOct)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Arg 2634 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-36); Thr 8 Asp 17 Arg 2834 Lys 27 -(GAB-GOct)-GLP-1 (7- 36); Thr 8 Asp 19 Arg 26 ' 34 Lys 7 -(GAB-GOct)-GLP-1 (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GOct)- GLP-1 (7-36)amide; Thr 3 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-37); Thi^Asp^Arg^^Lys 27 - (GAB-GOct)-GLP-l (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GOct)-GLP-1 (7-38); Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36); Arg 3 Lys 26 -(GAB-GLit)-GLP-1 (7-36); Arg 2634 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36)amide; Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7- 36)amide; Arg 2634 Lys 36 -(GAB-GLit)-GLP-1(7-36)amide; Arg 26 Lys 34 -(GAB-GLit)-GLP- 1 (7-37); Arg 34 Lys 6 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-37); Arg 26 Lys 34 -(GAB- GLit)-GLP-1(7-38); Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-38) ; Arg 2634 Lys 38 -(GAB-GLit)-GLP-1(7-38); Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-39); Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-39); Arg 2634 Lys 39 -(GAB- GLit)-GLP-1(7-39); Gly 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36)amide; Gly 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-36)amide; Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Gly 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-37); 149 Gly 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-38) ; Gly 8 Arg 2W4 Lys 38 -(GAB-GLit)-GLP-1(7-38) Gly 8 Arg 6 Lys 34 -(GAB-GLit)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-39) Gly 8 Arg 2634 Lys 39 -(GAB-GLit)-GLP-1(7-39); Val 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36); Val 8 Arg 3 Lys 26 -(GAB-GLit)-GLP-1 (7-36); Val 8 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Arg 2834 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Val 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-37) Val 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1(7-37); Val 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-38) Val 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-38) ; Val 8 Arg 26 ' 3 Lys 38 -(GAB-GLit)-GLP-1 (7-38) Val 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-39); Val 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-39) Val 8 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1(7-39); Ser 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-36); Ser 3 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-36); Ser 3 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Ser s Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-36)amide; Ser β Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-36)amide; Ser 3 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1(7- 36)amide; Ser 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-37) Ser s Arg 2634 Lys 36 -(GAB-GLit)-GLP-1(7-37); Ser 3 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-38) ; Ser 8 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1 (7-38) Ser 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-39); Ser 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-39) Ser a Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1(7-39); Thr 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-36); Thr 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-36); Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1(7-36); Thr 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-36)amide; Thr 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-36)amide; Thr 8 Arg 634 Lys 36 -(GAB-GLit)-GLP-1(7- 36)amide; Thr 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1 (7-37) Thr 8 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1(7-37); Thr 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-38) Thi rg^Lys∞-fGAB-GLitJ-GLP-l (7-38) ; Thr 3 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1(7-38) Thr 8 Arg 26 Lys 34 -(GAB-GLit)-GLP-1(7-39); Thr 8 Arg 34 Lys 26 -(GAB-GLit)-GLP-1(7-39) Thr 8 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1(7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Gly 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)- GLP-1(7-38); Gly 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Gly 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)- GLP-1 (7-36); Gly 8 Glu 35 Arg 28 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Gly^lu∞Arg∞^Lys 37 - (GAB-GLit)-GLP-l (7-37); Gly 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Gly'Olu∞Arg^Lys 39 - (GAB-GLit)-GLP-1 (7-39); 150 Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Gly 8 Asp 35 Arg 2634 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Gly 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Gly 8 Asp 36 Arg 2634 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Gly 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Val 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Val 8 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Val 8 Glu 38 Arg 2634 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Val 8 Glu 35 Arg 2834 Lys 36 -(GAB-GLit)- GLP-1 (7-36); Val 8 Glu 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; VafGlu∞Arg^Lys 37 - (GAB-GLit)-GLP-l (7-37); Val 8 Glu 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)-GLP-1 (7-38); VaPGIu∞Arg^Lys 39 - (GAB-GLit)-GLP-1 (7-39); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Val 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Val 8 Asp 35 Arg 2634 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Val 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Asp 3δ Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Val 8 Asp 37 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Val 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Ser 8 Glu 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Ser 3 Glu 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Ser 8 Glu 35 Arg 26 ' 3 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Ser 8 Glu 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Sei^Glu∞Arg^Lys 37 - (GAB-GLit)-GLP-l (7-37); Ser 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Ser 8 Glu 38 Arg 26 ' 3 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Ser 8 Asp 36 Arg 2634 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Ser 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Ser 8 Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Ser 8 Asp 35 Arg 2634 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Ser 3 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Ser 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Ser 8 Asp 37 Arg 634 Lys 38 -(GAB-GLit)-GLP-1 (7- 38); Ser fl Asp 38 Arg 6 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Thr B Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 38 -(GAB-GLit)-GLP-1 (7- 36)amide; Thr 8 Glu 36 Arg 2634 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Thr 8 Glu 38 Arg 2634 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Thr 3 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)- GLP-1 (7-36); Thr 8 Glu 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Thi^Glu∞Arg∞^Lys 37 - 151 39 (GAB-GLit)-GLP-l (7-37); Thr 8 Glu 37 Arg 2634 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Thr 8 Glu 38 Arg 26 ' 34 Lys : (GAB-GLit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 26 ' 34 Lys 36 -(GAB-GLit)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7- 36)amide; Thr 8 Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)- GLP-1 (7-38); Thr s Asp 38 Arg 26 ' 34 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Thr 8 Asp 35 Arg 2634 Lys 36 -(GAB- GLit)-GLP-1 (7-36); Thr 8 Asp 35 Arg 2634 Lys 36 -(GAB-GLit)-GLP-1 (7-36)amide; Thr s Asp 36 Arg 26 ' 34 Lys 37 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Asp 37 Arg 26 ' 34 Lys 38 -(GAB-GLit)-GLP-1 (7-38); Thr 8 Asp 38 Arg 2634 Lys 39 -(GAB-GLit)-GLP-1 (7-39); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-38) Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP- 1 (7-36)amide; Gly 8 Asp 19 Arg 634 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2634 Lys 18 -(GAB- GLit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 26 ' 3 Lys 18 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide Arg 2834 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-GLit)-GLP-1 (7-38) Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 263 Lys 23 -(GAB-GLit)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP- 1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Asp 9 Arg 2634 Lys 23 -(GAB- GLit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 23 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Arg 6 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36)amide Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 7 -(GAB-GLit)-GLP-1 (7-38) Gly 8 Asp 19 Arg 6 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36) Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1(7-36)amide; Gly 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP- 1 (7-36)amide; Gly 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Gly 8 Asp 19 Arg 2834 Lys 27 -(GAB- GLit)-GLP-1 (7-38); Gly 8 Asp 17 Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-38); Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 8 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-38) Val 8 Asp 19 Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Val 8 Asp 17 Arg 2634 Lys 8 -(GAB-GLit)-GLP-1 (7-36) Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Val 8 Asp 19 Arg 2634 Lys 18 -(GAB- GLit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Arg 2634 Lys 23 -(GAB-Gϋt)-GLP-1 (7-38); 152 VaI 8 Asp 19 Arg 2634 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP- 1 (7-36)amide; Val 8 Asp 1 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Val 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB- GLit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 3 Lys 23 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 7 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 3 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-38) Val 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36) Val 8 Asp 9 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36)amide; Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP- 1 (7-36)amide; Val 8 Asp 19 Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Val 8 Asp 19 Arg 263 Lys 27 -(GAB- GLit)-GLP-1 (7-38); Val 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 8 -(GAB-GLit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-38); Ser fi Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Ser 8 Asp 7 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7- 36); Ser 8 Asp 9 Arg 26 - 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)- GLP-1 (7-36)amide; Ser s Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); SeH'Asp^Arg^Lys 18 - (GAB-GLit)-GLP-l (7-38); Ser 8 Asp 7 Arg 26 ' 34 Lys 8 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 3 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-38); Ser B Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Ser B Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7- 36); Ser s Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide; Ser 3 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Sei^Asp^Arg∞^Lys 23 - (GAB-GLit)-GLP-l (7-38); Ser 3 Asp 17 Arg 26 ' 3 Lys 23 -(GAB-GLit)-GLP-1 (7-38); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36)amide; Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-38); Ser 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7- 36); Ser 8 Asp 19 Arg 26 ' 34 Lys 7 -(GAB-GLit)-GLP-1 (7-36)amide; Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)- GLP-1 (7-36)amide; Ser 8 Asp 19 Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Sei^Asp^Arg^Lys 27 - (GAB-GLit)-GLP-l (7-38); Ser 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-38); Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-38) Thr s Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36) Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-36)amide; Thr 3 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP- 1 (7-36)amide; Thr 8 Asp 19 Arg 2634 Lys 18 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Asp 19 Arg 26 ' 34 Lys 18 -(GAB- GLit)-GLP-1 (7-38); Thr 3 Asp 17 Arg 26 ' 34 Lys 18 -(GAB-GLit)-GLP-1 (7-38); 153 Arg 2634 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-38) Thr 8 Asp 19 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 3 Lys 23 -(GAB-GLit)-GLP-1 (7-36) Thr 8 Asp 19 Arg 2634 Lys 23 (GAB-GLit)-GLP-1(7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP- 1 (7-36)amide; Thr & sp 19 Arg 2634 Lys 23 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Asp 9 Arg 26 ' 34 Lys 23 -(GAB- GLit)-GLP-1 (7-38); hr 8 Asp 17 Arg 26 ' 34 Lys 23 -(GAB-GLit)-GLP-1 (7-38); Arg 2634 Lys 27 -(GAB- GLit)-GLP-1 (7-36); Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-36)amide Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-38) Thr 8 Asp 9 Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-36); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-36) Thr^Asp^Arg^Lys 27 (GAB-GLit)-GLP-l (7-36)amide; Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP- 1 (7-36)amide; Thr δ Asp 19 Arg 2634 Lys 27 -(GAB-GLit)-GLP-1 (7-37); Thr 8 Asp 19 Arg 26 ' 34 Lys 27 -(GAB- GLit)-GLP-1 (7-38); Thr 8 Asp 17 Arg 26 ' 34 Lys 27 -(GAB-GLit)-GLP-1 (7-38); Other preferred derivatives of GLP-1 analogs of the present invention are: Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-37); Lys 2W4 -bis-(Glut ADod)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-39) Arg 26 Lys 3436 -bis Glut-ADod)-GLP-1 (7-36) Arg 34 Lys 2636 -bis-(Glut-ADod)-GLP-1(7-36) Arg Lys^ -bis Glut-ADod)-GLP-1 (7-37) Arg 34 Lys 2636 -bis-(Glut-ADod)-GLP-1(7-37) Arg∞Lys^-bis-i Glut-ADod)-GLP-1 (7-37) Arg 34 Lys 26 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Arg Lys^^-bis- Glut-ADod)-GLP-1 (7-39) Arg 34 Lys 2839 -bis-(Glut-ADod)-GLP-1 (7-39) Arg 2634 Lys 3639 -bis-(Glut-ADod)-GLP -1(7-39); Arg 26 Lys 1834 -bis- Glut-ADod)-GLP-1 (7-36) Arg 34 Lys 18 ' 26 -bis-(Glut-ADod)-GLP-1 (7-36) Arg 26 Lys 1834 -bis- Glut-ADod)-GLP-1 (7-37) Arg 34 Lys 18 ' 26 -bis-(Giut-ADod)-GLP-1(7-37) Arg 26 Lys 1834 -bis- Glut-ADod)-GLP-1 (7-38) Arg 34 Lys 18 ' 26 -bis-(Glut-ADod)-GLP-1(7-38) Arg 26 Lys 1!W -bis- Glut-ADod)-GLP-1 (7-39) Arg 34 Lys 18 ' 26 -bis-(Glut-ADod)-GLP-1(7-39); Arg 26 Lys 2334 -bis- Glut-ADod)-GLP-1 (7-36) Arg 34 Lys 23 ' 26 -bis-(Glut-ADod)-GLP-1(7-36) Arg 26 Lys 2334 -bis- Glut-ADod)-GLP-1 (7-37) Arg 34 Lys 2326 -bis-(Glut-ADod)-GLP-1 (7-37) Arg 26 Lys 2334 -bis- Glut-ADod)-GLP-1 (7-38) Arg 34 Lys 23 ' 26 -bis-(Glut-ADod)-GLP-1(7-38) Arg Lys∞^-bis- Glut-ADod)-GLP-1 (7-39) Arg 34 Lys 23 ' 26 -bis-(Glut-ADod)-GLP-1(7-39); Arg∞Lys^-bis- Glut-ADod)-GLP-1 (7-36) Arg 3 Lys 27 ' 26 -bis-(Glut-ADod)-GLP-1 (7-36) Arg 26 Lys 2734 -bis- Glut-ADod)-GLP-1 (7-37) Arg 34 Lys 2726 -bis-(Glut-ADod)-GLP-1(7-37) Arg 26 Lys 2734 -bis- Glut-ADod)-GLP-1 (7-38) Arg 34 Lys 27 ' 26 -bis-(Glut-ADod)-GLP-1(7-38) Arg 26 Lys 2734 -bis-ι Glut-ADod)-GLP-1 (7-39) Arg 34 Lys 27 ' 26 -bis-(Glut-ADod)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-37); Gly 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-38); Gly 8 Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-39) 154 Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ADod)-GLP-1(7-36) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-36) Gly 8 Arg 26 Lys 3436 -bis-(Glut-ADod)-GLP-1(7-37) Gly 8 Arg 34 Lys 2W6 -bis-(Glut-ADod)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(Glut-ADod)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Gly 8 Arg 26 Lys 3438 -bis-(Glut-ADod)-GLP-1(7-38) Gly 8 Arg 34 Lys 2638 -bis-(Glut-ADod)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-ADod)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ADod)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ADod)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 3639 -bis-(Glut-ADod)-GLP- 1(7-39); Val 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-37); Val 8 Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-38); Val 8 Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-39) Val 8 Arg 6 Lys 34 ' 38 -bis-(Glut-ADod)-GLP-1 (7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ADod)-GLP-1 (7-37) Val 8 Arg 34 Lys 2636 -bis-(Glut-ADod)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Val 8 Arg 26 Lys 3438 -bis-(Glut-ADod)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glut-ADod)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(Glut-ADod)-GLP-1(7-38); Val 8 Arg 26 Lys 3439 -bis-(Glut-ADod)-GLP-1(7-39) Val 8 Arg 34 Lys 2639 -bis-(Glut-ADod)-GLP-1(7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Glut-ADod)-GLP-1(7-39) Ser 8 Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-36); Ser 8 Lys 26 ' 3 -bis-(Glut-ADod)-GLP-1 (7-37) Ser 8 Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-38); Ser 3 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ADod)-GLP-1(7-36) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ADod)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-37) Ser 3 Arg 26 Lys 34 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ADod)-GLP-1(7-38) Ser 3 Arg 34 Lys 26 ' 38 -bis-(Glut-ADod)-GLP-1(7-38) Ser 3 Arg 2634 Lys 36 ' 38 -bis-(Glut-ADod)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ADod)-GLP-1 (7- 39); Ser s Arg 34 Lys 26 ' 39 -bis-(Glut-ADod)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ADod)-GLP- 1(7-39); Thr 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-36); Thr*Lys 2634 -bis-(Glut-ADod)-GLP-1 (7-37); Thr 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Glut-ADod)-GLP-1 (7-39) Thr 8 Arg 26 Lys 3436 -bis-(Glut-ADod)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ADod)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ADod)-GLP-1(7-37) Thr 8 Arg 26 Lys 3437 -bis-(Glut-ADod)-GLP-1 (7-37) Thr 3 Arg 34 Lys 26 ' 37 -bis-(Glut-ADod)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ADod)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Glut-ADod)-GLP-1(7-38) Thr 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-ADod)-GLP-1 (7-38); Thr 8 Arg 26 Lys 3439 -bis-(Glut-ADod)-GLP-1 (7- 39); Thr 8 Arg 34 Lys 2639 -bis-(Glut-ADod)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ADod)-GLP- 1(7-39); 155 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-37); Lys 2634 -bis-(Glut- ATet)-GLP-1 (7-38); Lys 2634 -bis-(Glut-ATet)-GLP-1 (7-39) Arg 26 Lys 3 ' 36 -bis- Glut-ATet)-GLP-1 (7-36) Arg^Lys '∞-bis- Glut-ATet)-GLP-1 7-36) Arg Lys^∞-bis- Glut-ATet)-GLP-1 (7-37) Arg 3 4Lys 26,36. bJs . Glut-ATet)-GLP-1 7-37) Arg Lys^-bis- Glut-ATet)-GLP-1 (7-37) Arg 34 Lys 26 ' 37 -bis- Glut-ATet)-GLP-1 7-37) Arg∞Lys^∞-bis- Glut-ATet)-GLP-1 (7-39) Arg 34 Lys 26 ' 39 -bis- Glut-ATet)-GLP-1 7-39) Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ATet)-GLP -1(7-39); Arg 26 Lys 1834 -bis. Glut-ATet)-GLP-1 (7-36) Arg^Lys^-bis- Glut-ATet)-GLP-1 7-36) Arg 26 Lys 1834 -bi* Glut-ATet)-GLP-1 (7-37) Arg^Lys^-bis- Glut-ATet)-GLP-1 7-37) Arg^Lys^'^-biS' Glut-ATet)-GLP-1 (7-38) Arg^Lys^-bis- Glut-ATet)-GLP-1 7-38) Arg 26 Lys 1834 -bis Glut-ATet)-GLP-1 (7-39) Arg 34 Lys 1826 -bis-(Glut-ATet)- GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis- Glut-ATet)-GLP-1 (7-36) Arg^Lys '∞-bis- Glut-ATet)-GLP-1 7-36) Arg 26 Lys 23, 34 . bJs . Glut-ATet)-GLP-1 (7-37) Arg^Lys ∞-bis- Glut-ATet)-GLP-1 7-37) Arg 26 Lys 2334 -bis- Glut-ATet)-GLP-1 (7-38) Arg^Lys ^-bis- Glut-ATet)-GLP-1 7-38) Arg 26 Lys 2334 -bis- Glut-ATet)-GLP-1 (7-39) Arg 34 Lys 23 ' 26 -bis-(Glut-ATet)- GLP-1(7-39); Arg 26 Lys 2734 -bis- Glut-ATet)-GLP-1 (7-36) Arg 34 Lys 27 6 -bis- Glut-ATet)-GLP-1 7-36) Arg 26 Lys 2734 -bis- Glut-ATet)-GLP-1 (7-37) Arg^Lys^ -bis- Glut-ATet)-GLP-1 7-37) Arg 26 Lys 2734 -bis- Glut-ATet)-GLP-1 (7-38) Arg^Lys^^-bis- Glut-ATet)-GLP-1 7-38) Arg 26 Lys 2734 -bis- Glut-ATet)-GLP-1 (7-39) A Arrgg 33 LLyyss 2277 '' 2266 --bbiiss--((GGlluutt--AATTeett))--GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-37); Gly 8 Lys -26,34 bis-(Glut-ATet)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-39) Gly 8 Arg 26 Lys 3436 -bis-(Glut-ATet)-GLP-1(7-36) Gly 8 Arg 34 Lys 2636 -bis-(Glut-ATet)-GLP-1(7-36) Gly 8 Arg 26 Lys 3436 -bis-(Glut-ATet)-GLP-1(7-37) Gly 8 Arg 34 Lys 2636 -bis-(Glut-ATet)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(Glut-ATet)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ATet)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glut-ATet)-GLP-1(7-38) Gly 8 Arg 2634 Lys 3638 -bis-(Glut-ATet)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ATet)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39); Val 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-36); Val 8 Lys 26 ' 3 -bis-(Glut-ATet)-GLP-1 (7-37); Valtys 2634 - bis-(Glut-ATet)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-39) Val 8 Arg 6 Lys 34 ' 36 -bis-(Glut-ATet)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ATet)-GLP-1 (7-36) Val 8 Arg 6 Lys 3436 -bis-(Glut-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 2637 -bis-(Glut-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ATet)-GLP-1(7-38) Val 8 Arg 34 Lys 2638 -bis-(Glut-ATet)-GLP-1(7-38) 156 Val 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-ATet)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39); Val 8 Arg 34 Lys 2639 -bis-(Glut-ATet)-GLP-1(7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Glut-ATet)-GLP-1(7-39); Ser 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-36); Ser 8 Lys 2634 -bis-(Glut-ATet)-GLP-1 (7-37); Sei^Lys 2634 - bis-(Glut-ATet)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-39) Ser s Arg 26 Lys 34 ' 36 -bis-(Glut-ATet)-GLP-1(7-36) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ATet)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ATet)-GLP-1 (7-37) Ser 3 Arg 34 Lys 26 ' 36 -bis-(Glut-ATet)-GLP-1 (7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ATet)-GLP-1(7-38) Ser 3 Arg 34 Lys 26 ' 38 -bis-(Glut-ATet)-GLP-1(7-38) Ser a Arg 26 ' 34 Lys 36 ' 38 -bis-(Glut-ATet)-GLP-1 (7-38); Ser 3 Arg 26 Lys 34 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39) Ser 8 Arg 3 Lys 26 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 3639 -bis-(Glut-ATet)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(Glut-ATet)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-37); Thrtys 26 ' 34 - bis-(Glut-ATet)-GLP-1 (7-38); Thr s Lys 26 ' 34 -bis-(Glut-ATet)-GLP-1 (7-39) Thr β Arg 26 Lys 34 ' 36 -bis-(Glut-ATet)-GLP-1 (7-36) Thr 3 Arg 34 Lys 2636 -bis-(Glut-ATet)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ATet)-GLP-1 (7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ATet)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ATet)-GLP-1(7-37) Thr 8 Arg 26 Lys 3438 -bis-(Glut-ATet)-GLP-1(7-38) Thr 8 Arg 34 Lys 2638 -bis-(Glut-ATet)-GLP-1(7-38) Thr β Arg 2634 Lys 36 ' 38 -bis-(Glut-ATet)-GLP-1 (7-38); Thr 3 Arg 26 Lys 34 ' 39 -bis-(Glut-ATet)-GLP-1 (7-39) Thr 8 Arg 34 Lys 2δ ' 39 -bis-(Glut-ATet)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 3639 -bis-(Glut-ATet)-GLP-1 (7-39); Lys 2634 -bis-(Glut-AHex)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-37); Lys 26 ' 34 -bis-(Glut- AHex)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-39) Arg∞Lys^-bia (Glut-AHex)-GLP-1 (7-36) Arg 34 Lys 26 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis (Glut-AHex)-GLP-1(7-37) Arg 34 Lys 2636 -bis-(Glut-AHex)-GLP-1(7-37) Arg^Lys 34 ' 37 -^* (Glut-AHex)-GLP-1(7-37) Arg 34 Lys 26 ' 37 -bis-(Glut-AHex)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis (Glut-AHex)-GLP-1 (7-39) Arg 34 Lys 26 ' 39 -bis-(Glut-AHex)-GLP-1(7-39) Arg 26 ' 34 Lys 3639 -bis .-(Glut-AHex)-GLP-l (7-39); Arg^Lys^-bia (Glut-AHex)-GLP-1(7-36) Arg 34 Lys 18 ' 26 -bis-(Glut-AHex)-GLP-1(7-36) Arg 26 Lys 1834 -bis (Glut-AHex)-GLP-1 (7-37) Arg 34 Lys 18 ' 26 -bis-(Glut-AHex)-GLP-1(7-37) Arg Lys^-bis (Glut-AHex)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(Glut-AHex)-GLP-1 (7-38) Arg 26 Lys 1834 -bis- (Glut-AHex)-GLP-1(7-39) Arg 34 Lys 1826 -bis-(Glut-AHex)-GLP-1(7-39); Arg 28 Lys 2334 -bis. (Glut-AHex)-GLP-1(7-36) Arg 34 Lys 23 ' 26 -bis-(Glut-AHex)-GLP-1(7-36) Arg 26 Lys 2334 -bis (Glut-AHex)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Glut-AHex)-GLP-1 (7-37) Arg∞Lys∞^-bis-i (Glut-AHex)-GLP-1(7-38) Arg 34 Lys 2326 -bis-(Glut-AHex)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis (Glut-AHex)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(Glut-AHex)-GLP-1 (7-39); 157 Arg 26 Lys 27 ' 34 -bis-(Glut-AHex)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(Glut-AHex)-GLP-1(7-36) Arg 26 Lys 734 -bis-(Glut-AHex)-GLP-1(7-37) Arg 34 Lys 27 ' 26 -bis-(Glut-AHex)-GLP-1(7-37) Arg 26 Lys 2734 -bis-(Glut-AHex)-GLP-1 (7-38) Arg 34 Lys 27 ' 26 -bis-(Glut-AHex)-GLP-1(7-38) Arg 26 Lys 2734 -bis-(Glut-AHex)-GLP-1(7-39) Arg 34 Lys 2726 -bis-(Glut-AHex)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1(7-36); Gly 8 Lys 2634 -bis-(Glut-AHex)-GLP-1(7-37); Gly 8 Lys 2634 -bis-(Glut-AHex)-GLP-1 (7-38); Gly 8 Lys 2634 -bis-(Glut-AHex)-GLP-1 (7-39) Gly 8 Arg 26 Lys 3436 -bis-(Glut-AHex)-GLP-1(7-36) Gly 8 Arg 3 Lys 26 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1(7-37) Gly 8 Arg 34 Lys 2636 -bis-(Glut-AHex)-GLP-1(7-37) Gly 8 Arg 26 Lys 3 ' 37 -bis-(Glut-AHex)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glut-AHex)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glut-AHex)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AHex)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-AHex)-GLP-1(7-38); Gly 8 Arg 26 Lys 3439 -bis-(Glut-AHex)-GLP-1(7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glut-AHex)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 3639 -bis-(Glut-AHex)-GLP-1(7-39) Val 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-37); Valtys 2634 . bis-(Glut-AHex)-GLP-1 (7-38); Val 8 Lys 2634 -bis-(Glut-AHex)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1 (7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AHex)-GLP-1 (7-36) Val 8 Arg 26 Lys 3436 -bis-(Glut-AHex)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AHex)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glut-AHex)-GLP-1(7-37) Val 8 Arg 34 Lys 2637 -bis-(Glut-AHex)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glut-AHex)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AHex)-GLP-1 (7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(Glut-AHex)-GLP-1(7-38); Val 8 Arg 6 Lys 3439 -bis-(Glut-AHex)-GLP-1(7-39) Val 8 Arg 34 Lys 2639 -bis-(Glut-AHex)-GLP-1(7-39); Val 8 Arg 6 ' 3 Lys 36 ' 39 -bis-(Glut-AHex)-GLP-1(7-39); Ser 3 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-37); Ser 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-38); Ser 3 Lys 6 ' 34 -bis-(Glut-AHex)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Ser 8 Arg 3 Lys 26 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1(7-37) Ser 8 Arg 3 Lys 2636 -bis-(Glut-AHex)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glut-AHex)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Glut-AHex)-GLP-1 (7-37) Ser 8 Arg 26 Lys 3438 -bis-(Glut-AHex)-GLP-1(7-38) Ser 8 Arg 34 Lys 2638 -bis-(Glut-AHex)-GLP-1(7-38) Ser 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-AHex)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glut-AHex)-GLP-1 (7- 39); Ser 8 Arg 34 Lys 26 ' 39 -bis-(Glut-AHex)-GLP-1 (7-39); Ser 8 Arg 2634 Lys 36 ' 39 -bis-(Glut-AHex)-GLP- 1(7-39); Thr 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-36); Thr B Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-37); Thr 8 Lys 2634 -bis-(Glut-AHex)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Glut-AHex)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AHex)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AHex)-GLP-1(7-37) Thr 8 Arg 34 Lys 2636 -bis-(Glut-AHex)-GLP-1(7-37) Thr 3 Arg 26 Lys 3437 -bis-(Glut-AHex)-GLP-1(7-37) Thr 3 Arg 34 Lys 26 ' 37 -bis-(Glut-AHex)-GLP-1 (7-37) 158 Thr £ Arg 26 Lys 3438 -bis-(Glut-AHex)-GLP-1 (7-38); Thr 8 Arg 34 Lys 2638 -bis-(Glut-AHex)-GLP-1 (7-38) Thr 8 Arg 263 Lys 36 ' 38 -bis-(Glut-AHex)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Glut-AHex)-GLP-1 (7-39) Thr 8 Arg 34 Lys 26 ' 39 -bis-(Glut-AHex)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-AHex)-GLP-1 (7-39) Lys 2634 -bis-(Glut-AOct)-GLP-1 (7-36); Lys 2634 -bis-(Glut-AOct)-GLP-1 (7-37); Lys 2634 -bis-(Glut- AOct)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-39) Arg Lys^ -bis (Glut-AOct)-GLP-l (7-36); Arg^Lys 2 "' 36 -^ Glut-AOct)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-ι (Glut-AOct)-GLP-l (7-37); Arg^Lys∞'∞-bis Glut-AOct)-GLP-1(7-37) Arg Lys^-bis- (Glut-AOct)-GLP-l (7-37); Arg^Lys∞^-bis-i Glut-AOct)-GLP-1(7-37) Arg∞Lys^-bis (Glut-AOct)-GLP-l (7-39); Arg 34 Lys 2639 -bis- Glut-AOct)-GLP-1(7-39) Arg ^Lys∞^-biss-(Glut-AOct)-GLP- -1(7-39) Arg 26 Lys 1834 -bis (Glut-AOct)-GLP-l (7-36); Arg3 Lys i8. 2 6. bjs . Glut-AOct)-GLP-1 (7-36) Arg 26 Lys i8,34. bjs . (Glut-AOct)-GLP-l (7-37); Arg^Lys^-bis- Glut-AOct)-GLP-1(7-37) Arg Lys 18 ' 34 -^* (Glut-AOct)-GLP-l (7-38); Arg^Lys^^-bis- Glut-AOct)-GLP-1(7-38) Arg 26 Lys 1834 -bis. (Glut-AOct)-GLP-l (7-39); Arg 34 Lys 18 ' 26 -bis-(Glut-AOct) ■GLP-1(7-39); Arg 26 Lys 2334 -bis (Glut-AOct)-GLP-l (7-36); Arg 34 Lys 23 ' 26 -bis. Glut-AOct)-GLP-1(7-36) Arg 26 Lys 2334 -bis-ι (Glut-AOct)-GLP-l (7-37); Arg^Lys 23 ' 26 -^* Glut-AOct)-GLP-1(7-37) Arg 26 Lys 2334 -bis- (Glut-AOct)-GLP-l (7-38); Arg^Lys∞'∞-bis. Glut-AOct)-GLP-1(7-38) Arg 26 Lys 2334 -bis-ι (Glut-AOct)-GLP-l (7-39); Arg 34 Lys 2326 -bis-(Glut-AOct) GLP-1 (7-39); Arg 26 Lys 27 ' 34 -bis-ι (Glut-AOct)-GLP-l (7-36); Arg 34 Lys 27 ' 26 -bis^ Glut-AOct)-GLP-1(7-36) Arg 26 Lys 2734 -bis- (Glut-AOct)-GLP-l (7-37); Arg 34 Lys 2726 -bis Glut-AOct)-GLP-1(7-37) Arg 26 Lys 2734 -bis (Glut-AOct)-GLP-l (7-38); Arg 34 Lys 2726 -bis-ι Glut-AOct)-GLP-1(7-38) Arg 26 Lys 273 -bis (Glut-AOct)-GLP-l (7-39); Arg 34 Lys 27 ' 26 -bis-(Glut-AOct) GLP-1(7-39); Gly 8 Lys ,2 2 6 6 ^' 34 -bis-(Glut-AOct)-GLP-1 (7-36); Gly 8 Lys 2634 -bis-(Glut-AOct)-GLP-1 (7-37); Gly 8 Lys ,26,34 bis-(Glut-AOct)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Gly 8 Arg 26 Lys 3 ' 36 -bis-(Glut-AOct)-GLP-1 (7-37) Gly 8 Arg 34 Lys 2636 -bis-(Glut-AOct)-GLP-1 (7-37) Gly 8 Arg 26 Lys 3437 -bis-(Glut-AOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glut-AOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glut-AOct)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AOct)-GLP-1 (7-38) Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glut-AOct)-GLP-1(7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glut-AOct)-GLP-1(7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glut-AOct)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-AOct)-GLP-1(7-39); Val 8 Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-37); Valtys 2634 - bis-(Glut-AOct)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AOct)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1 (7-37); Val 8 Arg 34 Lys 6 ' 36 -bis-(Glut-AOct)-GLP-1 (7-37); 159 Val 8 Arg 26 Lys 34 ' 37 -bis-(Glut-AOct)-GLP-1 (7-37); Val 8 Arg 34 Lys 2637 -bis-(Glut-AOct)-GLP-1 (7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glut-AOct)-GLP-1 (7-38); Val 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AOct)-GLP-1 (7-38) Val 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-AOct)-GLP-1(7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Glut-AOct)-GLP-1(7-39) Val 8 Arg 34 Lys 2639 -bis-(Glut-AOct)-GLP-1(7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Glut-AOct)-GLP-1(7-39); Ser 8 Lys 26 ' 3 -bis-(Glut-AOct)-GLP-1 (7-36); Ser B Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-37); Sertys 26 ' 34 - bis-(Glut-AOct)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Ser s Arg 34 Lys 26 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Ser 3 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AOct)-GLP-1 (7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glut-AOct)-GLP-1 (7-37) Ser 8 Arg 34 Lys 2637 -bis-(Glut-AOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 3438 -bis-(Glut-AOct)-GLP-1(7-38) Ser fl Arg 34 Lys 26 - 38 -bis-(Glut-AOct)-GLP-1(7-38) Ser 3 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glut-AOct)-GLP-1 (7-38); Ser 8 Arg 26 Lys 3439 -bis-(Glut-AOct)-GLP-1 (7-39) Ser 8 Arg 34 Lys 26 ' 39 -bis-(Glut-AOct)-GLP-1 (7-39); Ser 8 Arg 6 ' 34 Lys 3639 -bis-(Glut-AOct)-GLP-1 (7-39); Thr 8 Lys 28 ' 34 -bis-(Glut-AOct)-GLP-1 (7-36); Thr 8 Lys 26 ' 3 -bis-(Glut-AOct)-GLP-1 (7-37); Thrtys 2834 bis-(Glut-AOct)-GLP-1 (7-38); Thr s Lys 26 ' 34 -bis-(Glut-AOct)-GLP-1 (7-39) Thr fi Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Thr 8 Arg 34 Lys 6 ' 36 -bis-(Glut-AOct)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-AOct)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-AOct)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(Glut-AOct)-GLP-1(7-37) Thr 8 Arg 34 Lys 2637 -bis-(Glut-AOct)-GLP-1(7-37) Thr 8 Arg 26 Lys 3438 -bis-(Glut-AOct)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Glut-AOct)-GLP-1(7-38) Thr £ Arg 2634 Lys 3638 -bis-(Glut-AOct)-GLP-1 (7-38); Thr 8 Arg 28 Lys 34 ' 39 -bis-(Glut-AOct)-GLP-1 (7-39) Thr 8 Arg 34 Lys 2639 -bis-(Glut-AOct)-GLP-1 (7-39); Thr 8 Arg 2634 Lys 3639 -bis-(Glut-AOct)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-37); Lys 263 -bis-(Glut-ALit)- GLP-1 (7-38); Lys 634 -bis-(Glut-ALit)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 34 Lys 26 ' 36 -bis-(Glut-ALit)-GLP-1 (7-36); Arg^Lys 3436 - bis-(Glut-ALit)-GLP-1 (7-37); Arg 34 Lys 2636 -bis-(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 34 ' 37 -bis-(Glut- ALit)-GLP-1 (7-37); Arg 34 Lys 26 ' 37 -bis-(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 34 ' 39 -bis-(Glut-ALit)-GLP- 1 (7-39); Arg 34 Lys 2639 -bis-(Glut-ALit)-GLP-1 (7-39); Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Arg 26 Lys 18 ' 34 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 34 Lys 18 ' 26 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 26 Lys 1834 - bis-(Glut-ALit)-GLP-1 (7-37); Arg 34 Lys 18 6 -bis-(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 1834 -bis-(Glut- ALit)-GLP-1 (7-38); Arg 3 Lys 8 ' 26 -bis-(Glut-ALit)-GLP-1 (7-38); Arg 26 Lys 1834 -bis-(Glut-ALit)-GLP- 1 (7-39); Arg 34 Lys 18 ' 26 -bis-(Glut-ALit)-GLP-1 (7-39); Arg 26 Lys 23 ' 34 -bis-(Glut-Aϋt)-GLP-1 (7-36); Arg 34 Lys 23 ' 26 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 26 Lys 2334 - bis-(Glut-ALit)-GLP-1 (7-37); Arg 34 Lys 2326 -bis-(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 2334 -bis-(Glut- ALit)-GLP-1 (7-38); Arg 34 Lys 2326 -bis-(Glut-ALit)-GLP-1 (7-38); Arg 26 Lys 2334 -bis-(Glut-ALit)-GLP- 1 (7-39); Arg 34 Lys 23 ' 26 -bis-(Glut-ALit)-GLP-1 (7-39); 160 Arg 25 Lys 27 ' 34 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 34 Lys 2726 -bis-(Glut-ALit)-GLP-1 (7-36); Arg 26 Lys 2734 - bis-(Glut-ALit)-GLP-1 (7-37); Arg 34 Lys 27 ' 26 -bis-(Glut-ALit)-GLP-1 (7-37); Arg 26 Lys 27 ' 34 -bis-(Glut- ALit)-GLP-1 (7-38); Arg 34 Lys 27 ' 26 -bis-(Glut-ALit)-GLP-1 (7-38); Arg 26 Lys 27 ' 34 -bis-(Glut-ALit)-GLP- 1 (7-39); Arg 34 Lys 27 ' 26 -bis-(Glut-ALit)-GLP-1 (7-39); Gly 8 Lys 2634 -bis-(Glut-ALit)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-37); Gly 8 Lys 2634 - bis-(Glut-ALit)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1(7-36); Gly 8 Arg 34 Lys 2636 -bis-(Glut-ALit)-GLP-1 (7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1(7-37); Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ALit)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ALit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ALit)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ALit)-GLP-1(7-38); Gly 8 Arg M Lys 26 ' 38 -bis-(Glut-ALit)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-ALit)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ALit)-GLP-1(7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ALit)-GLP-1(7-39); Gly 8 Arg 6 ' 34 Lys 36 ' 39 -bis-(Glut-ALit)-GLP-1(7-39); Val 8 Lys 2634 -bis-(Glut-ALit)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-37); Va Lys 2634 - bis-(Glut-ALit)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-39) Val 8 Arg 26 Lys 3436 -bis-(Glut-ALit)-GLP-1(7-36); Val 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ALit)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1(7-37); Val 8 Arg 34 Lys 2636 -bis-(Glut-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 3437 -bis-(Glut-ALit)-GLP-1(7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ALit)-GLP-1(7-38); Val 8 Arg 34 Lys 2638 -bis-(Glut-ALit)-GLP-1 (7-38) Val 8 Arg 2634 Lys 36 ' 38 -bis-(Glut-ALit)-GLP-1(7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ALit)-GLP-1(7-39) Val 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ALit)-GLP-1(7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Ser 3 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-37); Sei^Lys 26 - 34 - bis-(Glut-ALit)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-39) Ser s Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1(7-36); Ser 3 Arg 34 Lys 2636 -bis-(Glut-ALit)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1(7-37); Ser 8 Arg 34 Lys 2636 -bis-(Glut-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glut-ALit)-GLP-1(7-37); Ser 8 Arg 34 Lys 2637 -bis-(Glut-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ALit)-GLP-1 (7-38); Ser 8 Arg 34 Lys 2638 -bis-(Glut-ALit)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glut-ALit)-GLP-1(7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39) Ser 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Ser 8 Arg 2634 Lys 36 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(Glut-ALit)-GLP-1 (7-36); Thr 8 Lys 2634 -bis-(Glut-ALit)-GLP-1 (7-37); Thrtys 2634 - bis-(Glut-ALit)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Glut-ALit)-GLP-1 (7-39) Thr 8 Arg 26 Lys 3436 -bis-(Glut-ALit)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ALit)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glut-ALit)-GLP-1 (7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glut-ALit)-GLP-1(7-37) Thr 3 Arg 26 Lys 3437 -bis-(Glut-ALit)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Glut-ALit)-GLP-1 (7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Glut-ALit)-GLP-1(7-38) Thr 8 Arg 34 Lys 2638 -bis-(Glut-ALit)-GLP-1(7-38) 161 Thr B Arg 26 ' 34 Lys 3638 -bis-(Glut-ALit)-GLP-1(7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Glut-ALit)-GLP-1(7-39); Thr 8 Arg 34 Lys 26 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glut-ALit)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-37); Lys 2634 -bis- (Aspa-ADod)-GLP-l (7-38); Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(Aspa-ADod)-GLP-1 (7-37) Arg 34 Lys 26 ' 37 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 6 Lys 34 ' 39 -bis-(Aspa-ADod)-GLP-1(7-39) Arg 34 Lys 2639 -bis-(Aspa-ADod)-GLP-1(7-39) Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-ADod)-GLP-1 (7-39); Arg 26 Lys 18 ' 34 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 3 Lys 1826 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 26 Lys 1834 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 26 Lys 1834 -bis-(Aspa-ADod)-GLP-1(7-38) Arg 34 Lys 18 ' 26 -bis-(Aspa-ADod)-GLP-1 (7-38) Arg 26 Lys 18 ' 34 -bis-(Aspa-ADod)-GLP-1(7-39) Arg 34 Lys 18 ' 26 -bis-(Aspa-ADod)-GLP-1 (7-39); Arg 26 Lys 2334 -bis-(Aspa-ADod)-GLP-1 (7-36) Arg 34 Lys 23 ' 26 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 26 Lys 23 ' 34 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(Aspa-ADod)-GLP-1(7-38) Arg 34 Lys 2326 -bis-(Aspa-ADod)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(Aspa-ADod)-GLP-1(7-39) Arg 34 Lys 2326 -bis-(Aspa-ADod)-GLP-1(7-39); Arg 26 Lys 2734 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(Aspa-ADod)-GLP-1(7-36) Arg 26 Lys 27 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-37) Arg 34 Lys 27 ' 26 -bis-(Aspa-ADod)-GLP-1(7-37) Arg 26 Lys 27 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-38) Arg 3 Lys 27 ' 26 -bis-(Aspa-ADod)-GLP-1(7-38) Arg 26 Lys 27 ' 34 -bis-(Aspa-ADod)-GLP-1(7-39) Arg 34 Lys 2726 -bis-(Aspa-ADod)-GLP-1(7-39); Gly 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1(7-36); Gly 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1(7-37); Gly 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 2636 -bis-(Aspa-ADod)-GLP-1 (7- 36); Gly 8 Arg 26 Lys 3436 -bis-(Aspa-ADod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP- 1 (7-37); Gly 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ADod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ADod)- GLP-1 (7-37); Gly 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ADod)-GLP-1 (7-38); Gly 8 Arg 34 Lys 26 ' 38 -bis-(Aspa- ADod)-GLP-1 (7-38); Gly 8 Arg 26 ' 3 Lys 36 ' 38 -bis-(Aspa-ADod)-GLP-1 (7-38); GI Arg∞Lys^-bis- (Aspa-ADod)-GLP-l (7-39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ADod)-GLP-1 (7-39); Gly'Αrg∞^Lys 36 ' 39 - bis-(Aspa-ADod)-GLP-1 (7-39); Val 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-36); Val 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1 (7-37); Val 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 6 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-37); 162 Val 8 Arg 26 Lys 3437 -bis-(Aspa-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ADod)-GLP-1 (7-37); Val 8 Arg 26 Lys 3438 -bis-(Aspa-ADod)-GLP-1 (7-38); Val 8 Arg 34 Lys 2638 -bis-(Aspa-ADod)-GLP-1 (7-38); Val 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-ADod)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-ADod)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ADod)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-ADod)-GLP- 1(7-39); Ser 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-36); Ser 8 Lys 26 ' 3 -bis-(Aspa-ADod)-GLP-1 (7-37); Ser*Lys 2634 -bis-(Aspa-ADod)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-39) Ser 8 Arg 26 Lys 3436 -bis-(Aspa-ADod)-GLP-1 (7-36); Ser 3 Arg 34 Lys 2636 -bis-(Aspa-ADod)-GLP-1 (7- 36); Ser β Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-37); Ser 3 Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP- 1 (7-37); Ser 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ADod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 2637 -bis-(Aspa-ADod)- GLP-1 (7-37); Ser 8 Arg 26 Lys 3438 -bis-(Aspa-ADod)-GLP-1 (7-38); Ser 3 Arg 34 Lys 26 ' 38 -bis-(Aspa- ADod)-GLP-1 (7-38); Ser 8 Arg 2634 Lys 36 ' 38 -bis-(Aspa-ADod)-GLP-1 (7-38); Sei^Arg Lys^-bis- (Aspa-ADod)-GLP-l (7-39); Ser 8 Arg 34 Lys 2639 -bis-(Aspa-ADod)-GLP-1 (7-39); Sei^Arg^^Lys 36 ' 39 - bis-(Aspa-ADod)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(Aspa-ADod)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-37); Thr 8 Lys 26 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-38); Thr 8 Lys 6 ' 34 -bis-(Aspa-ADod)-GLP-1 (7-39) Thr a Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP-1 (7- 36); Thr fi Arg 26 Lys 34 ' 36 -bis-(Aspa-ADod)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ADod)-GLP- 1 (7-37); Thr 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ADod)-GLP-1 (7-37); Thr £ Arg 34 Lys 26 ' 37 -bis-(Aspa-ADod)- GLP-1 (7-37); Thr 3 Arg 26 Lys 34 ' 38 -bis-(Aspa-ADod)-GLP-1 (7-38); Thr 8 Arg 34 Lys 26 ' 38 -bis-(Aspa- ADod)-GLP-1 (7-38); Thr 8 Arg 26 ' 34 Lys 3638 -bis-(Aspa-ADod)-GLP-1 (7-38); Thi^Arg Lys^∞-bis- (Aspa-ADod)-GLP-l (7-39); Thr 8 Arg 3 Lys 26 ' 39 -bis-(Aspa-ADod)-GLP-1 (7-39); ThHΑrg^Lys 36 ' 39 - bis-(Aspa-ADod)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-36); Lys 2634 -bis-(Aspa-ATet)-GLP-1 (7-37); Lys 2634 -bis-(Aspa- ATet)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 34 Lys 2636 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 26 Lys 3 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-37) Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 34 Lys 637 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 26 Lys 3439 -bis-(Aspa-ATet)-GLP-1(7-39) Arg 34 Lys 26 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39) Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39); Arg 26 Lys 18 ' 34 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 34 Lys 826 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 26 Lys 1834 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 26 Lys 18 ' 34 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 34 Lys 18 ' 6 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 26 Lys 18 ' 34 -bis-(Aspa-ATet)-GLP-1(7-39) Arg 34 Lys 1826 -bis-(Aspa-ATet)-GLP-1(7-39); 163 Arg 26 Lys 2334 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 34 Lys 23 ' 26 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 26 Lys 23 ' 34 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 34 Lys 23 ' 26 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 26 Lys 2334 -bis-(Aspa-ATet)-GLP-1(7-39) Arg 34 Lys 23 ' 6 -bis-(Aspa-ATet)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(Aspa-ATet)-GLP-1(7-36) Arg 26 Lys 2734 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 34 Lys 27 ' 26 -bis-(Aspa-ATet)-GLP-1(7-37) Arg 6 Lys 27 ' 34 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 34 Lys 27 ' 26 -bis-(Aspa-ATet)-GLP-1(7-38) Arg 26 Lys 2734 -bis-(Aspa-ATet)-GLP-1 (7-39) Arg 34 Lys 27 ' 26 -bis-(Aspa-ATet)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-37) Gly 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ATet)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ATet)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(Aspa-ATet)-GLP-1 (7-38); Gly 8 Arg 26 Lys 3439 -bis-(Aspa-ATet)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 3639 -bis-(Aspa-ATet)-GLP- 1 (7-39); Val 8 Lys 2634 -bis-(Aspa-ATet)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-37); Val 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1(7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1(7-36) Val 8 Arg 26 Lys 3436 -bis-(Aspa-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 2636 -bis-(Aspa-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 3437 -bis-(Aspa-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Val 8 Arg 2634 Lys 36 ' 38 -bis-(Aspa-ATet)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39) Val 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 3639 -bis-(Aspa-ATet)-GLP-1 (7-39) Ser 8 Lys 2634 -bis-(Aspa-ATet)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-37) Ser 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-38); Ser 8 Lys 26 ' 3 -bis-(Aspa-ATet)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1(7-36) Ser 3 Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-37) Ser £ Arg 26 Lys 34 ' 37 -bis-(Aspa-ATet)-GLP-1 (7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ATet)-GLP-1(7-37) Ser 3 Arg 26 Lys 34 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-ATet)-GLP-1 (7-38); Ser 8 Arg 26 Lys 3439 -bis-(Aspa-ATet)-GLP-1 (7- 39); Ser 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39); Ser 8 Arg 2634 Lys 3639 -bis-(Aspa-ATet)-GLP- 1(7-39); 164 Thr 8 Lys 2634 -bis-(Aspa-ATet)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-37) Thr 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Aspa-ATet)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1(7-36) Thr B Arg 34 Lys 26 - 36 -bis-(Aspa-ATet)-GLP-1 (7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ATet)-GLP-1 (7-37) Thr 3 Arg 34 Lys 836 -bis-(Aspa-ATet)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 - 37 -bis-(Aspa-ATet)-GLP-1(7-37) Thr 3 Arg 34 Lys 2637 -bis-(Aspa-ATet)-GLP-1 (7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Thr 3 Arg 34 Lys 6 ' 38 -bis-(Aspa-ATet)-GLP-1(7-38) Thr 3 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-ATet)-GLP-1 (7-38); Thr s Arg 26 Lys 3439 -bis-(Aspa-ATet)-GLP-1 (7- 39); Thr 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ATet)-GLP-1 (7-39); Thr 8 Arg 2634 Lys 36 ' 39 -bis-(Aspa-ATet)-GLP- 1(7-39); Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-37); Lys 2634 -bis- (Aspa-AHex)-GLP-l (7-38); Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-39) Arg 6 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(Aspa-AHex)-GLP-1 7-36) Arg 26 Lys 3436 -bis-(Aspa-AHex)-GLP-1(7-37) Arg 34 Lys 2636 -bis-(Aspa-AHex)-GLP-1 7-37) Arg 6 Lys 3437 -bis-(Aspa-AHex)-GLP-1(7-37) Arg 34 Lys 2637 -bis-(Aspa-AHex)-GLP-1 7-37) Arg 26 Lys 34 ' 39 -bis-(Aspa-AHex)-GLP-1 (7-39) Arg 34 Lys 6 ' 39 -bis-(Aspa-AHex)-GLP-1 7-39) Arg 26 ' 34 Lys 3639 -bis-(Aspa-AHex)-GLP-1 (7-39) Arg 26 Lys 1834 -bis-(Aspa-AHex)-GLP-1(7-36) Arg 34 Lys 1826 -bis-(Aspa-AHex)-GLP-1 7-36) Arg 26 Lys 18 ' 34 -bis-(Aspa-AHex)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(Aspa-AHex)-GLP-1 7-37) Arg 26 Lys 18 ' 34 -bis-(Aspa-AHex)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(Aspa-AHex)-GLP-1 7-38) Arg 26 Lys 18 ' 34 -bis-(Aspa-AHex)-GLP-1(7-39) Arg 34 Lys 18 ' 28 -bis-(Aspa-AHex)-GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis-(Aspa-AHex)-GLP-1(7-36) Arg 3 Lys 2326 -bis-(Aspa-AHex)-GLP-1 7-36) Arg 26 Lys 2334 -bis-(Aspa-AHex)-GLP-1(7-37) Arg 34 Lys 23 ' 26 -bis-(Aspa-AHex)-GLP-1 7-37) Arg 26 Lys 23 ' 34 -bis-(Aspa-AHex)-GLP-1(7-38) Arg 34 Lys 2326 -bis-(Aspa-AHex)-GLP-1 7-38) Arg 26 Lys 23 ' 34-bis-(Aspa-AHex)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(Aspa-AHex)-GLP-1(7-39); Arg 26 Lys 27 ' 3 -bis-(Aspa-AHex)-GLP-1(7-36) Arg 34 Lys 2 26 -bis-(Aspa-AHex)-GLP-1 7-36) Arg 26 Lys 2734 -bis-(Aspa-AHex)-GLP-1(7-37) Arg 34 Lys 2726 -bis-(Aspa-AHex)-GLP-1 7-37) Arg 26 Lys 27 ' 34 -bis-(Aspa-AHex)-GLP-1(7-38) Arg 34 Lys 2726 -bis-(Aspa-AHex)-GLP-1 7-38) Arg 26 Lys 27 ' 34 -bis-(Aspa-AHex)-GLP-1(7-39) Arg 34 Lys 27 ' 26 -bis-(Aspa-AHex)-GLP-1(7-39); Gly 8 Lys 26 ' 34-bis-(Aspa-AHex)-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 7-37); Gly 8 Lys 6 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1(7-36); Gly 8 Arg 3 Lys 26 ' 36 -bis-(Aspa-AHex)-GLP-1 7-36) Gly 8 Arg 28 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1(7-37); Gly 8 Arg 34 Lys 2636 -bis-(Aspa-AHex)-GLP-1 7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-AHex)-GLP-1(7-37); Gly 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AHex)-GLP-1 7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-AHex)-GLP-1(7-38); Gly 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-AHex)-GLP-1 7-38) 165 Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-AHex)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-AHex)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-AHex)-GLP- 1(7-39); Val 8 Lys 2634 -bis-(Aspa-AHex)-GLP-1 (7-36); Val 8 Lys 2634 -bis-(Aspa-AHex)-GLP-1 (7-37); Val 8 Lys 2634 -bis-(Aspa-AHex)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1 (7-36); Val 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AHex)-GLP-1 (7-36) Val 8 Arg 26 Lys 3436 -bis-(Aspa-AHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 2636 -bis-(Aspa-AHex)-GLP-1 (7-37) Val 8 Arg 26 Lys 3 37 -bis-(Aspa-AHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AHex)-GLP-1 (7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38); Val 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38) Val 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-AHex)-GLP-1 (7- 39); Val 8 Arg 34 Lys 2639 -bis-(Aspa-AHex)-GLP-1 (7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Aspa-AHex)-GLP- 1(7-39); Ser 3 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-37); Ser £ Lys 2634 -bis-(Aspa-AHex)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1 (7-36); Ser 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AHex)-GLP-1 (7- 36); Ser B Arg 26 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1 (7-37); Ser 3 Arg 34 Lys 26 ' 36 -bis-(Aspa-AHex)-GLP- 1 (7-37); Ser 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-AHex)-GLP-1 (7-37); Ser 3 Arg 34 Lys 26 ' 37 -bis-(Aspa-AHex)- GLP-1 (7-37); Ser B Arg 26 Lys 3438 -bis-(Aspa-AHex)-GLP-1 (7-38); Ser 8 Arg 3 Lys 26 ' 38 -bis-(Aspa- AHex)-GLP-1 (7-38); Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38); Ser β Arg 2β Lys 34 ^ β -bis- (Aspa-AHex)-GLP-1(7-39); Ser 8 Arg 34 Lys 2839 -bis-(Aspa-AHex)-GLP-1 (7-39); Sei^Arg^^Lys 3639 - bis-(Aspa-AHex)-GLP-1 (7-39); Thr 8 Lys 263 -bis-(Aspa-AHex)-GLP-1 (7-36); Thr 8 Lys 6 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-37); Thr a Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Aspa-AHex)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AHex)-GLP-1 (7-36); Thr 8 Arg 34 Lys 2636 -bis-(Aspa-AHex)-GLP-1 (7-36) Thr 8 Arg 26 Lys 3436 -bis-(Aspa-AHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 2638 -bis-(Aspa-AHex)-GLP-1 (7-37) Thr 8 Arg 26 Lys 3437 -bis-(Aspa-AHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AHex)-GLP-1 (7-37) Thr 8 Arg 26 Lys 3438 -bis-(Aspa-AHex)-GLP-1 (7-38); Thr 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38) Thr 8 Arg 2634 Lys 36 ' 38 -bis-(Aspa-AHex)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-AHex)-GLP-1 (7- 39); Thr 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-AHex)-GLP-1 (7-39); Thr 8 Arg 2634 Lys 36 ' 39 -bis-(Aspa-AHex)-GLP- 1(7-39); Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-36); Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-37); Lys 26 ' 34 -bis-(Aspa- AOct)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(Aspa-AOct)-GLP-1 (7-36); Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1 (7-36); Arg 26 Lys 3436 -bis-(Aspa-AOct)-GLP-1 (7-37); Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1 (7-37); 166 Arg 26 Lys 34 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37); Arg 34 Lys 2837 -bis-(Aspa-AOct)-GLP-1(7-37); Arg 26 Lys 34 ' 39 -bis-(Aspa-AOct)-GLP-1(7-39); Arg 34 Lys 2639 -bis-(Aspa-AOct)-GLP-1(7-39); Arg 26 ' 34 Lys 3639 -bis-(Aspa-AOct)-GLP-1(7-39); Arg 26 Lys 18 ' 34 -bis-(Aspa-AOct)-GLP-1(7-36) Arg 34 Lys 1826 -bis-(Aspa-AOct)-GLP-1(7-36) Arg 26 Lys 1834 -bis-(Aspa-AOct)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(Aspa-AOct)-GLP-1(7-37) Arg 26 Lys 1834 -bis-(Aspa-AOct)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(Aspa-AOct)-GLP-1(7-38) Arg 26 Lys 1834 -bis-(Aspa-AOct)-GLP-1(7-39) Arg 34 Lys 1826 -bis-(Aspa-AOct)-GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis-(Aspa-AOct)-GLP-1(7-36) Arg 34 Lys 2326 -bis-(Aspa-AOct)-GLP-1(7-36) Arg 26 Lys 233 -bis-(Aspa-AOct)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Aspa-AOct)-GLP-1(7-37) Arg 26 Lys 3 ' 34 -bis-(Aspa-AOct)-GLP-1(7-38) Arg 34 Lys 23 ' 26 -bis-(Aspa-AOct)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(Aspa-AOct)-GLP-1(7-39) Arg 34 Lys 2326 -bis-(Aspa-AOct)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(Aspa-AOct)-GLP-1(7-36) Arg 34 Lys 2726 -bis-(Aspa-AOct)-GLP-1 (7-36) Arg 26 Lys 27 ' 34 -bis-(Aspa-AOct)-GLP-1(7-37) Arg 34 Lys 726 -bis-(Aspa-AOct)-GLP-1 (7-37) Arg 26 Lys 27 ' 34 -bis-(Aspa-AOct)-GLP-1(7-38) Arg 34 Lys 2726 -bis-(Aspa-AOct)-GLP-1 (7-38) Arg 26 Lys 27 ' 34 -bis-(Aspa-AOct)-GLP-1(7-39) Arg 34 Lys 2726 -bis-(Aspa-AOct)-GLP-1(7-39); Gly 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1(7-36); Gly 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1(7-37) Gly 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AOct)-GLP-1 (7-36); Gly 8 Arg 34 Lys 2636 -bis-(Aspa-AOct)-GLP-1 (7-36) Gly 8 Arg 26 Lys 3436 -bis-(Aspa-AOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AOct)-GLP-1 (7-37) Gly 8 Arg 26 Lys 3438 -bis-(Aspa-AOct)-GLP-1(7-38) Gly 8 Arg 34 Lys 2638 -bis-(Aspa-AOct)-GLP-1(7-38) Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-AOct)-GLP-1 (7 . 38) . Gly 8 Arg 26 Lys 3439 -bis-(Aspa-AOct)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 2639 -bis-(Aspa-AOct)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 3639 -bis-(Aspa-AOct)-GLP- 1(7-39); Val 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-36); Val 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-37); Val 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AOct)-GLP-1(7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-36) Val 8 Arg 26 Lys 3436 -bis-(Aspa-AOct)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-37) Val 8 Arg 26 Lys 3437 -bis-(Aspa-AOct)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Val 8 Arg 26 Lys 3438 -bis-(Aspa-AOct)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-AOct)-GLP-1 (7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(Aspa-AOct)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(Aspa-AOct)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-AOct)-GLP-1 (7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Aspa-AOct)-GLP- 1(7-39); 167 Ser 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-37); Ser 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-AOct)-GLP-1(7-36) Ser β Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-36) Ser 8 Arg 26 Lys 3436 -bis-(Aspa-AOct)-GLP-1 (7-37) Ser 3 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 3438 -bis-(Aspa-AOct)-GLP-1(7-38) Ser 8 Arg 34 Lys 2638 -bis-(Aspa-AOct)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Aspa-AOct)-GLP-1 (7-38); Ser 8 Arg 26 Lys 3439 -bis-(Aspa-AOct)-GLP-1 (7- 39); Ser s Arg 34 Lys 26 ' 39 -bis-(Aspa-AOct)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-AOct)-GLP- 1(7-39); Thr 3 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-37); Thr 8 Lys 2634 -bis-(Aspa-AOct)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Aspa-AOct)-GLP-1 (7-39) Thr s Arg 26 Lys 34 ' 38 -bis-(Aspa-AOct)-GLP-1 (7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-36) Thr 3 Arg 26 Lys 34 ' 36 -bis-(Aspa-AOct)-GLP-1 (7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Aspa-AOct)-GLP-1(7-37) Thr 3 Arg 26 Lys 34 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-AOct)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-AOct)-GLP-1(7-38) Thr 3 Arg 34 Lys 26 ' 38 -bis-(Aspa-AOct)-GLP-1(7-38) Thr 3 Arg 26 ' 34 Lys 3638 -bis-(Aspa-AOct)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 - 39 -bis-(Aspa-AOct)-GLP-1 (7- 39); Thr B Arg 34 Lys 26 ' 39 -bis-(Aspa-AOct)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-AOct)-GLP- 1(7-39); Lys 2634 -bis-(Aspa-ALit)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-37); Lys 2634 -bis-(Aspa- ALit)-GLP-1 (7-38); Lys 2634 -bis-(Aspa-ALit)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 34 Lys 26 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(Aspa-ALit)-GLP-1(7-39) Arg 3 Lys 839 -bis-(Aspa-ALit)-GLP-1(7-39) Arg 26 ' 34 Lys 3639 -bis-(Aspa-ALit)-GLP-1(7-39); Arg 26 Lys 18 ' 34 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 34 Lys 1826 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 26 Lys 18 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-37) Arg 34 Lys 18 ' 28 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 26 Lys 1834 -bis-(Aspa-ALit)-GLP-1(7-38) Arg 34 Lys 8 ' 26 -bis-(Aspa-ALit)-GLP-1 (7-38) Arg 26 Lys 18 ' 34 -bis-(Aspa-ALit)-GLP-1(7-39) Arg 34 Lys 1826 -bis-(Aspa-ALit)-GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 34 Lys 2326 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 26 Lys 23 ' 34 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 26 Lys 2334 -bis-(Aspa-ALit)-GLP-1(7-38) Arg 34 Lys 23 ' 26 -bis-(Aspa-ALit)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(Aspa-ALit)-GLP-1(7-39) Arg 34 Lys 2326 -bis-(Aspa-ALit)-GLP-1 (7-39); 168 Arg 26 Lys 2734 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 34 Lys 2726 -bis-(Aspa-ALit)-GLP-1(7-36) Arg 26 Lys 2734 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 34 Lys 2726 -bis-(Aspa-ALit)-GLP-1(7-37) Arg 26 Lys 27 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-38) Arg 34 Lys 27 ' 26 -bis-(Aspa-ALit)-GLP-1(7-38) Arg 26 Lys 27 ' 34 -bis-(Aspa-ALit)-GLP-1(7-39) Arg 34 Lys 27 ' 26 -bis-(Aspa-ALit)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-37); Gly 8 Lys 2634 - bis-(Aspa-ALit)-GLP-1 (7-38); Gly 8 Lys 2634 -bis-(Aspa-ALit)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1(7-36) Gly 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-36) Gly 8 Arg 28 Lys 3436 -bis-(Aspa-ALit)-GLP-1(7-37) Gly 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ALit)-GLP-1 (7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Gly 8 Arg 26 Lys 3438 -bis-(Aspa-ALit)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ALit)-GLP-1(7-38) Gly 8 Arg 2634 Lys 3638 -bis-(Aspa-ALit)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-ALit)-GLP-1(7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-ALit)-GLP-1(7-39); Val 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-37); Valtys 26 ' 34 . bis-(Aspa-ALit)-GLP-1 (7-38); Val 8 Lys 26 ' 3 -bis-(Aspa-ALit)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1(7-36) Val 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1 (7-36) Val 8 Arg 26 Lys 3438 -bis-(Aspa-ALit)-GLP-1(7-37) Val 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ALit)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ALit)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(Aspa-ALit)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(Aspa-ALit)-GLP-1(7-39) Val 8 Arg 3 Lys 26 - 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 3639 -bis-(Aspa-ALit)-GLP-1(7-39); Ser 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-36); Ser 8 Lys 263 -bis-(Aspa-ALit)-GLP-1 (7-37); SerYys 26 ' 34 - bis-(Aspa-ALit)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-39) Ser 8 Arg 26 Lys 3436 -bis-(Aspa-ALit)-GLP-1 (7-36) Ser 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ALit)-GLP-1 (7-38) Ser 3 Arg 34 Lys 26 ' 38 -bis-(Aspa-ALit)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 3638 -bis-(Aspa-ALit)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39) Ser 3 Arg 34 Lys 26 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Sei^Arg^Lys 3639 -bis-(Aspa-ALit)-GLP-1 (7-39); Thr 8 Lys 6 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Aspa-ALit)-GLP-1 (7-37); Thi^Lys 2634 - bis-(Aspa-ALit)-GLP-1 (7-38); Thr 3 Lys 2634 -bis-(Aspa-ALit)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Aspa-ALit)-GLP-1 (7-36) Thr 8 Arg 3 Lys 26 ' 36 -bis-(Aspa-ALit)-GLP-1(7-36) Thr 8 Arg 28 Lys 3436 -bis-(Aspa-ALit)-GLP-1(7-37) Thr 8 Arg 34 Lys 2636 -bis-(Aspa-ALit)-GLP-1(7-37) Thr 8 Arg 26 Lys 3437 -bis-(Aspa-ALit)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Aspa-ALit)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Aspa-ALit)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Aspa-ALit)-GLP-1(7-38) 169 Thr 8 Arg 2834 Lys 36 ' 38 -bis-(Aspa-ALit)-GLP-1 (7-38); Thr 8 Arg 26 Lys 3 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Thr 8 Arg 34 Lys 26 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Aspa-ALit)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-36); Lys 2634 -bis-(Glyc-ADod)-GLP-1 (7-37); Lys 26 ' 3 -bis-(Glyc- ADod)-GLP-1 (7-38); Lys 2634 -bis-(Glyc-ADod)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(Glyc-ADod)-GLP-1 (7-36) Arg 34 Lys 26 ' 36 -bis-(Glyc-ADod)-GLP-1 7-36) Arg 26 Lys 34 ' 36 -bis-(Glyc-ADod)-GLP-1(7-37) Arg 34 Lys 26 ' 36 -bis-(Glyc-ADod)-GLP-1 7-37) Arg 26 Lys 34 ' 37 -bis-(Glyc-ADod)-GLP-1(7-37) Arg 34 Lys 2637 -bis-(Glyc-ADod)-GLP-1 7-37) Arg 26 Lys 34 ' 39 -bis-(Glyc-ADod)-GLP-1(7-39) Arg 34 Lys 26 ' 39 -bis-(Glyc-ADod)-GLP-1 7-39) Arg 2634 Lys 36 ' 39 -bis-(Glyc-ADod)-GLP-1(7-39); Arg 26 Lys 18 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-36) Arg 34 Lys 18 ' 26 -bis-(Glyc-ADod)-GLP-1 7-36) Arg 26 Lys 18 ' 34 -bis-(Glyc-ADod)-GLP-1(7-37) Arg 34 Lys 18 ' 26 -bis-(Glyc-ADod)-GLP-1 7-37) Arg 26 Lys 1834 -bis-(Glyc-ADod)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(Glyc-ADod)-GLP-1 7-38) Arg 26 Lys 1834 -bis-(Glyc-ADod)-GLP-1(7-39) Arg 34 Lys 18 ' 26 -bis-(Glyc-ADod)-GLP-1(7-39); Arg 26 Lys 2334 -bis-(Glyc-ADod)-GLP-1(7-36) Arg 34 Lys 23 ' 26 -bis-(Glyc-ADod)-GLP-1 7-36) Arg 26 Lys 2334 -bis-(Glyc-ADod)-GLP-1(7-37) Arg 34 Lys 2326 -bis-(Glyc-ADod)-GLP-1 7-37) Arg 26 Lys 23 ' 34 -bis-(Glyc-ADod)-GLP-1(7-38) Arg 34 Lys 2326 -bis-(Glyc-ADod)-GLP-1 7-38) Arg 26 Lys 3 ' 34 -bis-(Glyc-ADod)-GLP-1(7-39) Arg 34 Lys 2326 -bis-(Glyc-ADod)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(Glyc-ADod)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(Glyc-ADod)-GLP-1 7-36) Arg 26 Lys 2734 -bis-(Glyc-ADod)-GLP-1(7-37) Arg 34 Lys 27 ' 26 -bis-(Glyc-ADod)-GLP-1 7-37) Arg 26 Lys 27 ' 34 -bis-(Glyc-ADod)-GLP-1(7-38) Arg 34 Lys 27 ' 26 -bis-(Glyc-ADod)-GLP-1 7-38) Arg 26 Lys 27 ' 34 -bis-(Glyc-ADod)-GLP-1(7-39) Arg 34 Lys 27 ' 26 -bis-(Glyc-ADod)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-37); Gly 8 Lys 26 . 34 -bis-(Glyc-ADod)-GLP-1 (7 . 38) . Gly 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-39) Gly 8 Arg 26 Lys 3436 -bis-(Glyc-ADod)-GLP-1(7-36) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ADod)-GLP-1(7-36) Gly 8 Arg 26 Lys 3436 -bis-(Glyc-ADod)-GLP-1 (7-37) Gly 8 Arg 34 Lys 2636 -bis-(Glyc-ADod)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(Glyc-ADod)-GLP-1 (7-37) Gly 8 Arg 34 Lys 2637 -bis-(Glyc-ADod)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ADod)-GLP-1(7-38) Gly 8 Arg 2634 Lys 3638 -bis-(Glyc-ADod)-GLP-1 (7-38); Gly 8 Arg 26 Lys 3439 -bis-(Glyc-ADod)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-ADod)-GLP-1 (7-39); Gly 8 Arg 2834 Lys 3639 -bis-(Glyc-ADod)-GLP- 1(7-39); Val 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-37); Val 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-39) Val 8 Arg 26 Lys 3436 -bis-(Glyc-ADod)-GLP-1 (7-36); Val 8 Arg 34 Lys 2636 -bis-(Glyc-ADod)-GLP-1 (7-36); Val 8 Arg 26 Lys 3436 -bis-(Glyc-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 2636 -bis-(Glyc-ADod)-GLP-1 (7-37); 170 Val 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ADod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-ADod)-GLP-1 (7-37); Val 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38); Val 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38); Val 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(Glyc-ADod)-GLP-1 (7- 39); Val 8 Arg 34 Lys 2639 -bis-(Glyc-ADod)-GLP-1 (7-39); Val 8 Arg 2634 Lys 36 ' 39 -bis-(Glyc-ADod)-GLP- 1(7-39); Ser 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-36); Ser 3 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-37); Ser 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-38); Ser 8 Lys 263 -bis-(Glyc-ADod)-GLP-1 (7-39) Ser 3 Arg 26 Lys 34 ' 36 -bis-(Glyc-ADod)-GLP-1(7-36) Ser 8 Arg 34 Lys 2636 -bis-(Glyc-ADod)-GLP-1(7-36) Ser 3 Arg 28 Lys 34 ' 36 -bis-(Glyc-ADod)-GLP-1 (7-37) Ser 3 Arg 34 Lys 26 ' 36 -bis-(Glyc-ADod)-GLP-1(7-37) Ser 8 Arg 26 Lys 3437 -bis-(Glyc-ADod)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-ADod)-GLP-1(7-37) Ser 3 Arg 26 Lys 3438 -bis-(Glyc-ADod)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ADod)-GLP-1(7-38) Ser 8 Arg 2634 Lys 36 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ADod)-GLP-1 (7- 39); Ser 8 Arg 34 Lys 2639 -bis-(Glyc-ADod)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 3639 -bis-(Glyc-ADod)-GLP- 1(7-39); Thr 8 Lys 2634 -bis-(Glyc-ADod)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-37); Thr 3 Lys 26 ' 34 -bis-(Glyc-ADod)-GLP-1 (7-38); Thr 8 Lys 2634 -bis-(Glyc-ADod)-GLP-1 (7-39) Thr 3 Arg 26 Lys 3436 -bis-(Glyc-ADod)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ADod)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ADod)-GLP-1(7-37) Thr 8 Arg 34 Lys 2636 -bis-(Glyc-ADod)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ADod)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-ADod)-GLP-1(7-37) Thr 8 Arg 26 Lys 3438 -bis-(Glyc-ADod)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ADod)-GLP-1(7-38) Thr 8 Arg 2634 Lys 36 ' 38 -bis-(Glyc-ADod)-GLP-1 (7-38); Thr 8 Arg 26 Lys 3439 -bis-(Glyc-ADod)-GLP-1 (7- 39); Thr 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-ADod)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-ADod)-GLP- 1(7-39); Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-37); Lys 2634 -bis-(Glyc- ATet)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Arg 26 Lys 3 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 34 Lys 6 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 26 Lys 34 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 34 Lys 26 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 26 Lys 3439 -bis-(Glyc-ATet)-GLP-1(7-39) Arg 34 Lys 26 ' 39 -bis-(Glyc-ATet)-GLP-1(7-39) Arg 26 ' 34 Lys 3639 -bis-(Glyc-ATet)-GLP-1(7-39); Arg 26 Lys 1834 -bis-(Glyc-ATet)-GLP-1 (7-36) Arg 34 Lys 1826 -bis-(Glyc-ATet)-GLP-1(7-36) Arg 26 Lys 1834 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 26 Lys 18 ' 34 -bis-(Glyc-ATet)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(Glyc-ATet)-GLP-1(7-38) Arg 26 Lys 18 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-39) Arg 34 Lys 18 ' 26 -bis-(Glyc-ATet)-GLP-1(7-39); 171 Arg Lys 23 ' 34 - bis-(Glyc-ATet) ■ GLP-1(7-36) Arg 34 Lys 2326 -bis-(Glyc-ATet)-GLP-1(7-36) Arg Lys 23 ' 34 - bis-(Glyc-ATet) -GLP-1(7-37) Arg 34 Lys 23 ' 26 -bis-(Glyc-ATet)-GLP-1(7-37) Arg Lys 23 ' 34 - bis-(Glyc-ATet) ■ GLP-1(7-38) Arg 34 Lys 23 ' 26 -bis-(Glyc-ATet)-GLP-1(7-38) Arg 26 Lys 2334 - bis-(Glyc-ATet) ■ GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(Glyc-ATet)-GLP-1(7-39); Arg 26 Lys 2734 - bis-(Glyc-ATet) ■ GLP-1(7-36) Arg 34 Lys 2726 -bis-(Glyc-ATet)-GLP-1(7-36) Arg 26 Lys 2734 - bis-(Glyc-ATet) -GLP-1(7-37) Arg 34 Lys 27 ' 26 -bis-(Glyc-ATet)-GLP-1(7-37) Arg 26 Lys 2734 - bis-(Glyc-ATet) ■ GLP-1(7-38) Arg 34 Lys 2726 -bis-(Glyc-ATet)-GLP-1(7-38) Arg 26 Lys 2734 - bis-(Glyc-ATet) -GLP-1(7-39) Arg 34 Lys 27 8 -bis-(Glyc-ATet)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(Giyc-ATet)-GLP-1 (7-37); Glytys 2634 - bis-(Glyc-ATet)-GLP-1 (7-38); Gly 8 Lys 2834 -bis-(Glyc-ATet)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Gly 8 Arg 34 Lys 2636 -bis-(Glyc-ATet)-GLP-1(7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Gly 8 Arg 34 Lys 2636 -bis-(Glyc-ATet)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ATet)-GLP-1 (7-37) Gly 8 Arg 34 Lys 2637 -bis-(Glyc-ATet)-GLP-1(7-37) Gly 8 Arg 26 Lys 3438 -bis-(Glyc-ATet)-GLP-1 (7-38) Gly 8 Arg 34 Lys 2638 -bis-(Glyc-ATet)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(Glyc-ATet)-GLP-1(7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ATet)-GLP-1(7-39) Gly 8 Arg 34 Lys 6 ' 39 -bis-(Glyc-ATet)-GLP-1(7-39); Gly 8 Arg 6 - 34 Lys 3639 -bis-(Glyc-ATet)-GLP-1(7-39); Val 8 Lys 2634 -bis-(Glyc-ATet)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-37); Val 8 Lys 2634 - bis-(Glyc-ATet)-GLP-1 (7-38); Val 8 Lys 2634 -bis-(Glyc-ATet)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 2636 -bis-(Glyc-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Val 8 Arg 34 Lys 637 -bis-(Glyc-ATet)-GLP-1(7-37) Val 8 Arg 26 Lys 3438 -bis-(Glyc-ATet)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ATet)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-ATet)-GLP-1(7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Giyc-ATet)-GLP-1(7-39) Val 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-ATet)-GLP-1(7-39); Val 8 Arg 26 ' 3 Lys 3639 -bis-(Glyc-ATet)-GLP-1 (7-39); Ser 8 Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-36); Ser 8 Lys 263 -bis-(Glyc-ATet)-GLP-1 (7-37); Sertys 2634 - bis-(Glyc-ATet)-GLP-1 (7-38); Ser a Lys 6 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-39) Ser 8 Arg 26 Lys 3436 -bis-(Glyc-ATet)-GLP-1 (7-36) Ser 8 Arg 34 Lys 2636 -bis-(Glyc-ATet)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Ser 8 Arg 26 Lys 3438 -bis-(Glyc-ATet)-GLP-1 (7-38) Ser 3 Arg 3 Lys 2638 -bis-(Glyc-ATet)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-ATet)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39) Ser 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39); Thr 8 Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-37); Thi^Lys 2634 - bis-(Glyc-ATet)-GLP-1 (7-38); Thr B Lys 26 ' 34 -bis-(Glyc-ATet)-GLP-1 (7-39) 172 Thr a Arg 26 Lys 3436 -bis-(Glyc-ATet)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ATet)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ATet)-GLP-1(7-37) Thr 8 Arg 34 Lys 2636 -bis-(Glyc-ATet)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ATet)-GLP-1 (7-37) Thr 3 Arg 34 Lys 26 ' 37 -bis-(Glyc-ATet)-GLP-1(7-37) Thr 8 Arg 26 Lys 3438 -bis-(Glyc-ATet)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ATet)-GLP-1(7-38) Thr 3 Arg 2634 Lys 36 ' 38 -bis-(Glyc-ATet)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39) Thr 3 Arg 34 Lys 26 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-ATet)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-37); Lys 26 ' 34 -bis-(Glyc AHex)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(Glyc-AHex)-GLP-1(7-36) Arg 34 Lys 2636 -bis-(Glyc-AHex)-GLP-1 (7-36) Arg 26 Lys 3436 -bis-(Glyc-AHex)-GLP-1 (7-37) Arg 34 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-37) Arg 26 Lys 3 37 -bis-(Glyc-AHex)-GLP-1(7-37) Arg 34 Lys 26 ' 37 -bis-(Glyc-AHex)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(Glyc-AHex)-GLP-1(7-39) Arg 34 Lys 26 ' 39 -bis-(Glyc-AHex)-GLP-1(7-39) Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AHex)-GLP-1(7-39); Arg 26 Lys 18 ' 3 -bis-(Glyc-AHex)-GLP-1 (7-36) Arg^Lys 18 ' 26 bis-(Glyc-AHex) GLP-1 (7-36) Arg 26 Lys 18 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-37) Arg 3 4Lys 18,26 bis-(Glyc-AHex) -GLP-1(7-37) Arg 26 Lys 18 ' 3 -bis-(Glyc-AHex)-GLP-1(7-38) Arg^Lys 1826 bis-(Glyc-AHex) •GLP-1(7-38) Arg 26 Lys 18 ' 34 -bis-(Glyc-AHex)-GLP-1(7-39) Arg 34 Lys 1826 -bis-(Gly AHex)-GLP-1(7- 39); Arg 26 Lys 2334 -bis-(Glyc-AHex)-GLP-1(7-36) Arg^Lys 23 ' 26 . bis-(Glyc-AHex) •GLP-1(7-36) Arg 26 Lys 23 ' 3 -bis-(Glyc-AHex)-GLP-1(7-37) Arg^Lys 23 ^ bis-(Glyc-AHex) ■GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-38) Arg^Lys 2326 bis-(Glyc-AHex) ■GLP-1(7-38) Arg 26 Lys 2334 -bis-(Glyc-AHex)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(Glyc AHex)-GLP-1(7- 39); Arg 26 Lys 27 ' 34 -bis-(Glyc-AHex)-GLP-1(7-36) Arg^Lys 2726 - bis-(Glyc-AHex) ■ GLP-1(7-36) Arg 26 Lys 27 ' 34 -bis-(Glyc-AHex)-GLP-1(7-37) Arg^Lys 2726 - bis-(Glyc-AHex) ■ GLP-1(7-37) Arg 26 Lys 27 ' 34 -bis-(Glyc-AHex)-GLP-1(7-38) Arg^Lys 2726 - bis-(Glyc-AHex) ■ GLP-1 (7-38) Arg 26 Lys 27 ' 34 -bis-(Glyc-AHex)-GLP-1(7-39) Arg 34 Lys 2726 -bis-(Glyc-AHex)-GLP-1(7-39); Gly 8 Lys 2634 -bis-(Glyc-AHex)-GLP-1 (7-36); Gly 8 Lys 6 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-37); Gly 8 Lys 2634 -bis-(Glyc-AHex)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AHex)-GLP-1(7-36) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AHex)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(Glyc-AHex)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-AHex)-GLP-1 (7-37) Gly 8 Arg 26 Lys 3438 -bis-(Glyc-AHex)-GLP-1 (7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AHex)-GLP-1(7-38) Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-AHex)-GLP-1 (7-38); Gly 8 Arg 6 Lys 3439 -bis-(Glyc-AHex)-GLP-1 (7- 39); Gly 8 Arg 3 Lys 26 ' 39 -bis-(Glyc-AHex)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AHex)-GLP- 1(7-39); 173 Val 8 Lys 2634 -bis-(Glyc-AHex)-GLP-1 (7-36); Val 8 Lys 2834 -bis-(Glyc-AHex)-GLP-1 (7-37); Val 8 Lys 2634 -bis-(Glyc- AHex)-GLP-1 (7-38); Val 8 Lys 26 ' 3 -bis-(Glyc-AHex)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-- i , Glyc-AHex)-GLP-1 (7-36) Val 8 Arg 34 Lys 2636 -bis-(Glyc-AHex)-GLP-1(7-36) Val 8 Arg 26 Lys 3436 -bis-(Glyc-AHex)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-AHex)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-AHex)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AHex)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AHex)-GLP-1(7-38) Val β Arg 2W4 Lys 3Wβ -bis-(GlyoAHex)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(Glyc-AHex)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 3 ^bis-(Glyc-AHex)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AHex)-GLP- 1(7-39); Ser 8 Lys 26 - 34 -bis-(Glyc-AHex)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-37); Ser 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AHex)-GLP-1(7-36) Ser 8 Arg 3 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-36) Ser 3 Arg 26 Lys 3436 -bis-(G!yc-AHex)-GLP-1(7-37) Ser B Arg 34 Lys 2636 -bis-(Glyc-AHex)-GLP-1(7-37) Ser 3 Arg 26 Lys 34 ' 37 -bis-(Glyc-AHex)-GLP-1(7-37) Ser 3 Arg 3 Lys 2637 -bis-(Glyc-AHex)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AHex)-GLP-1(7-38) Ser 8 Arg 34 Lys 2638 -bis-(Glyc-AHex)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-AHex)-GLP-1 (7-38); Ser B Arg 26 Lys 34 ' 39 -bis-(Glyc-AHex)-GLP-1 (7- 39); Ser 8 Arg 34 Lys 2639 -bis-(Glyc-AHex)-GLP-1 (7-39); Ser'-Arg^Lys∞'∞-bis-fGlyc-AHexJ-GLP- 1(7-39); Thr 3 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-37); Thr 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Glyc-AHex)-GLP-1 (7-39) Thr s Arg 26 Lys 34 ' 36 -bis-(Glyc-AHex)-GLP-1 (7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AHex)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AHex)-GLP-1 (7-37) Thr B Arg 34 Lys 2636 -bis-(Glyc-AHex)-GLP-1(7-37) Thr 8 Arg 26 Lys 3437 -bis-(Glyc-AHex)-GLP-1(7-37) Thr 8 Arg 3 Lys 2637 -bis-(Glyc-AHex)-GLP-1(7-37) Thr 3 Arg 26 Lys 3438 -bis-(Glyc-AHex)-GLP-1(7-38) Thr 8 Arg 34 Lys 2638 -bis-(Glyc-AHex)-GLP-1(7-38) Thr B Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-AHex)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-AHex)-GLP-1 (7- 39); Thr 3 Arg 34 Lys 2639 -bis-(Glyc-AHex)-GLP-1 (7-39); Thr 3 Arg 26 ' 34 Lys 3639 -bis-(Glyc-AHex)-GLP- 1(7-39); Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-36); Lys 2δ ' 34 -bis-(Glyc-AOct)-GLP-1 (7-37); Lys 2634 -bis-(Glyc- AOct)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Giyc-AOct)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(Glyc-AOct)-GLP-1(7-36); Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-(Glyc-AOct)-GLP-1 (7-37); Arg 34 Lys 2636 -bis-(Glyc-AOct)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(Glyc-AOct)-GLP-1(7-37); Arg 34 Lys 26 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Arg 34 Lys 2639 -bis-(Glyc-AOct)-GLP-1 (7-39) Arg 26 ' 3 Lys 36 ' 39 -bis-(Glyc-AOct)-GLP-1(7-39); 174 Arg 26 Lys 1834 -bis- (Glyc-AOct)-GLP-l 7-36) Arg 34 Lys 18 ' 26 -bis-(Glyc-AOct)-GLP-1(7-36) Arg 26 Lys 1834 -bis- (Glyc-AOct)-GLP-l 7-37) Arg 34 Lys 1826 -bis-(Glyc-AOct)-GLP-1(7-37) Arg 26 Lys 1834 -bis- (Glyc-AOct)-GLP-l 7-38) Arg 34 Lys 1826 -bis-(Glyc-AOct)-GLP-1(7-38) Arg 26 Lys 1834 -bis- (Glyc-AOct)-GLP-l 7-39) Arg 34 Lys 1826 -bis-(Glyc-AOct)-GLP-1(7-39); Arg 26 Lys 2334 -bis- (Glyc-AOct)-GLP-l 7-36) Arg 34 Lys 23 ' 26 -bis-(Glyc-AOct)-GLP-1(7-36) Arg 26 Lys 2334 -bis- (Glyc-AOct)-GLP-l 7-37) Arg 34 Lys 23 ' 26 -bis-(Glyc-AOct)-GLP-1(7-37) Arg∞Lys∞^-bis- (Glyc-AOct)-GLP-l 7-38) Arg 34 Lys 3 ' 26 -bis-(Glyc-AOct)-GLP-1(7-38) Arg 26 Lys 2334 -bis- (Glyc-AOct)-GLP-l 7-39) Arg 34 Lys 23 ' 26 -bis-(Glyc-AOct)-GLP-1(7-39); Arg 26 Lys 2734 -bis- (Glyc-AOct)-GLP-l 7-36) Arg 34 Lys 27 ' 26 -bis-(Glyc-AOct)-GLP-1(7-36) Arg 26 Lys 2734 -bis- (Giyc-AOct)-GLP-l 7-37) Arg 34 Lys 27 ' 26 -bis-(Glyc-AOct)-GLP-1(7-37) Arg 26 Lys 2734 -bis- (Glyc-AOct)-GLP-l 7-38) Arg 34 Lys 27 ' 26 -bis-(Glyc-AOct)-GLP-1(7-38) Arg 26 Lys 2734 -bis- (Glyc-AOct)-GLP-l 7-39) Arg 34 Lys 27 ' 26 -bis-(Glyc-AOct)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AOct)-GLP-1(7-36) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1(7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AOct)-GLP-1(7-38) Gly 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AOct)-GLP-1(7-38) Gly 8 Arg 26 ' 34 Lys 3638 -bis-(Glyc-AOct)-GLP-1(7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-AOct)-GLP-1(7-39) Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-AOct)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AOct)-GLP-1(7-39); Val 8 Lys 26 ' 3 -bis-(Glyc-AOct)-GLP-1 (7-36); Val 8 Lys 2634 -bis-(Glyc-AOct)-GLP-1 (7-37); Valtys 2634 - bis-(Glyc-AOct)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-39) Val 8 Arg 26 Lys 3 36 -bis-(Glyc-AOct)-GLP-1(7-36) Val 8 Arg 34 Lys 2636 -bis-(Glyc-AOct)-GLP-1(7-36) Val 8 Arg 26 Lys 3436 -bis-(Glyc-AOct)-GLP-1(7-37) Val 8 Arg 34 Lys 2636 -bis-(Glyc-AOct)-GLP-1(7-37) Val 8 Arg 26 Lys 3 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Val 8 Arg 34 Lys 2637 -bis-(Glyc-AOct)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AOct)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AOct)-GLP-1 (7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(Glyc-AOct)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(Glyc-AOct)-GLP-1 (7-39) Val 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-AOct)-GLP-1(7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Ser 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(Giyc-AOct)-GLP-1 (7-37); Ser 8 Lys 2634 -bis-(Glyc-AOct)-GLP-1 (7-38); Ser s Lys 2634 -bis-(Glyc-AOct)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AOct)-GLP-1(7-36) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1(7-36) Ser 8 Arg 26 Lys 3436 -bis-(Glyc-AOct)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-AOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AOct)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AOct)-GLP-1(7-38) 175 Ser 8 Arg 2634 Lys 36 ' 38 -bis-(Glyc-AOct)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Ser 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Ser 8 Arg 2634 Lys 3839 -bis-(Glyc-AOct)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(Giyc-AOct)-GLP-1 (7-36); Thr 8 Lys 2634 -bis-(Glyc-AOct)-GLP-1 (7-37); Thr 8 Lys 2634 -bis-(Glyc-AOct)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(Glyc-AOct)-GLP-1 (7-39) Thr 8 Arg 26 Lys 3 ' 36 -bis-(Glyc-AOct)-GLP-1 (7-36) Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-AOct)-GLP-1 (7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-AOct)-GLP-1 (7-37) Thr 8 Arg 34 Lys 2636 -bis-(Glyc-AOct)-GLP-1 (7-37) Thr 8 Arg 26 Lys 3437 -bis-(Glyc-AOct)-GLP-1 (7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-AOct)-GLP-1 (7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-AOct)-GLP-1 (7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-AOct)-GLP-1 (7-38) Thr 8 Arg 26 ' 34 Lys 3638 -bis-(Glyc-AOct)-GLP-1 (7-38); Thr 3 Arg 26 Lys 34 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39) Thr 8 Arg 34 Lys 26 - 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-AOct)-GLP-1 (7-39); Lys 26 ' 34 -bis-(Giyc-ALit)-GLP-1 (7-36); Lys 26 ' 34 -bis-(Glyc-ALit)-GLP-1 (7-37); Lys 26 ' 34 -bis-(Glyc- ALit)-GLP-1 (7-38); Lys 26 ' 34 -bis-(Glyc-ALit)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(Glyc-ALit)-GLP-1 7-36); Arg 34 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1 (7-36) Arg 26 Lys 3436 -bis-(Glyc-ALit)-GLP-1 7-37); Arg 34 Lys 2636 -bis-(Glyc-ALit)-GLP-1 (7-37) Arg 26 Lys 34 ' 37 -bis-(Glyc-ALit)-GLP-1 7-37); Arg 34 Lys 26 ' 37 -bis-(Glyc-ALit)-GLP-1 (7-37) Arg 26 Lys 34 ' 39 -bis-(Glyc-ALit)-GLP-1 7-39); Arg 34 Lys 26 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39) Arg 26 ' 34 Lys 3639 -bis-(Glyc-ALit)-GLP 1(7-39); Arg 26 Lys 1834 -bis-(Glyc-ALit)-GLP-1 7-36) Arg 34 Lys 18 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-36) Arg 26 Lys 18 ' 34 -bis-(Glyc-ALit)-GLP-1 7-37) Arg 34 Lys 1826 -bis-(Glyc-ALit)-GLP-1 (7-37) Arg 26 Lys 18 ' 34 -bis-(Glyc-ALit)-GLP-1 7-38) Arg 34 Lys 18 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-38) Arg 26 Lys 18 ' 34 -bis-(Glyc-ALit)-GLP-1 7-39) Arg^Lys 18,26 bis-(Glyc-ALit)-GLP-1 (7-39); Arg 26 Lys 23 - 34 -bis-(Glyc-ALit)-GLP-1 7-36) Arg 34 Lys 23 6 -bis-(Glyc-ALit)-GLP-1 (7-36) Arg 26 Lys 2334 -bis-(Glyc-ALit)-GLP-1 7-37) Arg 34 Lys 23 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-37) Arg 26 Lys 2334 -bis-(Glyc-ALit)-GLP-1 7-38) Arg 34 Lys 23 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-38) Arg 26 Lys 23 ' 34 -bis-(Glyc-ALit)-GLP-1 7-39) Arg 34 Lys 23 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-39); Arg 26 Lys 27 ' 34 -bis-(Glyc-ALit)-GLP-1 7-36) Arg 34 Lys 27 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-36) Arg 26 Lys 27 ' 34 -bis-(Glyc-ALit)-GLP-1 7-37) Arg 34 Lys 27 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-37) Arg 26 Lys 27 ' 34 -bis-(Glyc-ALit)-GLP-1 7-38) Arg 34 Lys 2726 -bis-(Glyc-ALit)-GLP-1 (7-38) Arg 26 Lys 27 ' 34 -bis-(Glyc-ALit)-GLP-1 7-39) Arg 34 Lys 27 ' 26 -bis-(Glyc-ALit)-GLP-1 (7-39); Gly 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-36) Gly 8 Lys 26 ' 34-bis-(Glyc-ALit)-GLP-1 (7.37). Gly 8 Lys 2634 - bis-(Glyc-ALit)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(Glyc-ALit)-GLP-1 (7-39) Gly 8 Arg 28 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1 (7-36) Gly 8 Arg 34 Lys 2W6 -bis-(Glyc-ALit)-GLP-1 (7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1 (7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ALit)-GLP-1 (7-37) Gly 8 Arg 34 Lys 6 ' 37 -bis-(Glyc-ALit)-GLP-1 (7-37) 176 Gly 8 Arg 26 Lys 3 ' 38 -bis-(Glyc-ALit)-GLP-1 (7-38); Gly 8 Arg 34 Lys 2638 -bis-(Glyc-ALit)-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 3638 -bis-(Giyc-ALit)-GLP-1(7-38); Gly 8 Arg 6 Lys 3439 -bis-(Glyc-ALit)-GLP-1(7-39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(Glyc-ALit)-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 ' 39 -bis-(Glyc-ALit)-GLP-1(7-39); Val 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(Glyc-ALit)-GLP-1 (7-37); Valtys 26 ' 34 - bis-(Glyc-ALit)-GLP-1 (7-38); Val 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1(7-36); Val 8 Arg 34 Lys 2636 -bis-(Glyc-ALit)-GLP-1(7-36) Val 8 Arg 26 Lys 3436 -bis-(Glyc-ALit)-GLP-1(7-37); Val 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ALit)-GLP-1(7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(Glyc-ALit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-ALit)-GLP-1 (7-38); Val 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ALit)-GLP-1(7-38) Val 8 Arg 2634 Lys 38 ' 38 -bis-(Glyc-ALit)-GLP-1(7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ALit)-GLP-1(7-39) Val 8 Arg 34 Lys 2839 -bis-(Glyc-ALit)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-ALit)-GLP-1(7-39); Ser 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-36); Ser 3 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-37); Ser^Lys 2634 - bis-(Glyc-ALit)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(Glyc-ALit)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1(7-36) Ser s Arg 3 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1(7-37) Ser β Arg 34 Lys 2636 -bis-(Glyc-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ALit)-GLP-1(7-37) Ser 8 Arg 34 Lys 2637 -bis-(Glyc-ALit)-GLP-1(7-37) Ser 8 Arg 26 Lys 3438 -bis-(Glyc-ALit)-GLP-1 (7-38) Ser 8 Arg 34 Lys 26 ' 38 -bis-(Glyc-ALit)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(Glyc-ALit)-GLP-1(7-38) Ser 3 Arg 26 Lys 34 ' 39 -bis-(Glyc-ALit)-GLP-1(7-39) Ser B Arg 34 Lys 26 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39); Ser 8 Arg 2634 Lys 36 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-36); Thr 8 Lys 263 -bis-(Glyc-ALit)-GLP-1 (7-37); Thrtys 2634 - bis-(Glyc-ALit)-GLP-1 (7-38); Thr 8 Lys 2634 -bis-(Glyc-ALit)-GLP-1 (7-39) Thr fi Arg 6 Lys 34 ' 36 -bis-(Glyc-ALit)-GLP-1(7-36); Thr B Arg 34 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1(7-36) Thr 8 Arg 26 Lys 34 ' 36 -bis-(Glyc-Aϋt)-GLP-1(7-37); Thr 8 Arg 34 Lys 26 ' 36 -bis-(Glyc-ALit)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(Glyc-ALit)-GLP-1(7-37); Thr 3 Arg 34 Lys 26 ' 37 -bis-(Glyc-ALit)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(Glyc-ALit)-GLP-1(7-38); Thr 8 Arg 34 Lys 2638 -bis-(Glyc-ALit)-GLP-1(7-38) Thr 8 Arg 26 ' 3 Lys 3638 -bis-(Glyc-ALit)-GLP-1(7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39) Thr 3 Arg 34 Lys 26 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(Glyc-ALit)-GLP-1 (7-39); Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-36); Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-37); Lys 2634 -bis-(GAB- GDod)-GLP-1 (7-38); Lys 2634 -bis-(GAB-GDod)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1(7-36); Arg 34 Lys 2636 -bis-(GAB-GDod)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1(7-37); Arg 34 Lys 2636 -bis-(GAB-GDod)-GLP-1(7-37) Arg 26 Lys 3 ' 37 -bis-(GAB-GDod)-GLP-1(7-37); Arg 34 Lys 2637 -bis-(GAB-GDod)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(GAB-GDod)-GLP-1(7-39); Arg 34 Lys 26 ' 39 -bis-(GAB-GDod)-GLP-1(7-39) Arg 26 ' 34 Lys 3639 -bis-(GAB-GDod)-GLP-1(7-39); 177 Arg 26 Lys 1834 -bis-(GAB-GDod)-GLP-1(7-36) Arg 3 Lys 18 ' 26 -bis-(GAB-GDod)-GLP-1(7-36) Arg 26 Lys 18 ' 34 -bis-(GAB-GDod)-GLP-1(7-37) Arg 34 Lys 826 -bis-(GAB-GDod)-GLP-1(7-37) Arg 26 Lys 18 ' 34 -bis-(GAB-GDod)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(GAB-GDod)-GLP-1(7-38) Arg 26 Lys 18 ' 34 -bis-(GAB-GDod)-GLP-1 (7-39) Arg 34 Lys 18 ' 26 -bis-(GAB-GDod)-GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis-(GAB-GDod)-GLP-1 (7-36) Arg 34 Lys 23 ' 26 -bis-(GAB-GDod)-GLP-1(7-36) Arg 26 Lys 23 ' 34 -bis-(GAB-GDod)-GLP-1 (7-37) Arg 34 Lys 23 ' 26 -bis-(GAB-GDod)-GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(GAB-GDod)-GLP-1(7-38) Arg 34 Lys 2328 -bis-(GAB-GDod)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(GAB-GDod)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(GAB-GDod)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(GAB-GDod)-GLP-1(7-36) Arg 34 Lys 2726 -bis-(GAB-GDod)-GLP-1(7-36) Arg 26 Lys 2734 -bis-(GAB-GDod)-GLP-1(7-37) Arg 34 Lys 2726 -bis-(GAB-GDod)-GLP-1(7-37) Arg 6 Lys 27 ' 34 -bis-(GAB-GDod)-GLP-1(7-38) Arg 34 Lys 27 ' 26 -bis-(GAB-GDod)-GLP-1(7-38) Arg 26 Lys 7 ' 34 -bis-(GAB-GDod)-GLP-1 (7-39) Arg 34 Lys 7 ' 26 -bis-(GAB-GDod)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-36); Gly 8 Lys 2634 -bis-(G AB-G Dod)-G LP-1 (7-37) ; Gly 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-38); Gly 8 Lys 2634 -bis-(GAB-GDod)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GDod)-GLP-1 (7- 36); Gly 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GDod)-GLP- 1 (7-37); Gly 8 Arg 26 Lys 3437 -bis-(GAB-GDod)-GLP-1 (7-37); Gly 8 Arg 34 Lys 2637 -bis-(GAB-GDod)- GLP-1 (7-37); Gly 8 Arg 26 Lys 3438 -bis-(GAB-GDod)-GLP-1 (7-38); Gly 8 Arg 34 Lys 2638 -bis-(GAB- GDod)-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38); Gly B Arg 26 Lys 34 - 3β -bis- (GAB-GDod)-GLP-l (7-39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GDod)-GLP-1 (7-39); Gly^rg^^Lys 36 ' 39 - bis-(GAB-GDod)-GLP-1 (7-39); Val 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-36); Val 8 Lys 2634 -bis-(GAB-GDod)-GLP-1 (7-37); Val 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-39) Val 8 Arg 26 Lys 3436 -bis-(GAB-GDod)-GLP-1 (7-36); Val 8 Arg 34 Lys 2636 -bis-(GAB-GDod)-GLP-1 (7-36) Val 8 Arg 26 Lys 3436 -bis-(GAB-GDod)-GLP-1 (7-37); Val 8 Arg 34 Lys 2636 -bis-(GAB-GDod)-GLP-1 (7-37) Val 8 Arg 26 Lys 3437 -bis-(GAB-GDod)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GDod)-GLP-1 (7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38); Val 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38) Val 8 Arg 2634 Lys 36 - 38 -bis-(GAB-GDod)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GDod)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GDod)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GDod)-GLP- 1(7-39); Ser 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-36); Ser 3 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-37); Ser 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-39) Ser B Arg 6 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-36); Ser 8 Arg 34 Lys 2636 -bis-(GAB-GDod)-GLP-1 (7- 36); Ser 3 Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GDod)-GLP- 178 1 (7-37); Ser 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GDod)-GLP-1 (7-37); Ser 8 Arg 34 Lys 2637 -bis-(GAB-GDod)- GLP-1 (7-37); Ser s Arg 6 Lys 34 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38); Ser 8 Arg 34 Lys 2638 -bis-(GAB- GDod)-GLP-1 (7-38); Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38); Ser 8 Arg 2β Lys 34 * , -bis- (GAB-GDod)-GLP-l (7-39); Ser B Arg 34 Lys 26 ' 39 -bis-(GAB-GDod)-GLP-1 (7-39); Ser'Αrg^Lys 36 ' 39 - bis-(GAB-GDod)-GLP-1 (7-39); Thr 8 Lys 2634 -bis-(GAB-GDod)-GLP-1 (7-36); Thr 8 Lys 2634 -bis-(GAB-GDod)-GLP-1 (7-37); Thr 8 Lys 6 ' 3 -bis-(GAB-GDod)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(GAB-GDod)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GDod)-GLP-1 (7- 36); Thr 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GDod)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GDod)-GLP- 1 (7-37); Thr 8 Arg 26 Lys 3437 -bis-(GAB-GDod)-GLP-1 (7-37); Thr 8 Arg 3 Lys 26 ' 37 -bis-(GAB-GDod)- GLP-1 (7-37); Thr 8 Arg 26 Lys 3438 -bis-(GAB-GDod)-GLP-1 (7-38); Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB- GDod)-GLP-1 (7-38); Thr 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GDod)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis- (GAB-GDod)-GLP-l (7-39); Thr a Arg 34 Lys 26 ' 39 -bis-(GAB-GDod)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 - bis-(GAB-GDod)-GLP-1 (7-39); Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-36); Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-37); Lys 26 ' 3 -bis-(GAB- GTet)-GLP-1 (7-38); Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-39) Arg 26 Lys 3 36 -bis-(GAB-GTet)-GLP-1 (7-36) Arg 34 Lys 2636 -bis-(GAB-GTet)-GLP-1(7-36) Arg 26 Lys 3436 -bis-(GAB-GTet)-GLP-1 (7-37) Arg 34 Lys 2636 -bis-(GAB-GTet)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(GAB-GTet)-GLP-1 (7-37) Arg 34 Lys 26 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(GAB-GTet)-GLP-1 (7-39) Arg 34 Lys 26 ' 39 -bis-(GAB-GTet)-GLP-1(7-39) Arg^Lys∞∞-bis-tGAB-GTetJ-GLP -1(7-39) Arg 26 Lys 1834 -bis-(GAB-GTet)-GLP-1 (7-36) Arg^Lys 1826 - bis-(GAB-GTet)-GLP-1 (7-36) Arg 26 Lys 18 ' 34 -bis-(GAB-GTet)-GLP-1 (7-37) Arg^Lys 1826 - bis-(GAB-GTet)-GLP-1 (7-37) Arg 26 Lys 18 ' 34 -bis-(GAB-GTet)-GLP-1 (7-38) Arg^Lys 1826 - bis-(GAB-GTet)-GLP-1 (7-38) Arg 26 Lys 1834 -bis-(GAB-GTet)-GLP-1 (7-39) Arg 34 Lys 1826 -bis-(GAB- GTet)-GLP-1(7-39); Arg 26 Lys 2334 -bis-(GAB-GTet)-GLP-1 (7-36) Arg^Lys 23 ' 26 - bis-(GAB-GTet)-GLP-1 (7-36) Arg 26 Lys 23 ' 3 -bis-(GAB-GTet)-GLP-1 (7-37) Arg^Lys 23 ' 26 - bis-(GAB-GTet)-GLP-1 (7-37) Arg 26 Lys 2334 -bis-(GAB-GTet)-GLP-1 (7-38) Arg^Lys 2326 - bis-(GAB-GTet)-GLP-1 (7-38) Arg 26 Lys 23 ' 34 -bis-(GAB-GTet)-GLP-1 (7-39) Arg 34 Lys 2326 -bis-(GAB- GTet)-GLP-1(7-39); Arg 26 Lys 2734 -bis-(GAB-GTet)-GLP-1 (7-36) Arg^Lys 2726 - bis-(GAB-GTet)-GLP-1 (7-36) Arg 26 Lys 2734 -bis-(GAB-GTet)-GLP-1 (7-37) Arg^Lys 2726 - bis-(GAB-GTet)-GLP-1 (7-37) Arg 26 Lys 2734 -bis-(GAB-GTet)-GLP-1 (7-38) Arg^Lys 2726 - bis-(GAB-GTet)-GLP-1 (7-38) Arg 26 Lys 2734 -bis-(GAB-GTet)-GLP-1 (7-39) Arg 34 Lys 2726 -bis-(GAB- GTet)-GLP-1(7-39); 179 Gly 8 Lys 2W4 -bis-(GAB-GTet)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-37); Gly 8 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-38); Gly 8 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-39) Gly 8 Arg 26 Lys 3436 -bis-(GAB-GTet)-GLP-1(7-36) Gly 8 Arg 3 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Gly 8 Arg 26 Lys 3436 -bis-(GAB-GTet)-GLP-1(7-37) Gly 8 Arg 3 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(GAB-GTet)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Gly 8 Arg 26 Lys 3438 -bis-(GAB-GTet)-GLP-1(7-38) Gly 8 Arg 34 Lys 2638 -bis-(GAB-GTet)-GLP-1(7-38) Gly 8 Arg 2634 Lys 36 ' 38 -bis-(GAB-GTet)-GLP-1 (7-38); Gly 8 Arg 26 Lys 3439 -bis-(GAB-GTet)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GTet)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GTet)-GLP- 1(7-39); Val 8 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-37); Val 8 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-38); Val 8 Lys 26 ' 3 -bis-(GAB-GTet)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GTet)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Val 8 Arg 34 Lys 2W7 -bis-(GAB-GTet)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GTet)-GLP-1(7-38) Val 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GTet)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(GAB-GTet)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GTet)-GLP-1 (7-39) Val 8 Arg 34 Lys 2639 -bis-(GAB-GTet)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 3839 -bis-(GAB-GTet)-GLP-1 (7-39) Ser 3 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-36); Ser 3 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-37) Ser 8 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-38); Ser 3 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-39) Ser 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Ser 8 Arg 26 Lys 3436 -bis-(GAB-GTet)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-37) Ser 8 Arg 6 Lys 34 ' 37 -bis-(GAB-GTet)-GLP-1 (7-37) Ser 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Ser 3 Arg 26 Lys 3438 -bis-(GAB-GTet)-GLP-1(7-38) Ser 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GTet)-GLP-1(7-38) Ser 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GTet)-GLP-1 (7-38); Ser 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GTet)-GLP-1 (7- 39); Ser 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GTet)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GTet)-GLP- 1 (7-39); Thr 8 Lys 26 ' 34 -bis-(GAB-GTet)-GLP-1 (7-36); Thr 8 Lys 2634 -bis-(GAB-GTet)-GLP-1 (7-37); ThHtys 2634 -bis-(GAB-GTet)-GLP-1 (7-38); Thr 8 Lys 26 ' 3 -bis-(GAB-GTet)-GLP-1 (7-39) Thr 3 Arg 26 Lys 34 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Thr 3 Arg 34 Lys 26 ' 36 -bis-(GAB-GTet)-GLP-1(7-36) Thr 8 Arg 26 Lys 3436 -bis-(GAB-GTet)-GLP-1(7-37) Thr β Arg 34 Lys 26 ' 38 -bis-(GAB-GTet)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GTet)-GLP-1(7-37) Thr 8 Arg 26 Lys 3 ' 38 -bis-(GAB-GTet)-GLP-1(7-38) Thr 3 Arg 34 Lys 26 ' 38 -bis-(GAB-GTet)-GLP-1(7-38) Thr 8 Arg 26 ' 34 Lys 3638 -bis-(GAB-GTet)-GLP-1 (7-38); Thr 8 Arg 28 Lys 3439 -bis-(GAB-GTet)-GLP-1 (7- 180 39); Thr a Arg 34 Lys 26 ' 39 -bis-(GAB-GTet)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GTet)-GLP- 1(7-39); Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-36); Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-37); Lys 2634 -bis-(GAB- GHex)-GLP-1 (7-38); Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-39) Arg 26 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-36) Arg 34 Lys 2636 -bis-(GAB-GHex)-GLP-1(7-36) Arg 26 Lys 3436 -bis-(GAB-GHex)-GLP-1 (7-37) Arg 34 Lys 26 ' 36 -bis-(GAB-GHex)-GLP-1(7-37) Arg 26 Lys 3437 -bis-(GAB-GHex)-GLP-1(7-37) Arg 3 Lys 2637 -bis-(GAB-GHex)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(GAB-GHex)-GLP-1(7-39) Arg 34 Lys 2639 -bis-(GAB-GHex)-GLP-1(7-39) Arg 2634 Lys 36 ' 39 -bis-(GAB-GHex)-GLP-1(7-39); Arg 26 Lys 1834 -bis-(GAB-GHex)-GLP-1(7-36) Arg 3 Lys 1826 -bis-(GAB-GHex)-GLP-1(7-36) Arg 26 Lys 18 ' 34 -bis-(GAB-GHex)-GLP-1(7-37) Arg 34 Lys 18 ' 26 -bis-(GAB-GHex)-GLP-1(7-37) Arg 6 Lys 18 ' 3 -bis-(GAB-GHex)-GLP-1(7-38) Arg 34 Lys 1826 -bis-(GAB-GHex)-GLP-1(7-38) Arg 26 Lys 18 ' 34 -bis-(GAB-GHex)-GLP-1(7-39) Arg 34 Lys 18 ' 26 -bis-(GAB-GHex)-GLP-1(7-39); Arg 26 Lys 2334 -bis-(GAB-GHex)-GLP-1(7-36) Arg 34 Lys 23 ' 26 -bis-(GAB-GHex)-GLP-1(7-36) Arg 26 Lys 23 ' 34 -bis-(GAB-GHex)-GLP-1(7-37) Arg 34 Lys 23 ' 26 -bis-(GAB-GHex)-GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(GAB-GHex)-GLP-1(7-38) Arg 34 Lys 23 ' 26 -bis-(GAB-GHex)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(GAB-GHex)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(GAB-GHex)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(GAB-GHex)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(GAB-GHex)-GLP-1(7-36) Arg 26 Lys 27 ' 34 -bis-(GAB-GHex)-GLP-1(7-37) Arg 34 Lys 27 ' 26 -bis-(GAB-GHex)-GLP-1(7-37) Arg 26 Lys 27 ' 34 -bis-(GAB-GHex)-GLP-1(7-38) Arg 34 Lys 2726 -bis-(GAB-GHex)-GLP-1(7-38) Arg 26 Lys 27 ' 34 -bis-(GAB-GHex)-GLP-1(7-39) Arg 34 Lys 2726 -bis-(GAB-GHex)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1(7-37); Gly 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-36); Gly 8 Arg 34 Lys 2636 -bis-(GAB-GHex)-GLP-1 (7-36) Gly 8 Arg 6 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GHex)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GHex)-GLP-1 (7-37); Gly 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GHex)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38); Gly 8 Arg 34 Lys 2638 -bis-(GAB-GHex)-GLP-1 (7-38) GIy 8 Arg 2634 Lys 36 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GHex)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 2639 -bis-(GAB-GHex)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GHex)-GLP- 1(7-39); Val 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-37); Val 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-38); Val 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-36); Val 8 Arg 3 Lys 26 ' 36 -bis-(GAB-GHex)-GLP-1 (7-36); Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GHex)-GLP-1 (7-37); 181 Val 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GHex)-GLP-1 (7-37); Val 8 Arg 34 Lys 2637 -bis-(GAB-GHex)-GLP-1 (7-37); Val 8 Arg 26 Lys 3438 -bis-(GAB-GHex)-GLP-1 (7-38); Val 8 Arg 34 Lys 2638 -bis-(GAB-GHex)-GLP-1 (7-38); Val 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38); Val 8 Arg 26 Lys 3439 -bis-(GAB-GHex)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GHex)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GHex)-GLP- 1(7-39); Ser 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-37); Ser 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-38); Ser 3 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-39) Ser 8 Arg 26 Lys 3436 -bis-(GAB-GHex)-GLP-1 (7-36); Ser 8 Arg 34 Lys 2636 -bis-(GAB-GHex)-GLP-1 (7- 36); Ser 8 Arg 26 Lys 3436 -bis-(GAB-GHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GHex)-GLP- 1 (7-37); Ser 3 Arg 26 Lys 3 ' 37 -bis-(GAB-GHex)-GLP-1 (7-37); Ser 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GHex)- GLP-1 (7-37); Ser 8 Arg 26 Lys 3438 -bis-(GAB-GHex)-GLP-1 (7-38); Ser 8 Arg 34 Lys 2638 -bis-(GAB- GHex)-GLP-1 (7-38); Ser s Arg 26 ' 34 Lys 3638 -bis-(GAB-GHex)-GLP-1 (7-38); Sei^Arg Lys^∞-bis- (GAB-GHex)-GLP-l (7-39); Ser 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GHex)-GLP-1 (7-39); Ser^Arg^Lys 36 ' 39 - bis-(GAB-GHex)-GLP-1 (7-39); Thr 8 Lys 26 ' 34 -bis-(GAB-GHex)-GLP-1 (7-36); Thr 8 Lys 2834 -bis-(GAB-GHex)-GLP-1 (7-37); Thr 8 Lys 2634 -bis-(GAB-GHex)-GLP-1 (7-38); Thr 8 Lys 263 -bis-(GAB-GHex)-GLP-1 (7-39) Thr 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GHex)-GLP-1 (7-36); Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GHex)-GLP-1 (7-36) Thr 8 Arg 26 Lys 3436 -bis-(GAB-GHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GHex)-GLP-1 (7-37) Thr 8 Arg 26 Lys 3437 -bis-(GAB-GHex)-GLP-1 (7-37); Thr 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GHex)-GLP-1 (7-37) Thr 3 Arg 26 Lys 34 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38); Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38) Thr B Arg 2634 Lys 36 ' 38 -bis-(GAB-GHex)-GLP-1 (7-38); Thr 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GHex)-GLP-1 (7- 39); Thr 8 Arg 34 Lys 2639 -bis-(GAB-GHex)-GLP-1 (7-39); Thr 8 Arg 2634 Lys 3639 -bis-(GAB-GHex)-GLP- 1(7-39); Lys 263 -bis-(GAB-GOct)-GLP-1 (7-36); Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-37); Lys 2634 -bis-(GAB- GOct)-GLP-1 (7-38); Lys 2634 -bis-(GAB-GOct)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(GAB-GOct)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-36) Arg 26 Lys 3436 -bis-(GAB-GOct)-GLP-1(7-37) Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Arg 26 Lys 34 ' 37 -bis-(GAB-GOct)-GLP-1(7-37) Arg 34 Lys 2637 -bis-(GAB-GOct)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(GAB-GOct)-GLP-1 (7-39) Arg 34 Lys 26 ' 39 -bis-(GAB-GOct)-GLP-1(7-39) Arg 26 ' 34 Lys 3639 -bis-(GAB-GOct)-GLP-1(7-39); Arg 26 Lys 18 ' 34 -bis-(GAB-GOct)-GLP-1(7-36) Arg 34 Lys 18 ' 26 -bis-(GAB-GOct)-GLP-1(7-36) Arg 26 Lys 18 ' 34 -bis-(GAB-GOct)-GLP-1(7-37) Arg 34 Lys 1826 -bis-(GAB-GOct)-GLP-1(7-37) Arg 26 Lys 1834 -bis-(GAB-GOct)-GLP-1(7-38) Arg 34 Lys 18 ' 26 -bis-(GAB-GOct)-GLP-1(7-38) Arg 26 Lys 1834 -bis-(GAB-GOct)-GLP-1 (7-39) Arg 34 Lys 18 ' 26 -bis-(GAB-GOct)-GLP-1(7-39); 182 Arg 26 Lys 2334 -bis-(GAB-GOct)-GLP-1(7-36) Arg 34 Lys 23 ' 26 -bis-(GAB-GOct)-GLP-1(7-36) Arg 26 Lys 334 -bis-(GAB-GOct)-GLP-1(7-37) Arg 34 Lys 23 ' 26 -bis-(GAB-GOct)-GLP-1(7-37) Arg 26 Lys 23 ' 34 -bis-(GAB-GOct)-GLP-1(7-38) Arg 34 Lys 2326 -bis-(GAB-GOct)-GLP-1(7-38) Arg 26 Lys 2334 -bis-(GAB-GOct)-GLP-1(7-39) Arg 34 Lys 23 ' 26 -bis-(GAB-GOct)-GLP-1(7-39); Arg 26 Lys 27 ' 34 -bis-(GAB-GOct)-GLP-1(7-36) Arg 34 Lys 27 ' 26 -bis-(GAB-GOct)-GLP-1(7-36) Arg 26 Lys 27 ' 34 -bis-(GAB-GOct)-GLP-1 (7-37) Arg 3 Lys 2726 -bis-(GAB-GOct)-GLP-1(7-37) Arg 26 Lys 2734 -bis-(GAB-GOct)-GLP-1(7-38) Arg 34 Lys 27 ' 26 -bis-(GAB-GOct)-GLP-1(7-38) Arg 26 Lys 2734 -bis-(GAB-GOct)-GLP-1(7-39) Arg 34 Lys 27 ' 26 -bis-(GAB-GOct)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1(7-37); Gly 8 Lys 2634 -bis-(GAB-GOct)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-39) Gly 8 Arg 26 Lys 3436 -bis-(GAB-GOct)-GLP-1(7-36) Gly 8 Arg 34 Lys 2636 -bis-(GAB-GOct)-GLP-1 (7-36) Gly 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 3437 -bis-(GAB-GOct)-GLP-1(7-37) Gly 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GOct)-GLP-1(7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GOct)-GLP-1 (7-38) Gly 8 Arg 34 Lys 2638 -bis-(GAB-GOct)-GLP-1(7-38) Gly 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GOct)-GLP-1 (7-38); Gly 8 Arg 26 Lys 3439 -bis-(GAB-GOct)-GLP-1 (7- 39); Gly 8 Arg 34 Lys 2639 -bis-(GAB-GOct)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 ;39 -bis-(GAB-GOct)-GLP- 1(7-39); Val 8 Lys 2634 -bis-(GAB-GOct)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-37); Val 8 Lys 6 ' 34 -bis-(GAB-GOct)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GOct)-GLP-1(7-36) Val 8 Arg 34 Lys 2636 -bis-(GAB-GOct)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Val 8 Arg 34 Lys 2636 -bis-(GAB-GOct)-GLP-1(7-37) Val 8 Arg 26 Lys 3437 -bis-(GAB-GOct)-GLP-1(7-37) Val 8 Arg 3 Lys 26 ' 37 -bis-(GAB-GOct)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GOct)-GLP-1(7-38) Val 8 Arg 34 Lys 2638 -bis-(GAB-GOct)-GLP-1(7-38) Val 8 Arg 2634 Lys 36 ' 38 -bis-(GAB-GOct)-GLP-1 (7-38); Val 8 Arg 6 Lys 3 39 -bis-(GAB-GOct)-GLP-1 (7- 39); Val 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GOct)-GLP-1 (7-39); Val 8 Arg 26 ' 34 Lys 3639 -bis-(GAB-GOct)-GLP- 1(7-39); Ser 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-36); Ser s Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-37); Ser 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-38); Ser 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-39) Ser 8 Arg 26 Lys 3436 -bis-(GAB-GOct)-GLP-1 (7-36) Ser a Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-36) Ser 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 3437 -bis-(GAB-GOct)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 37 -bis-(GAB-GOct)-GLP-1(7-37) Ser 8 Arg 26 Lys 3438 -bis-(GAB-GOct)-GLP-1 (7-38) Ser 3 Arg 34 Lys 26 ' 38 -bis-(GAB-GOct)-GLP-1(7-38) Ser 8 Arg 2634 Lys 36 ' 38 -bis-(GAB-GOct)-GLP-1 (7-38); Ser 8 Arg 26 Lys 3 39 -bis-(GAB-GOct)-GLP-1 (7- 183 39); Ser 8 Arg 34 Lys 2639 -bis-(GAB-GOct)-GLP-1 (7-39); Ser 8 Arg 26 ' 34 Lys 36 ' 39 -bis-(GAB-GOct)-GLP- 1(7-39); Thr 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-36); Thr 8 Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-37); Thι^Lys 26 ' 34 -bis-(GAB-GOct)-GLP-1 (7-38); Thr 8 Lys 2634 -bis-(GAB-GOct)-GLP-1 (7-39) Thr 8 Arg 26 Lys 3436 -bis-(GAB-GOct)-GLP-1 (7-36); Thr 8 Arg 34 Lys 2636 -bis-(GAB-GOct)-GLP-1 (7-36) Thr 3 Arg 26 Lys 34 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GOct)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GOct)-GLP-1 (7-37) Thr 3 Arg 34 Lys 2637 -bis-(GAB-GOct)-GLP-1 (7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GOct)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GOct)-GLP-1(7-38) Thr 8 Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GOct)-GLP-1 (7-38); Thr 8 Arg 6 Lys 34 ' 39 -bis-(GAB-GOct)-GLP-1 (7- 39); Thr a Arg 34 Lys 26 ' 39 -bis-(GAB-GOct)-GLP-1(7-39); Thr B Arg 2634 Lys 36 ' 39 -bis-(GAB-GOct)-GLP- 1(7-39); Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-36); Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-37); Lys 2634 -bis-(GAB- GLit)-GLP-1 (7-38); Lys 2634 -bis-(GAB-GLit)-GLP-1 (7-39) Arg 26 Lys 3436 -bis-(GAB-GLit)-GLP-1(7-36) Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-37) Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1 (7-37) Arg 26 Lys 34 ' 37 -bis-(GAB-GLit)-GLP-1(7-37) Arg 34 Lys 2W7 -bis-(GAB-GLit)-GLP-1(7-37) Arg 26 Lys 34 ' 39 -bis-(GAB-GLit)-GLP-1(7-39) Arg 34 Lys 2639 -bis-(GAB-GLit)-GLP-1(7-39) Arg 2634 Lys 36 ' 39 -bis-(GAB-GLit)-GLP-1(7-39); Arg 26 Lys 18 ' 34 -bis-(GAB-GLit)-GLP-1(7-36) Arg^Lys^-bis- (GAB-GLit)-GLP-1(7-36) Arg 26 Lys 8 ' 34 -bis-(GAB-GLit)-GLP-1(7-37) Arg^Lys^∞-bis- (GAB-GLit)-GLP-1(7-37) Arg 26 Lys 1834 -bis-(GAB-GLit)-GLP-1(7-38) Arg^Lys^ -bis- (GAB-GLit)-GLP-1(7-38) Arg 26 Lys 1834 -bis-(GAB-GLit)-GLP-1(7-39) Arg 34 Lys 18 ' 26 -bis-(GAB-GLit) •GLP-1(7-39); Arg 26 Lys 23 ' 34 -bis-(GAB-GLit)-GLP-1 (7-36) Arg^Lys ∞-bis- (GAB-GLit)-GLP-1(7-36) Arg 26 Lys 2334 -bis-(GAB-GLit)-GLP-1(7-37) Arg 34 Lys 23 ' 26 -bis- (GAB-GLit)-GLP-1(7-37) Arg 26 Lys 2334 -bis-(GAB-GLit)-GLP-1(7-38) Arg^Lys∞^-bis- (GAB-GUt)-GLP-1(7-38) Arg 26 Lys 23 ' 34 -bis-(GAB-GLit)-GLP-1(7-39) Arg 34 Lys 2326 -bis-(GAB-GLit) -GLP-1 (7-39); Arg 26 Lys 734 -bis-(GAB-GLit)-GLP-1(7-36) Arg^Lys^-bis (GAB-GLit)-GLP-1(7-36) Arg 26 Lys 27 ' 34 -bis-(GAB-GLit)-GLP-1(7-37) Arg 34 Lys 2726 -bis (GAB-GLit)-GLP-1(7-37) Arg 26 Lys 2734 -bis-(GAB-GLit)-GLP-1(7-38) Arg^Lys^-bis (GAB-GLit)-GLP-1(7-38) Arg 26 Lys 2734 -bis-(GAB-GLit)-GLP-1 (7-39) Arg 34 Lys 2726 -bis-(GAB-GLit)-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-37); Gly 8 Lys 2634 - bis-(GAB-GLit)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-39) Gly 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1 (7-36); Gly 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1 (7-36); Gly 8 Arg 26 Lys 3438 -bis-(GAB-GLit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 2636 -bis-(GAB-GLit)-GLP-1 (7-37); 184 Gly 8 Arg 26 Lys 3437 -bis-(GAB-GLit)-GLP-1 (7-37); Gly 8 Arg 34 Lys 2637 -bis-(GAB-GLit)-GLP-1 (7-37) Gly 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GLit)-GLP-1 (7-38); Gly 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GLit)-GLP-1 (7-38) Gly 8 Arg 6 ' 34 Lys 3638 -bis-(GAB-GLit)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39) Gly 8 Arg 34 Lys 2639 -bis-(GAB-GLit)-GLP-1 (7-39); Gly 8 Arg 2634 Lys 36 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39); Val 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-36); Val 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-37); Val 8 Lys 2634 - bis-(GAB-GLit)-GLP-1 (7-38); Val 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-39) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Val 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Val 8 Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GLit)-GLP-1(7-37) Val 8 Arg 34 Lys 26 ' 37 -bis-(GAB-GLit)-GLP-1(7-37) Val 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GLit)-GLP-1 (7-38) Val 8 Arg 34 Lys 2638 -bis-(GAB-GLit)-GLP-1(7-38) Val 8 Arg 26 ' 34 Lys 3638 -bis-(GAB-GLit)-GLP-1 (7-38); Val 8 Arg 26 Lys 34 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39) Val 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39); Val 8 Arg 2634 Lys 3639 -bis-(GAB-GLit)-GLP-1 (7-39); Ser s Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-36); Ser 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-37); Sertys 26 ' 34 - bis-(GAB-GLit)-GLP-1 (7-38); Ser B Lys 2834 -bis-(GAB-GLit)-GLP-1 (7-39) Ser £ Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Ser 8 Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Ser 3 Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 36 -bis-(GAB-GLit)-GLP-1(7-37) Ser 8 Arg 26 Lys 3437 -bis-(GAB-GLit)-GLP-1(7-37) Ser 3 Arg 34 Lys 26 ' 37 -bis-(GAB-GLit)-GLP-1(7-37) Ser B Arg 26 Lys 34 ' 38 -bis-(GAB-GLit)-GLP-1(7-38) Ser 8 Arg 34 Lys 2638 -bis-(GAB-GLit)-GLP-1(7-38) Ser a Arg 26 ' 34 Lys 36 ' 38 -bis-(GAB-GLit)-GLP-1 (7-38); Ser 8 Arg 26 Lys 3 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39) Ser 8 Arg 34 Lys 2639 -bis-(GAB-GLit)-GLP-1 (7-39); Ser 8 Arg 26 ' 3 Lys 3639 -bis-(GAB-GLit)-GLP-1 (7-39); Thr 3 Lys 2634 -bis-(GAB-GLit)-GLP-1 (7-36); Thr β Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-37); Thr^Lys 26 ' 34 bis-(GAB-GLit)-GLP-1 (7-38); Thr 8 Lys 26 ' 34 -bis-(GAB-GLit)-GLP-1 (7-39) Thr £ Arg 26 Lys 34 ' 36 -bis-(GAB-GLit)-GLP-1(7-36) Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GLit)-GLP-1(7-36) Thr 3 Arg 26 Lys 3436 -bis-(GAB-GLit)-GLP-1(7-37) Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-GLit)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 37 -bis-(GAB-GLit)-GLP-1(7-37) Thr 8 Arg 34 Lys 2637 -bis-(GAB-GLit)-GLP-1(7-37) Thr 8 Arg 26 Lys 34 ' 38 -bis-(GAB-GLit)-GLP-1(7-38) Thr 8 Arg 34 Lys 26 ' 38 -bis-(GAB-Gϋt)-GLP-1(7-38) Thr 8 Arg 26 ' 34 Lys 3638 -bis-(GAB-GLit)-GLP-1 (7-38); Thr 8 Arg 26 Lys 3439 -bis-(GAB-GLit)-GLP-1 (7-39) Thr 8 Arg 34 Lys 26 ' 39 -bis-(GAB-GLit)-GLP-1 (7-39); Thr 8 Arg 26 ' 34 Lys 3639 -bis-(GAB-GLit)-GLP-1 (7-39). Pharmaceutical compositions The present invention also relates to pharmaceutical compositions comprising a derivative of a GLP-1 analog of the present invention and a pharmaceutically acceptable vehicle or carrier. 185 Preferably, the pharmaceutical compositions comprise an isotonic agent, a preservative and a buffer. Examples of isotonic agents are sodium chloride, mannitol and glycerol. E- xamples of preservatives are phenol, m-cresol, methyl p-hydroxybenzoate and benzyl alcohol. Suitable buffers include sodium acetate and sodium phosphate. The pharmaceutical compositions preferably further comprise a surfactant in order to improve the solubility and/or the stability of the GLP-1 derivative. The pharmaceutical compositions preferably also comprise zinc. The pharmaceutial compositions preferably further comprise another antidiabetic agent. The term "antidiabetic agent" includes compounds for the treatment and/or prophylaxis of insulin resistance and diseases wherein insulin resistance is the pathophysiological mechanism. In one embodiment of this invention, the antidiabetic agent is an insulin, more preferably human insulin. In another embodiment the antidiabetic agent is a hypoglycaemic agent, preferably an oral hypoglycaemic agent. Oral hypoglycaemic agents are preferably selected from the group consisting of sulfonylureas, biguanides, thiazolidinediones, glucosidase inhibitors, glucagon antagonists, GLP-1 agonists, potasium channel openers, insulin sensitizers, hepatic enzyme inhibitors, glucose uptake modulators, compounds modifying the lipid metabolism, compounds lowering food intake, and agents acting on the ATP-dependent potassium channel of the β- cells. Preferred sulfonylureas are tolbutamide, glibenclamide, glipizide and gliclazide. A preferred biguanide is metformin. Preferred thiazolidinediones are troglitazone and ciglitazone. A preferred glucosidase inhibitors is acarbose. Preferred agents acting on the ATP-dependent potassium channel of the β-cells are: glibenclamide, glipizide, gliclazide, and repaglinide. The pharmaceutical compositions of the present invention may be administered pa- renterally to patients in need of such a treatment. Parenteral administration may be performed by subcutaneous, intramuscular or intravenous injection by means of a syringe, optionally a pen-like syringe. Alternatively, parenteral administration can be performed by means of an infusion pump. A further option is a composition which may be a powder or a liquid for the administration of the GLP-1 derivative in the form of a nasal or pulmonal spray. As a still further op- tion, the GLP-1 derivatives of the invention can also be administered transdermally, e.g. from a patch, optionally a iontophoretic patch, or transmucosally, e.g. bucally. The pharmaceutical compositions of the present invention may be prepared by conventional techniques, e.g. as described in Remington's Pharmaceutical Sciences, 1985 or in Remington: The Science and Practice of Pharmacy, 19 th edition, 1995. 186 For example, injectable compositions of the GLP-1 derivative of the invention can be prepared using the conventional techniques of the pharmaceutical industry which involves dissolving and mixing the ingredients as appropriate to give the desired end product. A composition for nasal administration of certain peptides may, for example, be prepa- red as described in European Patent No. 272097 (to Novo Nordisk A/S) or in WO 93/18785. In a preferred embodiment of the present invention, the GLP-1 derivative is provided in the form of a composition suitable for administration by injection. Such a composition can either be an injectable solution ready for use or it can be an amount of a solid composition, e.g. a lyophilised product, which has to be dissolved in a solvent before it can be injected. The in- jectable solution preferably contains not less than about 2 mg/ml, preferably not less than about 5 mg/ml, more preferred not less than about 10 mg/ml of the GLP-1 derivative and, preferably, not more than about 100 mg/ml of the GLP-1 derivative. Uses The present invention also relates to the use of a GLP-1 derivative of the invention for the preparation of a medicament which has a protracted profile of action relative to GLP-1 (7- 37). The present invention relates also to the use of a GLP-1 derivative of the invention for the preparation of a medicament with protracted effect for the treatment of non-insulin depen- dent diabetes mellitus. The present invention also relates to the use of a GLP-1 derivative of the invention for the preparation of a medicament with protracted effect for the treatment of insulin dependent diabetes mellitus. The present invention also relates to the use of a GLP-1 derivative of the invention for the preparation of a medicament with protracted effect for the treatment of obesity. In a further preferred embodiment, the present invention relates to a method of treating insulin dependent or non-insulin dependent diabetes mellitus in a patient in need of such a treatment, comprising administering to the patient a therapeutically effective amount of a derivative of GLP-1 analog of the present invention together with a pharmaceutically acceptable carrier. Methods of Production The parent peptide can be produced by a method which comprises culturing a host cell containing a DNA sequence encoding the polypeptide and capable of expressing the poly- 187 peptide in a suitable nutrient medium under conditions permitting the expression of the peptide, after which the resulting peptide is recovered from the culture. The medium used to culture the cells may be any conventional medium suitable for growing the host cells, such as minimal or complex media containing appropriate supplements. Suitable media are available from commercial suppliers or may be prepared of published recipes (e.g. in catalogues of the American Type Culture Collection). The peptide produced by the cells may then be recovered from the culture medium by conventional procedures including separating the host cells from the medium by centrifugation or filtration, precipitating the prote- inaceous components of the supernatant or filtrate by means of a salt, e.g. ammonium sulp- hate, purification by a variety of chromatographic procedures, e.g. ion exchange chromatography, gel filtration chromatography, affinity chromatography, or the like, dependent on the type of peptide in question. The DNA sequence encoding the parent peptide may suitably be of genomic or cDNA origin, for instance obtained by preparing a genomic or cDNA library and screening for DNA sequences coding for all or part of the peptide by hybridisation using synthetic oligonucleotide probes in accordance with standard techniques (see, for example, Sambrook, J, Fritsch, EF and Maniatis, T, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York, 1989). The DNA sequence encoding the peptide may also be prepared synthetically by established standard methods, e.g. the phosphoamidite method described by Be- aucage and Caruthers, Tetrahedron Letters 22 (1981), 1859 - 1869, or the method described by Matthes et al., EMBO Journal 3 (1984), 801 - 805. The DNA sequence may also be prepared by polymerase chain reaction using specific primers, for instance as described in US 4,683,202 or Saiki et al., Science 239 (1988), 487 - 491. The DNA sequence may be inserted into any vector which may conveniently be sub- jected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid. Alternatively, the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome(s) into which it has been integrated. The vector is preferably an expression vector in which the DNA sequence encoding the peptide is operably linked to additional segments required for transcription of the DNA, such as a promoter. The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homo- 188 logous or heterologous to the host cell. Examples of suitable promoters for directing the transcription of the DNA encoding the peptide of the invention in a variety of host cells are well known in the art, cf. for instance Sambrook et al., supra. The DNA sequence encoding the peptide may also, if necessary, be operably con- nected to a suitable terminator, polyadenylation signals, transcriptional enhancer sequences, and translational enhancer sequences. The recombinant vector of the invention may further comprise a DNA sequence enabling the vector to replicate in the host cell in question. The vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell or one which confers resistance to a drug, e.g. ampicillin, kanamycin, tetracyclin, chloramphenicol, neomycin, hygromycin or methotrexate. To direct a parent peptide of the present invention into the secretory pathway of the host cells, a secretory signal sequence (also known as a leader sequence, prepro sequence or pre sequence) may be provided in the recombinant vector. The secretory signal sequence is joined to the DNA sequence encoding the peptide in the correct reading frame. Secretory sig- nal sequences are commonly positioned 5' to the DNA sequence encoding the peptide. The secretory signal sequence may be that normally associated with the peptide or may be from a gene encoding another secreted protein. The procedures used to ligate the DNA sequences coding for the present peptide, the promoter and optionally the terminator and/or secretory signal sequence, respectively, and to insert them into suitable vectors containing the information necessary for replication, are well known to persons skilled in the art (cf., for instance, Sambrook et al.., supra). The host cell into which the DNA sequence or the recombinant vector is introduced may be any cell which is capable of producing the present peptide and includes bacteria, yeast, fungi and higher eukaryotic cells. Examples of suitable host cells well known and used in the art are, without limitation, E coli, Saccharomyces cerevisiae, or mammalian BHK or CHO cell lines. The GLP-1 derivatives of this invention can be used in the treatment of various diseases. The particular GLP-1 derivative to be used and the optimal dose level for any patient will depend on the disease to be treated and on a variety of factors including the efficacy of the specific peptide derivative employed, the age, body weight, physical activity, and diet of the patient, on a possible combination with other drugs, and on the severity of the case. It is recommended that the dosage of the GLP-1 derivative of this invention be determined for each individual patient by those skilled in the art. 189 In particular, it is envisaged that the GLP-1 derivative will be useful for the preparation of a medicament with a protracted profile of action for the treatment of non-insulin dependent diabetes mellitus and/or for the treatment of obesity. The present invention is further illustrated by the following examples which, however, are not to be construed as limiting the scope of protection. The features disclosed in the foregoing description and in the following examples may, both separately and in any combination thereof, be material for realising the invention in diverse forms thereof. EXAMPLES The following acronyms for commercially available chemicals are used: DMF N,N-Dimethylformamide. DCC N,N-Dicyclohexylcarbodiimide NMP N-Methyl-2-pyrrolidone. EDPA N-Ethyl-N,N-diisopropylamine. EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid. GTP Guanosine 5'-triphosphate. TFA Trifluoroacetic acid. THF Tetrahydrofuran H-Glu(OH)-OBu': L-Glutamic acid α-tert-butyl ester Cap-ONSu: Octanoic acid 2,5-dioxopyrrolidin-1-yl ester Lau-ONSu: Dodecanoic acid 2,5-dioxopyrrolidin-1-yl ester Myr-ONSu: Tetradecanoic acid 2,5-dioxopyrrolidin-1-yl ester. Pal-ONSu: Hexadecanoic acid 2,5-dioxopyrrolidin-1-yl ester. Ste-ONSu Octadecanoic acid 2,5-dioxopyrrolidin-1-yl ester. Cac-ONSu: Decanoic acid 2,5-dioxopyrrolidin-1-yl ester. Abbreviations: PDMS: Plasma Desorption Mass Spectrometry MALDI-MS: Matrix Assisted Laser Desorption/lonisation Mass Spectrometry HPLC: High Performance Liquid Chromatography amu: atomic mass units Lit-Glu(ONSu)-OBu': N α -Lithochoyl-L-glutamic acid α-t-butyl ester γ-2,5-dioxopyrrolidin-1-yl ester 190 Cap-Glu(ONSu)-OBu': N α -Octanoyl-L-glutamic acid α-t-butyl ester γ-2,5-dioxopyrrolidin-1- yl ester Cac-Glu(ONSu)-OBu 4 : N α -Decanoyl-L-glutamic acid α-t-butyl ester γ-2,5-dioxopyrrolidin- 1-yl ester Lau-Glu(ONSu)-OBu': N α -Dodecanoyl-L-glutamic acid α-t-butyl ester γ-2,5- dioxopyrrolidin-1-yl ester Myr-Glu(ONSu)-OBu': N -Tetradecanoyl-L-glutamic acid α-t-butyl ester γ-2,5- dioxopyrrolidin-1-yl ester Pal-Glu(ONSu)-OBu l : N α -Hexadecanoyl-(L)-glutamic acid α-t-butyl-γ-2,5- dioxopyrrolidin-1-yl diester. Ste-Glu(ONSu)-OBu l : N α -Octadecanoyl-(L)-glutamic acid α-t-butyl-γ-2,5- dioxopyrrolidin-1-yl diester Lau-β-Ala-ONSu: N β -Dodecanoyl-β-alanine 2,5-dioxopyrrolidin-1-yl ester Pal-β-Ala-ONSu: N β -Hexadecanoyl-β-alanine 2,5-dioxopyrrolidin-1-yl ester Lau-GABA-ONSu: N γ -Dodecanoyl-γ-aminobutyric acid 2,5-dioxopyrrolidin-1-yl ester Myr-GABA-ONSu: N γ -Tetradecanoyl-γ-aminobutyric acid 2,5-dioxopyrrolidin-1-yl ester Pal-GABA-ONSu: N γ -Hexadecanoyl-γ-aminobutyric acid 2,5-dioxopyrrolidin-1-yl ester Ste-GABA-ONSu: N γ -Octadecanoyl-γ-aminobutyric acid 2,5-dioxopyrrolidin-1-yl ester Pal-lsonip-ONSu: N-Hexadecanoyl-pipehdine-4-carboxylic acid 2,5-dioxopyrrolidin-1- yl ester Pal-Glu(OBu')-ONSu: N α -Hexadecanoyi-L-glutamic acid α-2,5-dioxopyrrolidin-1-yl ester γ-t-butyl ester HOOC-(CH 2 ) 6 -COONSu: ω-Carboxyheptanoic acid 2,5-dioxopyrrolidin-1-yl ester. HOOC-(CH 2 ) 10 -COONSu ω-Carboxyundecanoic acid 2,5-dioxopyrrolidin-1-yl ester. HOOC-(CH 2 ) 12 -COONSu ω-Carboxytridecanoic acid 2,5-dioxopyrrolidin-1-yl ester. HOOC-(CH 2 ) 14 -COONSu ω-Carboxypentadecanoic acid 2,5-dioxopyrrolidin-1-yl ester. HOOC-(CH 2 ) 16 -COONSu ω-Carboxyheptadecanoic acid 2,5-dioxopyrrolidin-1-yl ester. HOOC-(CH 2 ) 18 -COONSu ω-Carboxynonadecanoic acid 2,5-dioxopyrrolidin-1-yl ester. Analytical Plasma Desorption Mass Spectrometry Sample preparation: The sample is dissolved in 0.1 % TFA EtOH (1 :1) at a concentration of 1 μg/μl. The sample solution (5-10 μl) is placed on a nitrocellulose target (Bio-ion AB, Uppsala, Sweden) 191 and allowed to adsorb to the target surface for 2 minutes. The target is subsequently rinsed with 2x25 μl 0.1 % TFA and spin-dried. Finally, the nitrocellulose target is placed in a target carrousel and introduced into the mass spectrometer. MS analysis: PDMS analysis was carried out using a Bio-ion 20 time-of flight instrument (Bio-ion Nordic AB, Uppsala, Sweden). An acceleration voltage of 15 kV was applied and molecular ions formed by bombardment of the nitrocellulose surface with 252-Cf fission fragments were accelerated towards a stop detector. The resulting time-of-flight spectrum was calibrated into a true mass spectrum using the H + and NO + ions at m/z 1 and 30, respectively. Mass spectra were generally accumulated for 1.0x10 6 fission events corresponding to 15-20 minutes. Resulting assigned masses all correspond to isotopically averaged molecular masses. The accuracy of mass assignment is generally better than 0.1 %. MALDI-MS MALDI-TOF MS analysis was carried out using a Voyager RP instrument (PerSeptive Biosystems Inc., Framingham, MA) equipped with delayed extraction and operated in linear mode. Alpha-cyano-4-hydroxy-cinnamic acid was used as matrix, and mass assignments were based on external calibration. Example 1 Synthesis of Arg 2634 , Lys 36 (N e -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-36)-OH. To a mixture of Arg 2634 , Lys 36 GLP-1 (7-36)-OH (12.2 mg, 3.67 μmol), EDPA (13.3 mg, 103 μmol), NMP (1.71 ml) and water (855 μl) was added a solution of Pal-Glu(ONSu)- OBu' (5.94 mg, 11 μmol), prepared as described in PCT application no. PCT/DK97/00340, in NMP (148 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (6 mg, 81 μmol) in water (0.6 ml). A 0.5 % aqueous solution of ammonium-acetate (38 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (20 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title 192 compound (3.1 mg, 23 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3695 +- 3. The resulting molecular weight is thus 3694 +- 3 amu (theoretical value 3694 amu). Example 2 Synthesis of Arg 2634 , Lys 36 (N ε -(γ-glutamyl(N α -octadecanoyl))) GLP-1 (7-36)-OH. To a mixture of Arg 2634 , Lys 36 GLP-1 (7-36)-OH (12.2 mg, 3.7 μmol), EDPA (13.3 mg, 103 μmol), NMP (1.71 ml) and water (855 μl) was added a solution of Ste-Glu(ONSu)- OBu' (6.25 mg, 11 μmol), prepared as described in PCT application no. PCT/DK97/00340, in NMP (1 ml). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (6 mg, 81 μmol) in water (0.6 ml). A 0.5 % aqueous solution of ammonium acetate (54 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (20 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (3.7 mg, 27 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3723 +- 3. The resulting molecular weight is thus 3722 +- 3 amu (theoretical value 3722 amu). Example 3 Synthesis of lithocholic acid 2,5-dioxopyrrolidin-1-yl ester. To a solution of lithocholic acid (5.44 g, 14.3 mmol) in a mixture of anhydrous THF (120 ml) and anhydrous acetonitril (30 ml) was added N-hydroxysuccinimide (1.78 g, 15 mmol). The mixture was cooled to 10°C, a solution of DCC (3.44 g, 16.7 mmol) in anhydrous THF (30 ml) was added drop wise, and the resulting reaction mixture stirred for 16 h at room temperature. The reaction mixture was filtered and partitioned between dichlorometha- ne (450 ml) and 10% aqueous Na 2 CO 3 (150 ml). The phases were separated, and the organic phase washed with 10% aqueous Na 2 CO 3 (150 ml), water (2x150 ml), and dried (MgSO 4 ). The solvent was concentrated in vacuo. The residue was crystallised from a mixture of dichloromethane (30 ml) and n-heptane (30 ml). The precipitate was dried in a vacuum drying oven for 36 h to give the title compound (3.46 g, 51 %). 193 Example 4 Synthesis of Lit-Glu(ONSu)-OBu'. A suspension of H-Glu(OH)-OBu' (1.28 g, 6.33 mmol), DMF (88 ml) and EDPA (0.82 g, 6.33 mmol) and lithocholic acid 2,5-dioxopyrrolidin-1-yl ester, prepared as described in example 3, was stirred for 16 h at room temperature. The reaction mixture was concentrated in vacuo and the residue dissolved in ethyl acetate (40 ml). The resulting solution was washed with 5% aqueous citric acid (2x25 ml), brine (10 ml), and filtered). The solvent was concentrated in vacuo and the residue dissolved in DMF (12 ml). The resulting solution was added drop wise to a 10% aqueous solution of citric acid whereby the product precipitates. The precipitate was collected and washed with iced water, and dried in vacuo. The crude product was recrystallised from a mixture of n-heptane (40 ml) and 2-propanol (17 ml). The precipitate was dried in a vacuum drying oven for 4 h to give the free acid intermediate. To a solution of the free acid intermediate in DMF (18 ml) was added hydroxysuccinimide (0.45 g, 3.91 mmol), followed by a solution of DCC (0.73 g, 3.56 mmol) in dichloromethane (18 ml). The resulting mixture was stirred at ambient temperature for 18 h, and then filtered. The filtrate was concentrated in vacuo to a solid, and the residue was dissolved in dichloromethane (25 ml), and the filtration repeated, the solvent removed in vacuo to give a foam. The residue was dissolved in refluxing n-heptane (35 ml), and the product crystallised b ad- dition of 2-propanol. The precipitate was collected, washed with cold n-heptane, dried at 35°C in vacuo to give the title compound (1.34 g, 57%). Example 5 Synthesis of Arg^.Lys 26 (N E -(γ-glutamyl(N α -lithochoyl))) GLP-1 (7-37)-OH. To a mixture of Arg 34 , Lys 26 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 340 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of Lit-Glu(ONSu)-OBu t (24 mg, 37 μmol), prepared as described in example 4, in NMP (600 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 75 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20 mg, 268 μmol) in water (2 ml). A 0.5 % aqueous solution of ammonium acetate (128 ml) was added, and the resulting mixture divided into two equal portions, and each portion eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (2x25 ml), and finally liberated from the cartridge by elution with TFA (2x25 ml). The combined eluates were concentrated in vacuo, and the residue purified 194 by column chromato-graphy using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (5 mg, 11 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3872 +- 3. The resulting molecular weight is thus 3871 +- 3 amu (theoretical value 3871 amu). Example 6 Synthesis of Arg^.Lys 34 (N ε -(γ-glιιtamyl(N α -hexadecanoyl))) GLP-1 (7-37)-OH To a mixture of Arg 26 ,Lys 34 GLP-1 (7-37)-OH (18 mg, 5.3 μmol), EDPA (19.3 mg, 149 μmol), NMP (2.52 ml) and water (1.26 ml) was added a solution of Pal-Glu(ONSu)-OBu' (8.6 mg, 16 μmol) in NMP (215 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (8.8 mg, 117 μmol) in water (0.88 ml). A 0.5 % aqueous solution of ammonium acetate (50 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (6 mg, 30 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3752 +- 3. The resulting molecular weight is thus 3751 +- 3 amu (theoretical value 3751 amu). Example 7 Synthesis of Gly 8 , Arg 2634 , Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-38)-OH. To a mixture of Gly 8 , Arg 2634 , Lys 38 GLP-1 (7-38)-OH (11.8 mg, 3.4 μmol), EDPA (12.1 mg, 94 μmol), NMP (1.65 ml) and water (0.83 ml) was added a solution of Pal- Glu(ONSu)-OBu* (5.4 mg, 10 μmol) in NMP (135 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 75 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (5.5 mg, 73.7 μmol) in water (553 μl). A 0.5 % aqueous solution of ammonium acetate (36 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the 195 cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (5 mg, 38 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3895 +- 3. The resulting molecular weight is thus 3894 +- 3 amu (theoretical value 3894 amu). Example 8 Synthesis of Gly 8 ,Glu 37 ,Arg 2634 ,Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-38)-OH. To a mixture of Gly 8 ,Glu 37 ,Arg 26 ' 34 ,Lys 38 GLP-1 (7-38)-OH (9 mg, 2.48 μmol), EDPA (9 mg, 69.4 μmol), NMP (1.25 ml) and water (0.63 ml) was added a solution of Pal- Glu(ONSu)-OBu* (4 mg, 7.4 μmol) in NMP (100 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 105 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (4.1 mg, 54.6 μmol) in water (410 μl). A 0.5 % aqueous solution of ammonium acetate (27 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (15 ml), and finally liberated from the cartridge by elution with TFA (15 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (2.9 mg, 29 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3967 +- 3. The resulting molecular weight is thus 3966 +- 3 amu (theoretical value 3967 amu). Example 9 Synthesis of Gly 8 ,Glu 37 ,Arg 2634 ,Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl))) GLP-1 (7-38)-OH. To a mixture of Gly 8 ,Glu 37 ,Arg 26 ' 34 ,Lys 38 GLP-1 (7-38)-OH (9 mg, 2.5 μmol), EDPA (9 mg, 69.4 μmol), NMP (1.25 ml) and water (0.63 ml) was added a solution of Ste-Glu(ONSu)- OBu' (4.2 mg, 7.4 μmol in NMP (105 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 105 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (4.1 mg, 54.6 μmol) in water (409 μl). A 0.5 % aqueous solution of ammonium acetate (27 ml) was added, and 196 the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (15 ml), and finally liberated from the cartridge by elution with TFA (15 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (3.2 mg, 32 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3995 +- 3. The resulting molecular weight is thus 3994 +- 3 amu (theoretical value 3995 amu). Example 10 Synthesis of Cap-Glu(ONSu)-OBu'. To a solution of octanoic acid (5 g, 34.7 mmol) and N-hydroxysuccinimide (4 g, 34.7 mmol) in anhydrous acetonitril (10 ml) was added a solution of DCC (7.15 g, 34.7 mmol) in anhydrous dichloromethane (15 ml), and the resulting reaction mixture stirred for 16 h at room temperature. The precipitated solid was filtered off and recrystallised from a mixture of n-heptane (40 ml) and 2-propanol (2 ml). The precipitate was dried in a vacuum drying oven for 16 h to give the intermediate Cap-ONSu. A suspension of the crude ester intermediate (3.9 g, 16.2 mmol), (L)-H-Glu(OH)-OBu t (3.28 g, 16.2 mmol), DMF (268 ml) and EDPA (2.1 g, 16.2 mmol) was stirred for 64 h at room temperature. The reaction mixture was concen- trated in vacuo and the residue dissolved in ethyl acetate (50 ml). The resulting solution was washed with 5% aqueous citric acid (2x25 ml). The solvent was concentrated in vacuo and the residue dissolved in DMF (36 ml). The resulting solution was added drop wise to a 10% aqueous solution of citric acid (357 ml) and extracted with ethyl acetate (200 ml), and dried (MgSO 4 ). The solvent was concentrated in vacuo to give the crude glutamic acid intermedi- ate. To a mixture of the crude glutamic acid intermediate, N-hydroxysuccinimide (1.85 g, 16.1 mmol) and DMF (25 ml) was added a solution of DCC (3.32 g, 16.1 mmol) in dichloromethane (15 ml). The resulting mixture was stirred at ambient temperature for 20 h. The reaction mixture was filtered and the solvent concentrated in vacuo. The residue was purified on a silica gel column (40- 63μ), eluted with a mixture of dichloromethane and acetonitril (1 : 1 ) to give the title compound (0.63 g, 6% over all). Example 11 Synthesis of Glu 37 ,Arg 26 ' 34 ,Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-38)-OH. 197 To a mixture of Glu 37 ,Arg 26 ' 34 ,Lys 38 GLP-1 (7-38)-OH (17.6 mg, 4.9 μmol), EDPA (17.6 mg, 136 μmol), NMP (1.23 ml) and water (2.46 ml) was added a solution of Pal- Glu(ONSu)-OBu' (7.9 mg, 14.6 μmol) in NMP (197 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 2 h at room temperature. The reaction was quenched by the addition of a solution of glycine (8 mg, 107 μmol) in water (804 μl). A 0.5 % aqueous solution of ammonium acetate (49 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (5.1 mg, 26 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3981 +- 3. The resulting molecular weight is thus 3980 +- 3 amu (theoretical value 3981 amu). Example 12 Synthesis of Arg 34 ,Lys 26 (N ε -(γ-glutamyl(N α -octadecanoyl))) GLP-1 (7-37)-OH. To a mixture of Arg 34 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 341 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of Ste-Glu(ONSu)-OBu' (20.7 mg, 36.5 μmol in NMP (517 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 2 h at room temperature. The reaction was quenched by the addition of a solution of glycine (20.1 mg, 268 μmol) in water (2.01 ml). A 0.5 % aqueous solution of ammonium-acetate (120 ml) was added, and the re- suiting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (15.4 mg, 34 %) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3781 +- 3. The resulting molecular weight is thus 3780 +- 3 amu (theoretical value 3779 amu). 198 Example 13 Synthesis of Arg 3 ,Lys 26 (N ε -decanoyl) GLP-1 (7-37) To a mixture of Arg 34 -GLP-1 (7-37)-OH (20 mg, 5.9 μmol), EDPA (21.4 mg, 165 μmol), NMP (2.8 ml) and water (1.4 ml) was added a solution of Cac-ONSu (4.8 mg, 17.7 μmol) in NMP (119 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 2h at room temperature. The reaction was quenched by the addition of a solution of glycine (9.8 mg, 130 μmol) in water (98 μl). The resulting mixture was purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (7.4 mg, 35%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3539.6 ± 3. The resulting molecular weight is thus 3538.6 ± 3 amu (theoretical value 3538 amu). Example 14 Synthesis of Arg 34 ,Lys 26 (N ε -(hexadecanoyl)) GLP-1 (7-37)-OH. To a mixture of Arg 34 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 340 μmol), NMP (2.88 ml) and water (2.88 ml) was added a solution of Pal-ONSu (12.9 mg, 36.5 μmol) in NMP (3.3 ml). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 110 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20.1 mg, 268 μmol) in water (201 μl). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (15 mg, 34 %) was isolated, and the product was analysed by PDMS. Example 15 Synthesis of Arg 2634 , Lys 27 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37)-OH To a mixture of Arg 2634 , Lys 27 GLP-1 (7-37)-OH (11.6 mg, 3.4 μmol), EDPA (12.3 mg, 94.9 μmol), NMP (1.6 ml) and water (0.8 ml) was added a solution of Pal-Glu(ONSu)- OBu' (5.5 mg, 10.2 μmol) in NMP (137 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (5.6 mg, 74.6 μmol) in water (560 μl). A 0.5 % aqueous solution of ammonium acetate (34 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound 199 washed with 5% aqueous acetonitril (15 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (2.1 mg, 16 %) was isolated, and the product was analysed by PDMS. Example 16 Synthesis of Arg 2634 , Lys 23 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37)-OH. To a mixture of Arg 2634 , Lys 23 GLP-1 (7-37)-OH (11.6 mg, 3.4 μmol), EDPA (12.3 mg, 94.9 μmol), NMP (1.6 ml) and water (0.8 ml) was added a solution of Pal-Glu(ONSu)- OBu 4 (5.5 mg, 10.2 μmol) in NMP (137 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (5.6 mg, 74.6 μmol) in water (560 μl). A 0.5 % aqueous solution of ammonium acetate (34 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (15 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (3.1 mg, 24 %) was isolated, and the product was analysed by PDMS. Example 17 Synthesis of Arg 2634 , Lys 18 (N E -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37)-OH To a mixture of Arg 2634 , Lys 18 GLP-1 (7-37)-OH (11.7 mg, 3.4 μmol), EDPA (12.2 mg, 94.6 μmol), NMP (1.6 ml) and water (0.8 ml) was added a solution of Pal-Glu(ONSu)- OBu' (5.5 mg, 10.2 μmol) in NMP (137 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 90 min. at room temperatu- re. The reaction was quenched by the addition of a solution of glycine (5.6 mg, 74.6 μmol) in water (560 μl). A 0.5 % aqueous solution of ammonium acetate (34 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The solvent was concentrated in vacuo, and the residue purified by co- 200 lumn chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (1.9 mg, 15 %) was isolated, and the product was analysed by PDMS. Example 18 Synthesis of Arg^.Lys 26 (N ε -(octanoyl)) GLP-1 (7-37)-OH. To a mixture of Arg 34 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 341 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of Cap-ONSu (8.8 mg, 36.5 μmol, prepared as described in example 10, in NMP (106 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 115 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20 mg, 268 μmol) in water (200 μl). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (18.8 mg, 44 %) was isolated, and the product was analysed by PDMS. Example 19 Synthesis of Arg 34 ,Lys 26 (N ε -(dodecanoyl)) GLP-1 (7-37)-OH. To a mixture of Arg 34 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 341 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of Lau-ONSu (8.8 mg, 36.5 μmol, prepared in a similar manner as described for Cap-ONSu in example 10), in NMP (271 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then al- lowed to stand for an additional 100 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20.1 mg, 268 μmol) in water (200 μl). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title com- pound (18 mg, 42 %) was isolated, and the product was analysed by PDMS. Example 20 Synthesis of Pal-GABA-ONSu. 201 A mixture of Pal-ONSu (3 g, 8.48 mmol), γ-aminobutyric acid (0.87 g, 8.48 mmol) in DMF (200 ml) was stirred at room temperature for 60 h. The reaction mixture was filtered and the filtrate was added drop wise to 10% aqueous citric acid (500 ml). The precipitated N- acylated intermediate was collected and dried in vacuo. To a suspension of the dried intermediate in DMF (35 ml) was added a solution of DCC (1.45 g, 7.0 mmol) in dichloromethane (20 ml). The resulting mixture was stirred at room temperature for 20 h, and then filtered. The solvent was removed in vacuo to give a solid residue. The residue was recrystallised from a mixture of n-heptane (50 ml) and 2-propanol (2.5 ml) to give the title compound (2.5 9, 75 %). Example 21 Synthesis of Arg 3 ,Lys 26 (N ε -(γ-aminobutyroyl(N γ -hexadecanoyl))) GLP-1 (7-37)-OH. To a mixture of Arg 34 , Lys 26 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 341 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of Pal-GABA-ONSu (16 mg, 36.5 μmol, prepared as described in example 20) in NMP (400 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 100 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20 mg, 268 μmol) in water (200 μl). The solvent was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB- CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (15.8 mg, 35 %) was isolated, and the product was analysed by PDMS. Example 22 Synthesis of N α -hexadecanoyl-D-glutamic acid α-t-butyl ester-γ-2,5-dioxopyrrolidin-1-yl ester. A mixture of Pal-ONSu (6.64 g, 18.8 mmol), D-glutamic acid α-tert-butyl ester (4.5 g, 18.8 mmol) and EDPA (4.85 g, 37.5 mmol) in DMF (538 ml) was stirred at room temperature for 60 h. The solvent was removed and the residue dissolved in ethyl acetate (175 ml). The resulting solution was extracted with 10% aqueous citric acid (2x125 ml), and the organic phase concentrated in vacuo. The residue was dissolved in DMF (60 ml), and the resulting mixture slowly added to 10% aqueous citric acid (500 ml). The precipitated compound was collected and dried in vacuo, to give the crude N-acylated glutamic acid intermediate. The crude intermediate was dissolved in DMF (35 ml), and a solution of DCC (3.5 g, 17 mmol) in dichloromethane (70 ml) was added. The resulting mixture was stirred at room 202 temperature for 20 h, and then filtered. The filtrate was concentrated in vacuo, and the solid residue recrystallised from a mixture of n-heptane (75 ml) and 2-propanol (5 ml), to give the title compound (5.2 g, 50 %) Example 23 Synthesis of Arg 34 ,Lys 26 (N ε -(γ-D-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37)-OH. To a mixture of Arg 34 , Lys 26 GLP-1 (7-37)-OH (41.1 mg, 12.2 μmol), EDPA (44 mg, 341 μmol), NMP (5.76 ml) and water (2.88 ml) was added a solution of N α -hexadecanoyl-D- glutamic acid α-t-butyl ester-γ-2,5-dioxopyrrolidin-1-yl ester (19.7 mg, 36.5 μmol) in NMP (491 μl). The reaction mixture was gently shaken for 5 min. at room temperature, and then allowed to stand for an additional 95 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (20 mg, 268 μmol) in water (2 ml). A 0.5 % aqueous solution of ammonium acetate (120 ml) was added, and the resulting mixture divided into to equal portions, and each portion eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobi- used compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The combined eluates were concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (10.5 mg, 23 %) was iso- lated, and the product was analysed by PDMS. Example 24 Synthesis of Lys 34 (N ε -(γ-glutamyl(N α -tetradecanoyl))) GLP-1 (7-37). To a mixture of GLP-1 (7-37)-OH (33.6 mg, 8.9 μmol), EDPA (32.4 mg, 250 μmol), NMP (2.1 ml) and water (2.1 ml) was added a solution of Myr-Glu^NSuJ-OBu 1 (9.1 mg, 17.9 μmol), prepared as described in PCT application no. PCT/DK97/00340, in NMP (228 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 80 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (14.8 mg, 197 μmol) in water (1.47 ml). A 0.5% aqueous solution of ammonium acetate (100 ml) was added, and the resulting mixture divided into two equal portions, and each portion eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (2x25 ml), and finally liberated from the cartridge by elution with TFA (2x25 ml). The combined eluates were concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard 203 acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (0.19 mg, 0.6%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3693 ± 3. The resulting molecular weight is thus 3692 ± 3 amu (theoretical value 3695 amu). Example 25 Synthesis of Arg 26 ' 34 ,Lys 8 (N ε -(γ-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37). To a mixture of Arg 2634 , Lys 8 -GLP-1 (7-37)-OH (10.3 mg, 3 μmol), EDPA (10.8 mg, 83 μmol), NMP (1.44 ml) and water (0.72 ml) was added a solution of Pal-Glu(ONSu)-OBu t (4.8 mg, 8.9 μmol), prepared as described in PCT application no. PCT/DK97/00340, in NMP (120 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 70 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (4.9 mg, 65.3 μmol) in water (490 μl). A 0.5% aqueous solution of ammonium acetate (30 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (3.2 mg, 28%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3836 ± 3. The resulting molecular weight is thus 3835 + 3 AMU (theoretical value 3836 AMU). Example 26 Synthesis of Lau-Glu(ONSu)-OBu'. To a solution of H-Glu-OBu 4 (3 g, 15 mmol) in DMF (344 ml) was added EDPA (2.58 ml, 15 mmol) and a solution of Lau-ONSu (4.5 g, 15 mmol), prepared in a similar manner as described for Cap-ONSu in example 10, in DMF (74 ml). The resulting mixture was stirred at ambient temperature for 18 h, and the solvent removed in vacuo. The oily residue was parti- tioned between ethyl acetate (150 ml) and 5% aqueous citric acid (250 ml). The organic phase was concentrated in vacuo. The residue was dissolved in DMF (40 ml) and the solution added drop by drop to a 10% aqueous citric acid solution (350 ml). The precipitated product was collected, washed with water and dried in vacuo for 18 h to give the intermediate free acid. To solution of the free acid intermediate in DMF (25 ml) was added N- 204 hydroxysuccinimide (1.7 g, 14.8 mmol) and a solution of N-(3-dimethylaminopropy_)-N'- ethylcarbodiimide (2.58 g, 13.5 mmol) in dichloromethane (52 ml). The resulting mixture was stirred at room temperature for 18 h, and the solvents removed in vacuo. The oily residue was partitioned between dichloromethane (80 ml) and water (80 ml). The organic phase was washed with 5% aqueous citric acid, dried (MgSO 4 ), and concentrated in vacuo to a solid. The solid residue was crystallised from a mixture of n-heptane (77 ml) and 2-propanol (50 ml), and finally recrystallised from n-heptane (76 ml) to give the title compound (2.96 g, 46%). Example 27 Synthesis of Arg 34 ,Lys 26 (N ε -(γ-glutamyl(N α -dodecanoyl))) GLP-1 (7-37). To a mixture of Arg^-GLP-I (7-37)-OH (20.6 mg, 6.1 μmol), EDPA (22 mg, 171 μmol), NMP (2.88 ml) and water (1.44 ml) was added a solution Lau-Glu(ONSu)-OBu' (10.2 mg, 21.2 μmol), prepared as described in example 26, in NMP (255 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 75 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (10 mg, 134 μmol) in water (100 μl). A 0.5% aqueous solution of ammonium acetate (61 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0- 100% in 60 minutes. The title compound (8.2 mg, 36%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3693 ± 3. The resulting molecular weight is 3692 ± 3 AMU (theoretical value 3693 AMU). Example 28 Synthesis of Lau-β-Ala-ONSu. To a solution of Lau-ONSu (4.25 g, 14.3 mmol), prepared in a similar manner to in DMF (400 ml) was added EDPA (1.84 g, 14.3 mmol) and β-alanine (1.27 g, 14.3 mmol). The resulting mixture was stirred at ambient temperature for 18 h. Water (250 ml) and DMF (50 ml) were added and the solution stirred for 1 h at room temperature. The solvents were removed in vacuo to give a solid. The solid residue was dissolved in DMF (50 ml) and the solution ad- 205 ded drop by drop to a 5% aqueous solution of citric acid (200 ml). The precipitate collected, washed with water (50 ml) and dried in vacuo to give the title compound (3.6 g, 93%). Example 29 Synthesis of Pal-β-Ala-ONSu. To a solution of Pal-ONSu (4.25 g, 14.3 mmol) in DMF (400 ml) was added EDPA (1.84 g, 14.3 mmol) and β-alanine (1.27 g, 14.3 mmol). The resulting mixture was stirred at ambient temperature for 18 h. Water (250 ml) and DMF (50 ml) were added and the solution stirred for 1 h at room temperature. The solvents were removed in vacuo to give a solid. The solid residue was dissolved in DMF (50 ml) and the solution added drop by drop to a 5% aqueous solution of citric acid (200 ml). The precipitate collected, washed with water (50 ml) and dried in vacuo to give the title compound (3.6 g, 93%). Example 30 Synthesis of Myr-GABA-ONSu. To a solution of Myr-ONSu (4 g, 12.3 mmol) in DMF (350 ml) was added EDPA (1.58 g, 12.3 mmol) and γ-aminobutyric acid (1.26 g, 12.3 mmol). The resulting mixture was stirred at ambient temperature for 18 h. Water (50 ml) was added and the solution stirred for 1 h at room temperature. The solvents were removed in vacuo to give a solid. The solid residue was dis- solved in DMF (75 ml) and the solution added drop by drop to a 5% aqueous solution of citric acid (250 ml). The precipitate collected, washed with water (100 ml) and dried in vacuo to give the free acid intermediate (3.65 g, 95%). To a solution of the free acid intermediate (3 g, 9.6 mmol), N-hydroxysuccinimide (1.65 g, 14.4 mmol) and N-(3-dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride (3.67 g, 19.1 mmol) in DMF (330 ml) was stirred for 18 h at room temperature, and the solvent removed in vacuo to give a solid. The solid residue was dissolved in dichloromethane (100 ml) and washed with brine (100 ml). The organic phase was dried (MgSO 4 ) and concentrated in vacuo to give a solid. The solid residue was recrystallised from n-heptane (75 ml) to give the title compound (2.8 g, 71%). Example 31 Synthesis of Pal-β-Ala-ONSu. To a solution of Pal-ONSu (0.9 g, 2.8 mmol) in DMF (100 ml) were added N- hydroxysuccinimide (0.35 g, 3 mmol) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (0.79 g, 4.1 mmol). The resulting mixture was stirred at ambient temperature for 40h, and 206 the solvent removed in vacuo. The solid residue was partitioned between water (50 ml) and dichloromethane (50 ml). The organic phase was separated, dried (MgSO 4 ) and the solvent removed in vacuo to give the title compound (1.1 g, 94%). Example 32 Synthesis of Arg 34 ,Lys 26 (N ε -(β-alanyl(N α -hexadecanoyl))) GLP-1 (7-37). To a mixture of Arg^-GLP-I (7-37)-OH (19.2 mg, 5.7 μmol), EDPA (20.5 mg, 159 μmol), NMP (2.7 ml) and water (1.35 ml) was added a solution Pal-β-Ala-ONSu (7.2 mg, 17 μmol), prepared as described in example 31 , in NMP (181 μl). The reaction mixture was gently sha- ken for 5 min., and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (9.3 mg, 125 μmol) in water (93 μl). The reaction mixture was purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (11.6 mg, 55%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3694 ± 3. The resulting molecular weight is thus 3693 ± 3 AMU (theoretical value 3693 AMU). Example 33 Synthesis of Pal-Glu(OBu')-ONSu. To a solution of H-Glu(OH)-OBu' (2.7 g, 11.3 mmol) and Pal-ONSu (3.98 g, 11.3 mmol) in DMF (300 ml) was added EDPA (3.2 g, 24.8 mmol). The resulting mixture was stirred at ambient temperature for 18h, and the solvent concentrated in vacuo to give an oil. The oily residue was dissolved in DMF (60 ml) and the solution added drop by drop to a 10% aqueous solution of citric acid (300 ml) whereby a precipitate was formed. The precipitate was collected, washed with cold water (25 ml), and dried in vacuo to give free acid intermediate (4.44 g, 89%). The free acid intermediate (4 g, 9.1 mmol) was dissolved in DMF (50 ml) and N- hydroxysuccinimide (1.15 g, 10 mmol) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (2.6 g, 13.6 mmol) were added. The resulting mixture was stirred at room temperature for 60h, the solvent concentrated in vacuo to give the crude title compound (8.2 9) Example 34 Synthesis of Arg 34 ,Lys 26 (N ε -(α-glutamyl(N α -hexadecanoyl))) GLP-1 (7-37). 207 To a mixture of Arg^-GLP-I (7-37)-OH (25.6 mg, 7.6 μmol), EDPA (27.4 mg, 212 μmol), NMP (3.5 ml) and water (1.75 ml) was added a solution of Pal-Glu(OBu')-ONSu (12.2 mg, 22.7 μmol), prepared as described in example 33, in NMP (305 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 100 min. at room tem- perature. The reaction was quenched by the addition of a solution of glycine (12.5 mg, 168 μmol) in water (125 μl). A 0.5% aqueous solution of ammonium acetate (72.5 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (30 ml). The eluate was concentrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (6.1 mg, 22%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3751 ± 3. The resulting molecular weight is thus 3750 ± 3 AMU (theoretical value 3751 AMU). Example 35 Synthesis of Ste-GABA-ONSu. To a solution of Ste-ONSu (3 g, 7.9 mmol) in DMF (270 ml) was added EDPA (1 g, 7.9 mmol) and a solution of γ-aminobutyric acid (0.81 g, 7.9 mmol) in water (40 ml). The resulting suspension was stirred at ambient temperature for 18 h, and then concentrated in vacuo to a final volume of 50 ml. The resulting suspension was added to a 5% aqueous solution of citric acid (500 ml) whereby a precipitate is formed. The precipitate was collected and washed with water (50 ml), and dried in vacuo for 4h to give the free acid intermediate (2.8 g, 97%). To a mixture of the free acid intermediate (2.6 g, 7 mmol), N-hydroxysuccinimide (1.21 g, 10.5 mmol) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (2.69 g, 14 mmol) in NMP (300 ml) was stirred for 70 h, and the solvent removed in vacuo to give a solid. The solid residue was dissolved in dichloromethane (100 ml) and washed with brine (2x100 ml). The organic phase was dried (MgSO 4 ) and concentrated in vacuo to give a solid. The solid residue was recrystallised from n-heptane (75 ml) to give the title compound (2.2 g, 67%). Example 36 Synthesis of Pal-lsonip-ONSu. 208 To a suspension of 1-hexadecanoylbenzotriazole (3 g, 8.4 mmol), prepared as described in the literature (Kreutzberger; van der Goot, Arch.Pharm., 307, 1974), in DMF (350 ml) were added EDPA (1.08 g, 8.4 mmol) and a solution of piperidine-4-carboxylic acid in water ( 20 ml). The resulting suspension was stirred at room temperature for 12d, and then concentra- ted in vacuo to an oil. The oily residue was added drop by drop to a 5% aqueous solution of citric acid (300 ml) whereby a precipitate was formed. The precipitate was collected and washed with water (50 ml), dried in vacuo for 2 h to give the free acid intermediate (3 g, 97%). To a solution of the free acid intermediate (2.8 g, 7.6 mmol), N-hydroxysuccinimide (1.31 g, 11.4 mmol) in DMF (250 ml) was added N-(3-dimethylaminopropyl)-N'- ethylcarbodiimide hydrochloride (2.92 g, 15.2 mmol). The resulting mixture was stirred at ambient temperature for 18h, and the solvent removed in vacuo to give an oil. The oily residue was dissolved in dichloromethane (100 ml), washed with brine (50 ml), dried (MgSO 4 ) and concentrated in vacuo to give the crude title compound (4.1 g, quant.). Example 37 Synthesis of Arg 34 ,Lys 26 (N ε -(piperidinyl-4-carbonyl(N-hexadecanoyl))) GLP-1 (7-37). To a mixture of Arg 34 -GLP-1 (7-37)-OH (25 mg, 7.4 μmol), EDPA (26.7 mg, 207 μmol), NMP (3.5 ml) and water (1.75 ml) was added a solution Pal-lsonip-ONSu (13.7 mg, 30 μmol), prepared as described in example 36 in NMP (343 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 90 min. at room temperature. The reaction was quenched by the addition of a solution of glycine (12.2 mg, 163 μmol) in water (122 μl). The reaction mixture was purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (12 mg, 44%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3734 + 3. The resulting molecular weight is thus 3733 ± 3 AMU (theoretical value 3733 AMU). Example 38 Synthesis of Arg 34 ,Lys 26 (N ε -(γ-glutamyl(N α -decanoyl))) GLP-1 (7-37) To a mixture of Arg 34 -GLP-1 (7-37)-OH (25 mg, 7.4 μmol), EDPA (26.7 mg, 207 μmol), NMP (3.5 ml) and water (1.75 ml) was added a solution of Cac-GlufONSuJ-OBu* (10 mg, 22.1 μmol) in NMP (252 μl). The reaction mixture was gently shaken for 5 min., and then allowed to stand for an additional 140 min. at room temperature. The reaction was quenched by the 209 addition of a solution of glycine (12.2 mg, 162 μmol) in water (122 μl). A 0.5% aqueous solution of ammonium acetate (73 ml) was added, and the resulting mixture eluted onto a Varian 5g C8 Mega Bond Elut ® , the immobilised compound washed with 5% aqueous acetonitril (25 ml), and finally liberated from the cartridge by elution with TFA (25 ml). The eluate was con- centrated in vacuo, and the residue purified by column chromatography using a cyanopropyl column (Zorbax 300SB-CN) and a standard acetonitril/TFA system. The column was heated to 65°C and the acetonitril gradient was 0-100% in 60 minutes. The title compound (12.2 mg, 45%) was isolated, and the product was analysed by PDMS. The m/z value for the protonated molecular ion was found to be 3669.7 ± 3. The resulting molecular weight is thus 3668.7 ± 3 amu (theoretical value 3667 amu). BIOLOGICAL FINDINGS Protraction of GLP-1 derivatives after s.c. administration The protraction of a number GLP-1 derivatives of the invention was determined by monitoring the concentration thereof in plasma after sc administration to healthy pigs, using the method described below. For comparison also the concentration in plasma of GLP-1(7- 37) after sc. administration was followed. The protraction of other GLP-1 derivatives of the invention can be determined in the same way. Pigs (50% Duroc, 25% Yorkshire, 25% Danish Landrace, app 40 kg) were fasted from the beginning of the experiment. To each pig 0.5 nmol of test compound per kg body weight was administered in a 50 μM isotonic solution (5 mM phosphate, pH 7.4, 0.02% Twe- en ® -20 (Merck), 45 mg/ml mannitol (pyrogen free, Novo Nordisk). Blood samples were drawn from a catheter in vena jugularis at the hours indicated in Table 1. 5 ml of the blood samples were poured into chilled glasses containing 175 μl of the following solution: 0.18 M EDTA, 1500 KIE/ml aprotinin (Novo Nordisk) and 3% bacitracin (Sigma), pH 7.4. Within 30 min, the samples were centrifuged for 10 min at 5-6000*g. Temperature was kept at 4°C. The supernatant was pipetted into different glasses and kept at minus 20°C until use. The plasma concentrations of the peptides were determined by RIA using a monoclonal antibody specific for the N-terminal region of GLP-1 (7-37). The cross reactivities were less than 1% with GLP-1(1-37) and GLP-1 (8-36)amide and < 0.1% with GLP-1 (9-37), GLP-1(10-36)amide and GLP-1 (11-36)amide. The entire procedure was carried out at 4°C. 210 The assay was carried out as follows: 100 μl plasma was mixed with 271 μl 96% ethanol, mixed using a vortex mixer and centrifuged at 2600*g for 30 min. The supernatant was decanted into Minisorp tubes and evaporated completely (Savant Speedvac AS290). The evaporation residue was reconstituted in the assay buffer consisting of 80 mM NaH 2 PO 4 /Na 2 HPO 4 , 0.1 % HSA (Orpha 20/21 , Behring), 10 mM EDTA, 0.6 mM thiomersal (Sigma), pH 7.5. Samples were reconstituted in volumes suitable for their expected concentrations, and were allowed to reconstitute for 30 min. To 300 μl sample, 100 μl antibody solution in dilution buffer containing 40 mM NaH 2 PO 4 /Na 2 HPO 4 , 0.1 % HSA, 0.6 mM thiomersal, pH 7.5, was added. A non-specific sample was prepared by mixing 300 μl buffer with 100 μl dilution buffer. Individual standards were prepared from freeze dried stocks, dissolved in 300 μl assay buffer. All samples were pre-incubated in Minisorp tubes with antibody as described above for 72 h. 200 μl tracer in dilution buffer containing 6-7000 CPM was added, samples were mixed and incubated for 48 h. 1.5 ml of a suspension of 200 ml per litre of he- parin-stabilised bovine plasma and 18 g per litre of activated carbon (Merck) in 40 mM NaH 2 PO 4 /Na 2 HPO 4 , 0.6 mM thiomersal, pH 7.5, was added to each tube. Before use, the suspension was mixed and allowed to stand for 2 h at 4°C. All samples were incubated for 1 h at 4°C and then centrifuged at 3400*g for 25 min. Immediately after the centrifugation, the supernatant was decanted and counted in a γ-counter. The concentration in the samples was calculated from individual standard curves. The findings show that the GLP-1 derivatives of the invention have a protracted profile of action relative to GLP-1 (7-37) and are much more persistent in plasma than GLP- 1(7-37). The time at which the peak concentration in plasma is achieved varies within wide limits, depending on the particular GLP-1 derivative selected. Stimulation of cAMP formation in a cell line expressing the cloned human GLP-1 receptor In order to demonstrate efficacy of the GLP-1 derivatives, their ability to stimulate formation of cAMP in a cell line expressing the cloned human GLP-1 receptor was tested. An EC 50 was calculated from the dose-response curve. Baby hamster kidney (BHK) cells expressing the human pancreatic GLP-1 receptor were used (Knudsen and Pridal, 1996, Eur. J. Pharm. 318, 429-435). Plasma membranes were prepared (Adelhorst et al, 1994, J. Biol. Chem. 269, 6275) by homogenisation in buffer (10 mmol/l Tris-HCI and 30 mmol/l NaCl pH 7.4, containing, in addition, 1 mmol/l dithiothreitol, 5 mg/l leupeptin (Sigma, St. Louis, MO, USA), 5 mg/l pepstatin (Sigma, St. Louis, MO, USA), 211 100 mg/l bacitracin (Sigma, St. Louis, MO, USA), and 16 mg/l aprotinin (Novo Nordisk A/S, Bagsvaerd, Denmark)). The homogenate was centrifuged on top of a layer of 41 w/v% sucrose. The white band between the two layers was diluted in buffer and centrifuged. Plasma membranes were stored at -80°C until used. The assay was carried out in 96-well microtiter plates in a total volume of 140 μl. The buffer used was 50 mmol/l Tris-HCI, pH 7.4 with the addition of 1 mmol/l EGTA, 1.5 mmol/l MgSO 4 , 1.7 mmol/l ATP, 20 mM GTP, 2 mmol/l 3-isobutyl-1-methylxanthine, 0.01 % Tween-20 and 0.1 % human serum albumin (Reinst, Behringwerke AG, Marburg, Germany). Compounds to be tested for agonist activity were dissolved and diluted in buffer, added to the membrane preparation and the mixture was incubated for 2 h at 37°C. The reaction was stopped by the addition of 25 μl of 0.05 mol/l HCI. Samples were diluted 10 fold before analysis for cAMP by a scintillation proximity assay (RPA 538, Amersha , UK).

Claims: 212 CLAIMS A derivative of GLP-1 analog of formula I: 7 8 9 10 11 12 13 14 15 16 17 His-Xaa-Xaa-Gly-Xaa-Phe-Thr-Xaa-Asp-Xaa-Xaa- 18 19 20 21 22 23 24 25 26 27 28 Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Phe- 29 30 31 32 33 34 35 36 37 38 Ile-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa 39 40 41 42 43 44 45 Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa wherein Xaa at position 8 is Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 9 is Glu, Asp, or Lys, Xaa at position 11 s Thr, Ala, Gly, Ser, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 14 s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 16 s Val, Ala, Gly, Ser, Thr, Leu, lie, Tyr, Glu, Asp, or Lys, Xaa at position 17 s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 18 s Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 19 s Tyr, Phe, Trp, Glu, Asp, or Lys, Xaa at position 20 s Leu, Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 21 s Glu, Asp, or Lys, Xaa at position 22 s Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 23 s Gin, Asn, Arg, Glu, Asp, or Lys, Xaa at position 24 s Ala, Gly, Ser, Thr, Leu, lie, Val, Arg, Glu, Asp, or Lys, Xaa at position 25 s Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 26 s Lys, Arg, Gin, Glu, Asp, or His, Xaa at position 27 s Glu, Asp, or Lys, Xaa at position 30 s Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, 213 Xaa at position 31 is Trp, Phe, Tyr, Glu, Asp, or Lys, Xaa at position 32 is Leu, Gly, Ala, Ser, Thr, lie, Val, Glu, Asp, or Lys, Xaa at position 33 is Val, Gly, Ala, Ser, Thr, Leu, lie, Giu, Asp, or Lys, Xaa at position 34 is Lys, Arg, Glu, Asp, or His, Xaa at position 35 is Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Xaa at position 36 is Arg, Lys, Glu, Asp, or His, Xaa at position 37 is Gly, Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, or is deleted, Xaa at position 38 is Arg, Lys, Glu, Asp, or His, or is deleted, Xaa at position 39 is Arg, Lys, Glu, Asp, or His, or is deleted, Xaa at position 40 is Asp, Glu, or Lys, or is deleted, Xaa at position 41 is Phe, Trp, Tyr, Glu, Asp, or Lys, or is deleted, Xaa at position 42 is Pro, Lys, Glu, or Asp, or is deleted, Xaa at position 43 is Glu, Asp, or Lys, or is deleted, Xaa at position 44 is Glu, Asp, or Lys, or is deleted, and Xaa at position 45 is Val, Glu, Asp, or Lys, or is deleted, or (a) a C-1-6-ester thereof, (b) amide, C-1-6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. when the amino acid at position 37, 38, 39, 40, 41 , 42, 43 or 44 is deleted, then each amino acid downstream of the amino acid is also deleted, B. the derivative of the GLP-1 analog contains only one or two Lys, C. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, D. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six, E. the derivative of GLP-1 analog of formula I is not selected from: Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-37), Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1(7-37), Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37), Arg 263 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37)-OH, Lys 26 ' 34 bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)-OH, 214 Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38)-OH, Arg^Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N e -(ω-carboxyheptadecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 26, 34 |_ ys 36 (N ε -( ω -carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyundecanoyl))-GLP-1(7-38)-OH, Lys 26 ' 34 bis(N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg ^Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1(7-36)-OH, Arg^Lys 26 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-38)-OH, Arg 26,3 4| _ ys 36 (N ε -( ω -carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1(7-36)-OH, Lys 2634 bis(N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg^Lys 26 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 34 Lys 26 (N ε -lithocholyl)-GLP-1 (7-37)-OH, Glu 22 ' 2330 Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 23 ' 26 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Lys 26 ' 34 -bis(N ε -(ω-carboxytridecanoyl))-GLP-1 (7-37)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Lys 2634 -bis(N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1(7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Arg 6 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, Arg 18 ' 23 ' 2630 ' 34 Lys 38 (N E -hexadecanoyl)-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-37)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1(7-38)-OH, 215 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-37); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-37); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 28 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 Lys 34 (N E -tetradecanoyl)-GLP-1 (7-39); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 26 ' 34 -bis(N E -tetradecanoyl)-GLP-1 (7-40); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-40); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-40); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1 (7-40); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-36); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1 (7-36); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36); 216 Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 26 ' 3 -bis(N ε -tetradecanoyl)-GLP-1(7-36); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-35); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-35); Lys 26 ' 34 -bis(N E -tetradecanoyl)-GLP-1(7-35); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-35); Gly 8 Lys 34 (N E -tetradecanoyl)-GLP-1(7-35); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-35); Arg M Lys M (N etradecanoyl)-GLP-1 (7-35); Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 26 (N E -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36)amide; Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N E -tetradecanoyl)-GLP-1(7-37); Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-38); Gly 8 Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1 (7-38); Arg 26 ' 3 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Arg 2634 Lys 38 (N E -tetradecanoyl)-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); 217 Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-40); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-40); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-40); Gly 8 Arg 6 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-40); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Lys 26ι34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38) ; Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 6 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-40); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-40); Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Lys 26,34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); 218 Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 26ι34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Lys 26 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Lys 26,34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-35); Gly 8 Lys 28 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-35); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-37); Arg 2634 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-38); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); 219 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-40); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-40); Arg 26 :34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-40); Gly 8 Arg 2634 Lys 36 (N E -(ro-carboxynonadecanoyl))-GLP-1 (7-40); Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-37); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N E -(7-deoxycholoyl))-GLP-1(7-37); Arg 26 Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-38); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 3 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 Lys 34 (N E -(7-deoxycholoyl))-GLP-1 (7-38); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N E -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-40); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-40); 220 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-36); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-35); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-35); Lys 26 ' 34 -bis(N E -(7-deoxycholoyl))-GLP-1(7-35); Gly 8 Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-35); Gly 8 Lys 34 (N E -(7-deoxycholoyl))-GLP-1 (7-35); Gly 8 Lys 26 ' 34 -bis(N E -(7-deoxycholoyl))-GLP-1(7-35); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-35); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(7-deoxychoioyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(choloyl))-GLP-1 (7-37); Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 26 (N E -(choloyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-37); 221 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N E -(7-deoxycholoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-38); Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Arg 2634 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N ε -(choloyl))-GLP-1(7-38); Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 2634 -bis(N E -(choloyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N E -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(choloyl))-GLP-1 (7-39); Lys 34 (N E -(choloyl))-GLP-1 (7-39); Lys 2634 -bis(N E -(choloyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1 (7-39); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-40); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-40); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-40); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-40); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-40); Lys 6 (N ε -(choloyl))-GLP-1 (7-40); Lys 34 (N ε -(choloyl))-GLP-1 (7-40); 222 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-40); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-40); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-40); Lys 26 (N ε -(choloyl))-GLP-1(7-36); Lys 34 (N ε -(choloyl))-GLP-1 (7-36); Lys 2634 -bis(N E -(choloyl))-GLP-1(7-36); Gly 8 Lys 26 (N E -(choloyl))-GLP-1(7-36); Gly 8 Lys 34 (N E -(choloyl))-GLP-1 (7-36); Gly 8 Lys 26 .34-bis(N ε -(choloyl))-GLP-1 (7-36); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-36); Lys 26 (N ε -(choloyl))-GLP-1(7-35); Lys 34 (N E -(choloyl))-GLP-1 (7-35); Lys 26 :34 -bis(N ε -(choloyl))-GLP-1 (7-35); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-35); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-35); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-35); Lys 26 (N ε -(choloyl))-GLP-1 (7-36)amide; Lys 34 (N ε -(choloyl))-GLP-1 (7-36)amide; Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 26 (N E -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N E -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-36)amide; Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-37); Arg 6 ,Lys 34 (N ε -(octanoyl)) GLP-1 (7-37)-OH; Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-37); 223 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 263 -bis(N ε -(lithocholoyl))-GLP-1 (7-37); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N E -(choloyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-38); Arg 2634 Lys 38 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-38) ; Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 26 ' 34 -bis(N E -(lithocholoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N E -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N E -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-38); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 (N E -(choloyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))Arg 3 -GLP-1(7-39); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N E -(choloyl))-GLP-1(7-39); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-39); Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-39); Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-39); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-40); Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-40); 224 Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-40); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-40); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(choloyl))-GLP-1(7-40); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-40); Lys 34 (N E -(lithocholoyl))-GLP-1 (7-40); Lys 26 ' 34 -bis(N E -(lithocholoyl))-GLP-1(7-40); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-40); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-40); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-40); Arg 6 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 2634 -bis(N E -(lithocholoyl))-GLP-1(7-36); Gly 8 Lys 26 (N E -(lithocholoyl))-GLP-1(7-36); Gly 8 Lys 34 (N E -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-36); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-35); Lys 34 (N E -(lithocholoyl))-GLP-1(7-35); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-35); Gly 8 Lys 26 (N E -(lithocholoyl))-GLP-1(7-35); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-35); Gly 8 Lys 26 ' 34 -bis(N E -(lithocholoyl))-GLP-1 (7-35); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-35); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-36)amide; Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Lys 26 ' 34 -bis(N E -(lithocholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 28 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36)amide; Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 28 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-37); 225 Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-37); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-38); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N E -(lithocholoyl))-GLP-1(7-39); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N E -(lithocholoyl))-GLP-1 (7-39); Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-40); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-40); Gly 8 Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1 (7-40); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-40) and Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-40). 2. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising one or more of the following substitutions: Ala at position 8 is substituted with Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Glu at position 9 is substituted with Asp or Lys, Thr at position 11 is substituted with Ala, Gly, Ser, Leu, lie, Val, Glu, Asp, or Lys, Ser at position 14 is substituted with Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Val at position 16 is substituted with Val, Ala, Gly, Ser, Thr, Leu, He, Tyr, Glu, Asp, or Lys, Ser at position 17 is substituted with Ser, Ala, Gly, Thr, Leu, He, Val, Glu, Asp, or Lys, Ser at position 18 is substituted with Ser, Ala, Gly, Thr, Leu, lie, Val, Glu, Asp, or Lys, Tyr at position 19 is substituted with Tyr, Phe, Trp, Glu, Asp, or Lys, Leu at position 20 is substituted with Leu, Ala, Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, 226 Glu at position 21 is substituted with Glu, Asp, or Lys, Gly at position 22 is substituted with Gly, Ala, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, Gin at position 23 is substituted with Gin, Asn, Arg, Glu, Asp, or Lys, Ala at position 24 is substituted with Ala, Gly, Ser, Thr, Leu, lie, Val, Arg, Glu, Asp, or Lys, Ala at position 25 is substituted with Ala, Gly, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, Lys at position 26 is substituted with Arg, Gin, Glu, Asp, or His, Glu at position 27 is substituted with Asp or Lys, Ala at position 30 is substituted with Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Trp at position 31 is substituted with Phe, Tyr, Glu, Asp, or Lys, Leu at position 32 is substituted with Gly, Ala, Ser, Thr, lie, Val, Glu, Asp, or Lys, Val at position 33 is substituted with Gly, Ala, Ser, Thr, Leu, lie, Glu, Asp, or Lys, Lys at position 34 is substituted with Arg, Glu, Asp, or His, Gly at position 35 is substituted with Ala, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, Arg at position 36 is substituted with Lys, Glu, Asp, or His, Gly at position 37 is substituted with Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, Arg at position 38 is substituted with Lys, Glu, Asp, or His, and Arg at position 39 is substituted with Lys, Glu, Asp, or His, or (a) a C-1-6-ester thereof, (b) amide, C-1-6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, O the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not selected from: Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37), Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-37), Lys 26 (N ε -tetradecanoyl)Arg 3 -GLP-1 (7-37), Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37), Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37)-OH, 227 Lys 26 ' 34 bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37)-OH, Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38)-OH, Arg 34 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptadecanoyl))-GLP-1(7-37)-OH, Arg 26,3 4| _ ys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxyheptadecanoyl))-GLP-1(7-38)-OH, Arg 26, 34Lys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyundecanoyl))-GLP-1(7-38)-OH, Lys 26 ' 34 bis(N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 26,3 4| _ ys 36 (N ε -( ω -carboxyundecanoyl))-GLP-1 (7-36)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-38)-OH, Arg 26,3 4Lys 36 (N ε -( ω -carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Lys 26 ' 34 bis(N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N E -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 34 Lys 26 (N ε -lithocholyl)-GLP-1 (7-37)-OH, Glu 22 ' 23 ' 30 Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 2326 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Lys 28 ' 34 -bis(N ε -(ω-carboxytridecanoyl))-GLP-1(7-37)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Lys 26 ' 34 -bis(N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 3 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, Arg 1823 ' 26 ' 3 3 Lys 38 (N ε -hexadecanoyl)-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, 228 Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-37)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1(7-38)-OH, Lys 26 (N E -tetradecanoyl)-GLP-1(7-37); Lys^N etradecanoy -GLP-l (7-37); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-37); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37); Lys 6 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 (N E -tetradecanoyl)-GLP-1 (7-39); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 26 ' 34 -bis(N E -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 26 (N E -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 26 (N E -tetradecanoyl)-GLP-1 (7-36); Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1 (7-36); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1 (7-36); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Lys 26 (N E -tetradecanoyl)-GLP-1(7-36)amide; Lys 34 (N E -tetradecanoyl)-GLP-1 (7-36)amide; 229 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-36)amide; Gly 8 Lys 26 ' 3 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Arg 26 Lys 3 (N ε -tetradecanoyI)-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N E -tetradecanoyl)-GLP-1(7-37); Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1(7-37); Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -tetradecanoyl)-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -tetradecanoyl)-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26ι34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1(7-38); 230 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Lys 26,34 -bis(N E -(ro-carboxynonadecanoyl))-GLP-1 (7-36)amide; Gly 8 Lys 6 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-37); Arg 26 ;34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); 231 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 3 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Lys 26 (N E -(7-deoxycholoyl))-GLP-1 (7-37); Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N E -(7-deoxycholoyl))-GLP-1 (7-37); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 2634 -bis(N E -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N E -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Lys 3 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-39); Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N E -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 2634 -bis(N E -(7-deoxycholoyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-36); Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 34 (N E -(7-deoxycholoyl))-GLP-1 (7-36); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-36)amide; 232 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N E -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-37); Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N E -(choloyl))-GLP-1(7-37); Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Lys 634 -bis(N ε -(choloyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 2634 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Lys 26 (N ε -(choloyl))-GLP-1 (7-38); Lys 34 (N E -(choloyl))-GLP-1 (7-38); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1 (7-38); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Lys 26 (N E -(7-deoxycholoyl))Arg 34 -GLP-1 (7-39); 233 Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Lys 26 (N ε -(choloyl))-GLP-1(7-39); Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Gly 8 Lys 2634 -bis(N ε -(choloyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -{choloyl))-GLP-1 (7-39); Lys 26 (N ε -(choloyl))-GLP-1(7-36); Lys 34 (N E -(choloyl))-GLP-1 (7-36); Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-36); Gly 8 Lys 34 (N E -(choloyl))-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-36); Arg 26 Lys 34 (N E -(choloyl))-GLP-1(7-36); Lys 26 (N ε -(choloyl))-GLP-1(7-36)amide; Lys 34 (N ε -(choloyl))-GLP-1 (7-36)amide; Lys 26 ' 34 -bis(N E -(choloyl))-GLP-1 (7-36)amide; Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-36)amide; Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 28 ' 34 -bis(N E -(choloyl))-GLP-1(7-36)amide; Arg 26 Lys 34 (N E -(choloyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Arg^.Lys 34 (N E -(octanoyl)) GLP-1 (7-37)-OH; Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 6 (N ε -(choloyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1 (7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 34 (N E -(lithocholoyl))-GLP-1(7-37); Lys 26 ' 34 -bis(N E -(lithocholoyl))-GLP-1(7-37); 234 Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-37); Arg 26 Lys 3 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-38); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-38); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-38); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 (N E -(choloyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-39); Arg 263 Lys 36 (N ε -(choloyl))-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 (N E -(lithocholoyl))-GLP-1(7-39); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1 (7-39); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Arg 26 Lys 34 (N E -(lithocholoyl))-GLP-1 (7-37); Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36); 235 Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36); Gly 8 Lys 2634 -bis(N ε -(lithocholoyl))-GLP-1(7-36); Arg 26 Lys 34 (N E -(lithocholoyl))-GLP-1(7-36); Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-36)amide; Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 28 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36)amide; Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-37); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-38); Gly 8 Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Arg 2634 Lys 38 (N ε -(lithocholoyl))-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1 (7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39); and Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-39). 3. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Ala at position 8 with Gly, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that 236 A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six, D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not selected from: Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37), Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Lys 26 ' 34-bis(N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1 (7-39); Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 26 (N E -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 34 (N E -tetradecanoyl)-GLP-1(7-36); Gly 8 Lys 2634 -bis(N ε -tetradecanoyl)-GLP-1 (7-36); Gly 8 Lys 26 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N E -tetradecanoyl)-GLP-1(7-37); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-37); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Lys 6 (N E -tetradecanoyl)Arg 34 -GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N E -tetradecanoyl)-GLP-1(7-38); GlyΑrg^Lys^N'-tetradecanoy -GLP-l (7-39); Gly 8 Lys 26 (N E -tetradecanoyl)Arg 34 -GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Gly 8 Lys 6 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); 237 Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Lys 2634 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36); Gly 8 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis(N E -(ω-carboxynonadecanoyl))-GLP-1 (7-36); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Gly 8 Arg 6 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-39); Gly 8 Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N E -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 2634 -bis(N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1(7-36); 238 Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 2634 -bis(N E -(7-deoxycholoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Gly 8 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(7-deoxycholoyl))-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-37); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 34 (N E -(choloyl))-GLP-1 (7-37); Gly 8 Lys 2634 -bis(N E -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Lys 26 (N E -(7-deoxycholoyl))Arg 34 -GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1 (7-39); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 634 -bis(N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))-GLP-1(7-36); Gly 8 Lys 34 (N ε -(choloyl))-GLP-1 (7-36); Gly 8 Lys 2634 -bis(N E -(choloyl))-GLP-1(7-36); Gly 8 Lys 26 (N E -(choloyl))-GLP-1 (7-36)amide; Gly 8 Lys 34 (N E -(choloyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N E -(choloyl))-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Lys 26 (N E -(lithocholoyl))-GLP-1(7-37); 239 Gly 8 Lys 3 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Lys 26 ' 34-bis(N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1 (7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 34 (N E -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N E -(choloyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-36); Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1(7-36); Gly 8 Lys 26 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Lys 26 ' 34 -bis(N ε -(lithocholoyl))-GLP-1 (7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1 (7-38); Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 6 Lys 34 (N E -(lithocholoyl))-GLP-1(7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-39); and Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-39). 4. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Ser at position 18 with Ala, Gly, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 240 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 5. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Tyr at position 19 with Phe, Trp, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 6. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Leu at position 20 with Ala, Gly, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C- 1 -6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 7. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Glu at position 21 with Asp or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1 -6- dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, 241 B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 8. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Gly at position 22 with Ala, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt the- reof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1 (7-39), is not Glu 2223 ' 30 Arg 26 ' 34 Lys 38 (N E -(γ-glutamyl(N α -tetradecanoyl)))-GLP- 1 (7-38)-OH. 9. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Gin at position 23 with Asn, Arg, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1 (7-39), is not selected from: Glu 2223 ' 30 Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Glu 2326 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, and Arg 18 ' 2326 ' 3034 Lys 38 (N E -hexadecanoyl)-GLP-1(7-38)-OH. 242 10. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Ala at position 24 with Gly, Ser, Thr, Leu, He, Val, Arg, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C- 1 -6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt the- reof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 11. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Ala at position 25 with Gly, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 12. A derivative of an analog of GLP-1(7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1(7-39), comprising the substitution of Lys at position 26 with Arg, Gin, His, Glu, or Asp, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1-6-alkyiamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not selected from: Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37), 243 Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-36)-OH, Arg 634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 36 (N E -(co-carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N E -(ω-carboxyheptadecanoyl))-GLP-1 (7-38)-OH, Arg 26,3 4 |_ ys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 634 Lys 36 (N E -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N E -(ω-carboxyundecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-36)-OH, Arg 26 ' 3 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 26,3 4Lys 36 (N ε -( ω -carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Glu 22 ' 2330 Arg 26 ' 34 Lys 38 (N ε -(γ-giutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 2326 Arg 3 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Arg 26 ' 3 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, Arg 1823 ' 26 ' 30 ' 34 Lys 38 (N ε -hexadecanoyl)-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1 (7-38)-OH, Arg 6 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-37); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-38); Arg^Lys^N etradecanoy -GLP-l (7-39); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36); Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N E -tetradecanoyl)-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -tetradecanoyl)-GLP-1(7-38); 244 Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 ' 3 Lys 36 (N E -tetradecanoyl)-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N E -(Q-carboxynonadecanoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 2W4 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-38); Arg 26 Lys 34 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 Lys 34 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Arg 26 Lys 34 (N E -(7-deoxycholoyl))-GLP-1 (7-37); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1 (7-39); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36); Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1 (7-37); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N E -(7-deoxycholoyl))-GLP-1 (7-38); Arg 26 Lys 34 (N E -(choloyl))-GLP-1 (7-38); Gly 8 Arg 26 Lys 34 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); 245 Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-39); Arg 26 Lys 34 (N ε -(choloyl))-GLP-1(7-36); Arg 26 Lys 3 (N ε -(choloyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N E -(choloyl))-GLP-1 (7-37); Arg 26 ,Lys 34 (N ε -(octanoyl)) GLP-1 (7-37)-OH; Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Arg 26 Lys 34 (N E -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 Lys 34 (N ε -(choloyl))-GLP-1 (7-38); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Arg 28 ' 34 Lys 38 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 28 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N E -(choloyl))-GLP-1 (7-39); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Arg 26 Lys 3 (N ε -(lithocholoyl))-GLP-1 (7-39); Arg 26 Lys 34 (N E -(lithocholoyl))-GLP-1(7-37); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-36); Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-36)amide; Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-37); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Arg 2634 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 Lys 34 (N ε -(lithocholoyl))-GLP-1 (7-39); Arg 2634 Lys 36 (N E -(lithocholoyl))-GLP-1 (7-39); and Gly 8 Arg 26 ' 34 Lys 36 (N E -(lithocholoyl))-GLP-1(7-39). 246 13. A derivative of the preceding claim wherein Lys at position 26 is substituted with Arg. 14. A derivative of an analog of GLP-1(7-36), GLP-1(7-37), GLP-1(7-38), or GLP-1(7-39), comprising the substitution of Glu at position 27 with Asp or Lys, wherein the derivative is opti- onally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1 -6- dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 15. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Ala at position 30 with Gly, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six, D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not Glu 22 ' 2330 Arg 26 ' 34 Lys 38 (N E -(γ-glutamyl(N α -tetradecanoyl)))-GLP- 1(7-38)-OH. 16. A derivative of an analog of GLP-1 (7-36), GLP-1(7-37), GLP-1(7-38), or GLP-1 (7-39), comprising the substitution of Trp at position 31 with Phe, Tyr, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, 247 C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 17. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Leu at position 32 with Gly, Ala, Ser, Thr, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 18. A derivative of an analog of GLP-1(7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1(7-39), comprising the substitution of Val at position 33 with Gly, Ala, Ser, Thr, Leu, He, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkyiamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 19. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Lys at position 34 with Arg, Glu, or Asp, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1 -6- dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six, 248 D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1 (7-39), is not selected from: Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1 (7-37), Gly 8 Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1(7-37), Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-36)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38)-OH, Arg^Lys 26 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-37)-OH, Arg 34 Lys 26 (N E -(ω-carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptadecanoyl))-GLP-1(7-38)-OH, Arg 26,3 4[ _ ys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-38)-OH, Arg 2634 Lys 36 (N E -(ω-carboxyundecanoyl))-GLP-1 (7-36)-OH, Arg^Lys 26 (N E -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg^Lys 26 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1(7-38)-OH, Arg 2634 Lys 36 (N E -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg^Lys 26 (N E -(ω-carboxypentadecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 34 Lys 26 (N ε -lithocholyl)-GLP-1(7-37)-OH, Glu 2223 ' 30 Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Glu 23 ' 26 Arg 34 Lys 38 (N ε -(γ-glutamyl(N°-tetradecanoyl)))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N E -(ω-carboxypentadecanoyl))-GLP-1(7-38)-OH, Arg 34 Lys 26 (N E -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1(7-38)-OH, Arg 2634 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1(7-38)-OH, Arg 18 ' 23 ' 26 ' 3 34 Lys 38 (N ε -hexadecanoyl)-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, Arg 34 Lys 26 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-37)-OH, Arg 26 ' 3 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1 (7-38)-OH, 249 Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-38); Arg 26 ' 34 Lys 38 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -tetradecanoyl)Arg 34 -GLP-1(7-39); Arg 2634 Lys 36 (N E -tetradecanoyl)-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N E -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-38); Arg 2634 Lys 3δ (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(ω-carboxynonadecanoyl))Arg 34 -GLP-1 (7-39); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-38); Gly 8 Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-38); Arg 2634 Lys 36 (N E -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Lys 26 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1 (7-39); Gly 8 Lys 6 (N ε -(7-deoxycholoyl))Arg 34 -GLP-1(7-39); Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Arg 2634 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); 250 Lys 26 (N E -(choloyl))Arg 34 -GLP-1(7-37); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-37); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(choloyl))-GLP-1(7-37); Lys 26 (N ε -(choloyl))Arg 3 -GLP-1 (7-38); Gly 8 Lys 26 (N E -(choloyl))Arg 34 -GLP-1 (7-38); Arg 634 Lys 36 (N ε -(choloyl))-GLP-1 (7-38); Arg 26 ' 34 Lys 38 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N E -(choloyl))-GLP-1(7-38); Lys 26 (N E -(choloyl))Arg 34 -GLP-1 (7-39); Gly 8 Lys 26 (N ε -(choloyl))Arg 34 -GLP-1(7-39); Arg 26 ' 3 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1 (7-39); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-37); Gly 8 Lys 26 (N E -(lithocholoyl))Arg 34 -GLP-1 (7-37); Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-37); Arg 2634 Lys 38 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(lithocholoyl))-GLP-1(7-37); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-38); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1(7-39); Gly 8 Lys 26 (N ε -(lithocholoyl))Arg 34 -GLP-1 (7-39); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39); and Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39). 20. A derivative of the preceding claim wherein Lys at position 34 is substituted with Arg. 21. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Gly at position 35 with Ala, Ser, Thr, Leu, He, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 251 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 22. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Arg at position 36 with His, Lys, Glu, or Asp, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1 -6- dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. D. the derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not selected from: Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37), Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-36)-OH, Arg 26,3 4 |_ ys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-37)-OH, Arg 26,3 4 |_ ys 36 (N ε -( ω -carboxyheptadecanoyl))-GLP-1 (7-36)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-37)-OH, Arg 2634 Lys 36 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-36)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-37)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 26 ' 34 Lys 36 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-36)-OH, Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1 (7-37); Gly 8 Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-37); Arg 26 ' 34 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-38); Arg 26 ' 34 Lys 36 (N E -tetradecanoyl)-GLP-1 (7-39); 252 Gly 8 Arg 2634 Lys 36 (N ε -tetradecanoyl)-GLP-1(7-39); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1(7-37); Arg 2634 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-38); Gly 8 Arg 26 ' 34 Lys 36 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(ω-carboxynonadecanoyl))-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-37); Gly 8 Arg 26 ' 34 Lys 36 (N E -(7-deoxycholoyl))-GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N E -(7-deoxycholoyl))-GLP-1 (7-38); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(7-deoxycholoyl))-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-37); Gly 8 Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Gly 8 Arg 634 Lys 36 (N ε -(choloyl))-GLP-1(7-38); Arg 2634 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Gly 8 Arg 26 ' 34 Lys 36 (N ε -(choloyl))-GLP-1(7-39); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-37); Gly 8 Arg 26 ' 3 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-37); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Gly 8 Arg 26 - 34 Lys 36 (N ε -(lithocholoyl))-GLP-1(7-38); Arg 26 ' 34 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39); and Gly 8 Arg 2634 Lys 36 (N ε -(lithocholoyl))-GLP-1 (7-39). 23. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Gly at position 37 with Ala, Ser, Thr, Leu, lie, Val, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1- 6-alkylamide, or C-1-6-dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, 253 C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six. 24. A derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP-1 (7-39), comprising the substitution of Arg at position 38 with His, Glu, Asp, or Lys, wherein the derivative is optionally in the form of (a) a C-1-6-ester thereof, (b) amide, C-1 -6-alkylamide, or C-1 -6- dialkylamide thereof and/or (c) a pharmaceutically acceptable salt thereof, provided that A. the derivative of the GLP-1 analog contains only one or two Lys, B. the ε-amino group of one or both Lys is substituted with a lipophilic substituent optionally via a spacer, C. the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 does not exceed six, D. the Derivative of an analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), or GLP- 1(7-39), is not selected from: Arg 2634 Lys 38 (N ε -(ω-carboxynonadecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N E -(ω-carboxyheptadecanoyl))-GLP-1(7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyundecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(ω-carboxyheptanoyl))-GLP-1 (7-38)-OH, Glu 22 ' 23 ' 30 Arg 263 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Glu 23 ' 26 Arg 34 Lys 38 (N ε -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N E -(γ-glutamyl(N α -tetradecanoyl)))-GLP-1(7-38)-OH, Arg 2634 Lys 38 (N E -(ω-carboxypentadecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -hexadecanoyl)))-GLP-1 (7-38)-OH, Arg 8 ' 23 ' 2630 ' 34 Lys 38 (N ε -hexadecanoyl)-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 8 (N ε -(ω-carboxytridecanoyl))-GLP-1 (7-38)-OH, Arg 26 ' 34 Lys 38 (N ε -(γ-glutamyl(N α -octadecanoyl)))-GLP-1 (7-38)-OH, Arg 2634 Lys 38 (N ε -tetradecanoyl)-GLP-1 (7-38); Arg 2634 Lys 38 (N E -(ω-carboxynonadecanoyl))-GLP-1 (7-38); Arg 26 ' 34 Lys 38 (N ε -(7-deoxycholoyl))-GLP-1 (7-38); Arg 6 ' 34 Lys 38 (N ε -(choloyl))-GLP-1(7-38); Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1 (7-37); and Arg 26 ' 34 Lys 38 (N ε -(lithocholoyl))-GLP-1(7-38). 254 25. The derivative of the analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), OR GLP-1 (7- 39) of any of claims 3-24, further comprising the substitution of Lys at position 26 with Arg. 26. The derivative of the analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), OR GLP-1 (7- 39) of any of claims 3-24, further comprising the substitution of Lys at position 34 with Arg. 27. The derivative of the analog of GLP-1 (7-36), GLP-1 (7-37), GLP-1 (7-38), OR GLP-1 (7- 39) of any of claims 3-24, further comprising the substitution of Lys at positions 26 and 34 with Arg. 28. The derivative of GLP-1 analog of any of claims 1-27, wherein only one Lys is present. 29. The derivative of GLP-1 analog of claim 28, wherein Lys is at the carboxy-terminus. 30. The derivative of GLP-1 analog of any of claims 1-29, wherein Glu or Asp is adjacent to Lys. 31. The derivative of GLP-1 analog of any of claims 1-30, wherein the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 is five. 32. The derivative of GLP-1 analog of any of claims 1-30, wherein the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 is four. 33. The derivative of GLP-1 analog of any of claims 1-30, wherein the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 is three. 34. The derivative of GLP-1 analog of any of claims 1-30, wherein the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 is two. 35. The derivative of GLP-1 analog of any of claims 1-30, wherein the total number of different amino acids between the derivative of the GLP-1 analog and the corresponding native form of GLP-1 is one. 255 36. The derivative of GLP-1 analog of claim 1 or any of claims 28-35, wherein the amino acids at positions 37-45 are absent. 37. The derivative of GLP-1 analog of claim 1 or any of claims 28-35, wherein the amino acids at positions 38-45 are absent. 38. The derivative of GLP-1 analog of claim 1 or any of claims 28-35, wherein the amino acids at positions 39-45 are absent. 39. The derivative of GLP-1 analog of claim 1 or any of claims 28-38, wherein Xaa at position 8 is Ala, Gly, Ser, Thr, or Val. 40. The derivative of GLP-1 analog of claim 1 or any of claims 28-39, wherein Xaa at po- sition 9 is Glu. 41. The derivative of GLP-1 analog of claim 1 or any of claims 28-40, wherein Xaa at position 11 is Thr. 42. The derivative of GLP-1 analog of claim 1 or any of claims 28-41 , wherein Xaa at position 14 is Ser. 43. The derivative of GLP-1 analog of claim 1 or any of claims 28-42, wherein Xaa at position 16 is Val. 44. The derivative of GLP-1 analog of claim 1 or any of claims 28-43, wherein Xaa at position 17 is Ser. 45. The derivative of GLP-1 analog of claim 1 or any of claims 28-44, wherein Xaa at po- sition 18 is Ser, Lys, Glu, or Asp. 46. The derivative of GLP-1 analog of claim 1 or any of claims 28-45, wherein Xaa at position 19 is Tyr, Lys, Glu, or Asp. 47. The derivative of GLP-1 analog of claim 1 or any of claims 28-46, wherein Xaa at position 20 is Leu,, Lys, Glu, or Asp. 48. The derivative of GLP-1 analog of claim 1 or any of claims 28-47, wherein Xaa at position 21 is Glu, Lys, or Asp. 256 49. The derivative of GLP-1 analog of claim 1 or any of claims 28-48, wherein Xaa at position 22 is Gly, Glu, Asp, or Lys. 50. The derivative of GLP-1 analog of claim 1 or any of claims 28-49, wherein Xaa at position 23 is Gin, Glu, Asp, or Lys. 51. The derivative of GLP-1 analog of claim 1 or any of claims 28-50, wherein Xaa at position 24 is Ala, Glu, Asp, or Lys. 52. The derivative of GLP-1 analog of claim 1 or any of claims 28-51 , wherein Xaa at position 25 is Ala, Glu, Asp, or Lys. 53. The derivative of GLP-1 analog of claim 1 or any of claims 28-52, wherein Xaa at po- sition 26 is Lys, Glu, Asp, or Arg. 54. The derivative of GLP-1 analog of claim 1 or any of claims 28-53, wherein Xaa at position 27 is Glu, Asp, or Lys. 55. The derivative of GLP-1 analog of claim 1 or any of claims 28-54, wherein Xaa at position 30 is Ala, Glu, Asp, or Lys. 56. The derivative of GLP-1 analog of claim 1 or any of claims 28-55, wherein Xaa at position 31 is Trp, Glu, Asp, or Lys. 57. The derivative of GLP-1 analog of claim 1 or any of claims 28-56, wherein Xaa at position 32 is Leu, Glu, Asp, or Lys. 58. The derivative of GLP-1 analog of claim 1 or any of claims 28-57, wherein Xaa at po- sition 33 is Val, Glu, Asp, or Lys. 59. The derivative of GLP-1 analog of claim 1 or any of claims 28-58, wherein Xaa at position 34 is Lys, Arg, Glu, or Asp. 60. The derivative of GLP-1 analog of claim 1 or any of claims 28-59, wherein Xaa at position 35 is Gly, Glu, Asp, or Lys. 61. The derivative of GLP-1 analog of claim 1 or any of claims 28-60, wherein Xaa at position 36 is Arg, Lys, Glu, or Asp. 257 62. The derivative of GLP-1 analog of claim 1 or any of claims 28-61 , wherein Xaa at position 37 is Gly, Glu, Asp, or Lys. 63. The derivative of GLP-1 analog of claim 1 or any of claims 28-62, wherein Xaa at position 38 is Arg or Lys. 64. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 26 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-36). 65. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 26 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-37). 66. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 26 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-38). 67. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 34 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-36). 68. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 34 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-37). 69. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 34 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP- 1(7-38). 70. The derivative of GLP-1 analog of claim 1 , wherein Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-36). 71. The derivative of GLP-1 analog of claim 1 , wherein Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-37). 258 72. The derivative of GLP-1 analog of claim 1 , wherein Xaa at positions 26 and 34 is Arg, Xaa at position 36 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). 73. The derivative of GLP-1 analog of claim 1 , wherein Xaa at positions 26 and 34 is Arg, Xaa at position 38 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). 74. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 36 is Lys, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-37). 75. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 36 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). 76. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 8 is Thr, Ser, Gly or Val, Xaa at position 37 is Glu, Xaa at position 38 is Lys, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-38). 77. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 18, 23 or 27 is Lys, and Xaa at positions 26 and 34 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-36). 78. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 18, 23 or 27 is Lys, and Xaa at positions 26 and 34 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1 (7-37). 79. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 18, 23 or 27 is Lys, and Xaa at positions 26 and 34 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). 80. The derivative of GLP-1 analog of claim 1, wherein Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 37-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-36). 259 81. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 38-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-37). 82. The derivative of GLP-1 analog of claim 1 , wherein Xaa at position 8 is Thr, Ser, Gly, or Val, Xaa at position 18, 23 or 27 is Lys, and Xaa at position 26 and 34 is Arg, each of Xaa at positions 39-45 is deleted, and each of the other Xaa is the amino acid in native GLP-1(7-38). 83. The derivative of GLP-1 analog of any of claims 1-82, wherein the lipophilic substituent is attached to the N-terminal amino acid residue. 84. The derivative of GLP-1 analog of any of claims 1-82, wherein the lipophilic substituent is attached to the C-terminal amino acid residue. 85. The derivative of GLP-1 analog of any of claims 1-82, wherein the lipophilic substitu- ent is attached to an amino acid residue which is not the N-terminal or C-terminal amino acid residue. 86. The derivative of GLP-1 analog of any one of the preceding claims, wherein the lipophilic substituent comprises from 4 to 40 carbon atoms, more preferred from 8 to 25 carbon atoms. 87. The derivative of GLP-1 analog of any one of the preceding claims, wherein a lipophilic substituent is attached to an amino acid residue in such a way that a carboxyl group of the lipophilic substituent forms an amide bond with the ε-amino group of Lys. 88. The derivative of GLP-1 analog of any one of the preceding claims, wherein the lipophilic substituent is attached to the parent peptide by means of a spacer. 89. The derivative of GLP-1 analog of claim 88, wherein the spacer is an unbranched al- kane α,ω-dicarboxylic acid group having from 1 to 7 methylene groups, preferably two methylene groups, which form a bridge between an amino group of the parent peptide and an amino group of the lipophilic substituent. 260 90. The derivative of GLP-1 analog of claim 88, wherein the spacer is an amino acid residue except Cys, or a dipeptide such as Gly-Lys. 91. The derivative of GLP-1 analog of claim 90, wherein the ε-amino group of Lys forms an amide bond with a carboxylic group of the amino acid residue or dipeptide spacer, and an amino group of the amino acid residue or dipeptide spacer forms an amide bond with a carboxyl group of the lipophilic substituent. 92. The derivative of GLP-1 analog of any one of the preceding claims, wherein the lipop- hilic substituent comprises a partially or completely hydrogenated cyclopentanophenathrene skeleton. 93. The derivative of GLP-1 analog of any of the claims 1-86, wherein the lipophilic substituent is an straight-chain or branched alkyl group. 94. The derivative of GLP-1 analog of any of the claims 1-86 wherein the lipophilic substituent is the acyl group of a straight-chain or branched fatty acid. 95. The derivative GLP-1 analog of claim 94 wherein the acyl group is selected from the group comprising CH 3 (CH 2 ) n CO-, wherein n is 4 to 38, preferably CH 3 (CH 2 ) 6 CO-, CH 3 (CH 2 ) 8 CO-, CH 3 (CH 2 ) 10 CO-, CH 3 (CH 2 ) 12 CO-, CH 3 (CH 2 ) 14 CO-, CH 3 (CH 2 ) 16 CO-, CH 3 (CH 2 ) 18 CO-, CH 3 (CH 2 ) 20 CO- and CH 3 (CH 2 ) 22 CO-. 96. The derivative of GLP-1 analog of any one of the claims 1-86 wherein the lipophilic substituent is an acyl group of a straight-chain or branched alkane α,ω-dicarboxylic acid. 97. The derivative of GLP-1 analog of claim 96 wherein the acyl group is selected from the group comprising HOOC(CH 2 ) m CO-, wherein m is from 4 to 38, preferably from 4 to 24, more preferred selected from the group comprising HOOC(CH 2 ) 14 CO-, HOOC(CH 2 ) 16 CO-, HOOC(CH 2 ) 18 CO-, HOOC(CH 2 ) 20 CO- and HOOC(CH 2 ) 22 CO-. 98. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula CH 3 (CH 2 ) p ((CH 2 ) q COOH)CHNH-CO(CH 2 ) 2 CO-, wherein p and q are integers and p+q is an integer of from 8 to 33, preferably from 12 to 28. 261 99. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula CH 3 (CH 2 ) r CO-NHCH(COOH)(CH 2 ) 2 CO-, wherein r is an integer of from 10 to 24. 100. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula CH 3 (CH 2 ) s CO-NHCH((CH 2 ) 2 COOH)CO-, wherein s is an integer of from 8 to 24. 101. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH-CO(CH 2 ) u CH 3 , wherein u is an integer of from 8 to 18. 102. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH-COCH((CH 2 ) 2 COOH)NH- CO(CH 2 ) w CH 3 , wherein w is an integer of from 10 to 16. 103. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH-CO(CH 2 ) 2 CH(COOH)NH- CO(CH 2 ) x CH 3 , wherein x is an integer of from 10 to 16. 104. The derivative of GLP-1 analog of any one of the claims 1-86, wherein the lipophilic substituent is a group of the formula -NHCH(COOH)(CH 2 ) 4 NH-CO(CH 2 ) 2 CH(COOH)NH- CO(CH 2 ) y CH 3 , wherein y is zero or an integer of from 1 to 22. 105. A pharmaceutical composition comprising a derivative of GLP-1 analog of any of claims 1-104 and a pharmaceutically acceptable vehicle or carrier. 106. The pharmaceutical composition of claim 105, further comprising another antidiabetic agent. 107. The pharmaceutical composition of claim 106, wherein the antidiabetic agent is an insulin, more preferably human insulin. 262 108. The pharmaceutical composition of claim 106, wherein the antidiabetic agent is a hy- poglaemic agent. 109. Use of a derivative of GLP-1 analog of any of claims 1-104 for the preparation of a medicament which has a protracted profile of action relative to GLP-1 (7-37). 110. Use of a derivative of GLP-1 analog of any of claims 1-104 for the preparation of a medicament with a protracted profile of action for the treatment of non-insulin dependent diabetes mellitus. 111. Use of a derivative of GLP-1 analog of any of claims 1-104 for the preparation of a medicament with a protracted profile of action for the treatment of insulin dependent diabetes mellitus. 112. Use of a derivative of GLP-1 analog of any of claims 1-104 for the preparation of a medicament with a protracted profile of action for the treatment of obesity. 113. A method of treating insulin dependent or non-insulin dependent diabetes mellitus in a patient in need of such a treatment, comprising administering to the patient a therapeutically effective amount of a derivative of GLP-1 analog of any of claims 1-104 together with a pharmaceutically acceptable carrier. 114. A method of treating obesity in a patient in need of such a treatment, comprising administering to the patient a therapeutically effective amount of the derivative of GLP-1 analog of any of claims 1 -104. NOVO NORDISK A/S

Inventors: HUUSFELDT PER OLAF, KNUDSEN LISELOTTE BJERRE, NIELSEN PER FRANKLIN, PEDERSEN FREDDY ZIMMERDAHL, HUUSFELDT, PER, OLAF, KNUDSEN, LISELOTTE, BJERRE, NIELSEN, PER, FRANKLIN, PEDERSEN, FREDDY, ZIMMERDAHL
Applicants: NOVONORDISK AS, NOVO NORDISK A/S
Application year: 1999
Main classification: C07K14
IPC codes: A61K38, A61P3, A61P5, C07K14